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Summary
The host range of a retrovirus depends largely upon the properties of the envelope 
glycoprotein, Env (Hunter, 1997). As a result this host range can be changed by replacing 
the envelope protein with that from another virus. The pseudotypes formed in this process 
possess the host range and fusion properties of the virus donating the envelope protein 
(Zavada, 1982). As retroviruses integrate into the genome of the infected host cell they 
have proved useful for the development of vectors for gene delivery (Miller, 1997). The 
host ranges of these vectors are restricted to cells that express the specific receptor 
recognised by the particular envelope protein. Several pseudotyped vectors have therefore 
been developed in order to increase host range or to target the vectors to specific cell types 
(Burns et al., 1993; Emi et al., 1991; Hatziioannou et al., 1998; Miller et a l, 1991; Spiegel 
et a l,  1998). The production of retroviral vectors pseudotyped with the envelope 
glycoprotein of the rhabdovirus vesicular stomatitis virus (VSV) was a significant advance 
in this field (Bums et a l, 1993; Emi et al., 1991). Not only did these vectors display the 
wide host range of VSV, but they were also very stable, allowing concentration to high 
titres. Unfortunately the VSV envelope protein causes cell fusion when expressed at high 
levels, making continual production of these vectors very difficult. In this study an attempt 
was made to produce similar vectors pseudotyped with the envelope glycoprotein of 
another rhabdovirus, rabies vims. These vectors displayed the host range properties of 
rabies, but they were produced at very low titres. The glycoprotein was capable of inducing 
cell fusion at low pH, indicating that it was functional. Therefore the low titres suggest that 
the rabies envelope protein was not incorporated efficiently into the retroviral vectors. 
Although these pseudotyped vectors did not prove to be useful as gene delivery vectors, the 
observations described here may provide interesting information on the processes of virion 
assembly and envelope incorporation.
The second part of this study involved investigations into the infectivity of the porcine 
endogenous retroviruses. Concern has been raised recently over the potential infectivity of 
these viruses following proposals to use porcine organs and tissues in human transplants. 
Endogenous retroviruses are integrated^t^oT'thfe host germ line (Boeke and Stoye, 1997) 
and would therefore be present in all transplanted cells. Initial cocultivation experiments 
indicated that these viruses could infect human cells. No obvious interference was
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observed with other mammalian C-type retroviruses, indicating that the porcine viruses 
recognise a novel receptor. Subsequent sequence analysis has revealed that at least three 
viral subgroups exist in the porcine genome. The determination of the env sequence of one 
of these viruses is reported here. The encoded protein has a very similar structure to the 
Env proteins of other mammalian C-type retroviruses, but shows significant differences in 
the predicted receptor binding regions. The porcine virus subgroups also differ from one 
another within these regions, suggesting that these viruses recognise different receptors, 
and may therefore have different host ranges.
Another potential application of the ability of retroviral vectors to incorporate foreign 
envelope proteins is in studies of the infectivity and host range of new viruses (Rong et al., 
1997; Wool-Lewis and Bates, 1998). In order to characterise these properties of the porcine 
endogenous retroviruses, pseudotyped vectors were produced, bearing the Env proteins of 
the three subgroups. Infected cells were then simply identified from the expression of a 
marker gene inserted in the vector genome. Analysis of the vectors revealed that at least 
two of the subgroups can infect human cells, and could therefore present a risk of infection 
to transplant recipients. Consequently it is important that further studies of these viruses 
are carried out in order to assess their tissue tropism and potential pathogenicity. These 
pseudotyped vectors should also be useful for such investigations of Env function and 
receptor usage of the porcine endogenous retroviruses.
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CHAPTER 1
Chapter 1 General Introduction
1.1 Retroviruses
The retroviruses are a large family of enveloped RNA viruses, approximately 80-100nm in 
diameter. Their genome normally consists of two identical single-stranded RNA molecules 
7-12 kb in length, enclosed within a protein core. The outer lipid envelope contains the 
viral glycoproteins that are involved in receptor recognition and cell infection. These 
viruses are associated with a variety of disorders including malignancies, anaemia, 
osteopetrosis, neurological disease and immunodeficiencies, as well as lifelong viraemia 
without obvious illness (Coffin, 1990; Rosenberg and Jolicoeur, 1997).
1.1.1 History
Retroviruses were first discovered in association with neoplastic diseases in chickens 
(Ellermann and Bang, 1908; Rous, 1911). These were originally thought to be restricted to 
birds and it was not until several years later that similar tumour causing viruses were 
recognised in mammals (reviewed by Levy, 1986; Vogt, P.K., 1997). In 1936, Bittner 
described a filterable ‘active milk-influence’ that could transmit mammary carcinoma in 
mice (Bittner, 1936; Bittner, 1942). This ‘influence’ was later shown to be a retrovirus, 
now known as mouse mammary tumour virus (MMTV). The first mammalian leukaemia 
virus, Gross murine leukaemia virus, was reported in 1951 (Gross, 1951). Following this 
discovery an enthusiastic search for virally induced tumours in mammals began. This 
resulted in the identification of a variety of viruses in mice, cats, cows, hamsters, rats and 
monkeys (reviewed by Levy, 1986; Vogt, P.K., 1997). Retroviruses have now been 
described in birds, mammals, amphibians, reptiles and fish (Hemiou et al., 1998). They 
may also be present in invertebrates such as molluscs (Oprandy and Chang, 1983) and 
insects (Finnegan, 1994; Hajek and Freisen, 1998; Kim et a l, 1994; Song et a l, 1994).
An early problem facing researchers in this field was the mechanism of retroviral 
replication. Other single-stranded RNA viruses had been shown to replicate via RNA- 
dependent RNA synthesis, creating double stranded replicative forms. However, no similar 
intermediate forms could be found in retrovirus-infected cells (reviewed by Vogt, P.K.,
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1997). In 1964, Temin put forward the provirus hypothesis (Temin, 1964b), which 
suggested that a DNA copy of the viral genome is synthesised, and then integrated into the 
host cell genome. This hypothesis was based on the observations that infection could be 
prevented by inhibitors of DNA synthesis and that viral RNA appeared to have homology 
with DNA from infected but not uninfected cells (Bader, 1965; Duesberg and Vogt, 1969; 
Temin, 1964a). Integration of genetic information would also help to explain how 
retroviruses can stably transform cells. The proposal went against the established ‘central 
dogma’ of one-way transfer of information from DNA to RNA to protein and, therefore, it 
was generally disregarded. It was not until the revolutionary discovery of a viral RNA- 
dependent DNA polymerase (Baltimore, 1970; Temin and Mizutani, 1970) that proof was 
finally obtained, and Temin’s hypothesis accepted. It is now known that this type of DNA 
polymerase, reverse transcriptase (RT), is not restricted to retroviruses, but is present in a 
variety of viral and nonviral genetic elements (reviewed by Vogt, P.K., 1997).
1.1.2 Classification
Retroviruses are broadly divided into two main groups depending on their genomic 
organisation. The simple viruses possess only the major coding regions: gag, encoding 
structural proteins; pro, the viral protease; pol, the viral enzymes including reverse 
transcriptase; and env, the envelope glycoproteins. Complex viruses also carry additional 
genes encoding regulatory proteins (reviewed by Vogt, P.K., 1997). Traditionally, 
retroviruses have subsequently been divided into three subgroups based on pathogenicity. 
These groups are oncovirinae, lentivirinae and spumavirinae. The oncovirinae consist of 
the viruses originally discovered in association with tumours, and other closely related 
viruses. They are present in all classes of vertebrates. The lentivirinae are also found in 
many species. They are associated with diseases that have a long incubation period, and 
often act by killing or causing loss of function in certain cell types. Relatively little is 
known about the spumavirinae, which have not, as yet, been associated with any disease 
(reviewed by Coffin, 1990; Levy, 1986).
The use of evolutionary relationships and morphology has resulted in a further division of 
these groups into seven genera, described in Table 1.1 (reviewed by Coffin, 1990; Vogt, 
P.K., 1997). These genera are based mainly on the sequence relatedness of the RT enzyme.
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In general, viruses in the same genus show identity at more than two thirds of the amino 
acid residues within the most conserved region of this enzyme. Little genomic sequence 
similarity is observed between genera, even amino acid identity is low except in the RT 
(reviewed by Vogt, V.M., 1997). A new nomenclature for retroviral classification has 
recently been proposed that encompasses novel viruses such as those found in fish 
(D.Onions, pers. com.). However, in order to avoid confusion, the system described in 
Table 1.1 will be used throughout this thesis.
Several different virion morphologies have been identified by thin section electron 
microscopy. A-type particles were first described as the immature, cytoplasmic precursors 
to B- and D-type particles. They now also include the endogenous intracistemal type-A 
particles (LAPs) found budding into and within the endoplasmic reticulum of several cell 
lines derived from rodents. Since these have budded through a membrane they are 
enveloped, unlike the cytoplasmic particles. A-type particles have an electron-lucent centre 
surrounded by one or two concentric electron-dense rings, giving a hollow, double-walled 
appearance. Newly budded B-type particles resemble A-type, but quickly mature into 
particles with an acentric round core and prominent envelope proteins. C-type particles 
include the majority of the avian and mammalian oncovirinae. Just after budding, these 
particles have a hollow core. This matures into a central, electron-dense, round or slightly 
angular structure. The lentiviruses resemble C-type particles while budding but the core 
then matures into a cone-shape. D-type particles have an acentric bar-shaped core. B- and 
D-type viruses and the spumaviruses differ from the majority of retroviruses in that they do 
not assemble at the plasma membrane. The cores of these viruses assemble within the 
cytoplasm, and are then transported to the plasma membrane for envelopment and release. 
The assembly and budding of most retroviruses appear to occur simultaneously (reviewed 
by Coffin, 1990; Vogt, V.M., 1997).
1.1.3 Viral structure
Retroviruses carry their genome as RNA but replicate via a DNA intermediate, the 
provirus. The viral genes encoded by the provirus, gag, pro, pol and env, are flanked by the 
long terminal repeats (LTRs). These are identical sequences formed during reverse 
transcription and composed of three regions, U3, R and U5. U3 is obtained from a unique
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sequence found at the 3’ end of the genomic RNA, U5 from a unique sequence found at the 
5’ end, and R from a sequence repeated at both ends. The lengths of these three regions 
vary significantly between different retroviruses. The majority of the transcriptional control 
elements of the provirus are found within U3. These include the promoter and several 
enhancer sequences. The particular enhancer sequences present are important determinants 
of the tissue specificity of viral replication (reviewed by Vogt, V.M., 1997).
The structural proteins of retroviruses are encoded by the gag gene. These are the matrix 
(MA), capsid (CA) and nucleocapsid (NC) proteins. The MA protein is believed to line the 
lipid membrane. MA from avian sarcoma leukosis virus (ASLV) and murine leukaemia 
virus (MLV) can be chemically crosslinked to the phospholipid phosphatidylethanolamine 
(Pepinsky and Vogt, 1979). The protein is myristylated in the majority of retroviruses. This 
involves the cotranslational addition of a 14-carbon fatty acid, and is a modification 
common to many cellular proteins associated with membranes. MA is thought to be 
involved in the budding process of the virus, and may also direct incorporation of the 
envelope proteins. CA is the largest of the Gag proteins. It is thought to form a shell 
between the MA and the nucleoprotein core, although its function is unknown at present. 
The NC protein is a small basic protein bound to the genomic RNA within the core of the 
virion. It promotes binding of the primer tRNA and stabilisation of the dimeric genomic 
RNA. The core of the virion also contains the viral enzymes RT and integrase (IN), 
encoded by the pol gene. These enzymes control the reverse transcription and integration 
processes necessary for viral replication. The position of the protease (PR) within the 
virion is not yet known. It is required for the cleavage of the Gag and Pol proteins after 
budding of the virion from the cell (reviewed by Vogt, V.M., 1997).
The viral lipid membrane contains the envelope spike glycoproteins encoded by env. The 
spikes contain two proteins held together by noncovalent interactions, and occasionally by 
disulphide bonds. These are the surface glycoprotein (SU) and the transmembrane protein 
(TM). The Env proteins are a major determinant of the host range of the virus as they 
recognise and interact with a specific cellular receptor. SU contains the receptor binding 
domains while TM contains the fusion peptide and is required for the process of membrane 
fusion (reviewed by Hunter, 1997; Vogt, V.M., 1997).
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Fig. 1.1 Schematic representation of a cross-section through a retroviral virion, and a mammalian C-type 
provirus. SU, surface envelope glycoprotein; TM, transmembrane envelope protein; MA, matrix protein; CA, 
capsid protein; NC, nucleocapsid protein; PR, viral protease; RT, reverse transcriptase; IN, integrase.
1.1.4 Life cycle
The retroviral life cycle is illustrated in Fig. 1.2. The first step in this cycle is attachment to 
the cell surface. This is accomplished through the recognition and binding of a specific 
receptor molecule by the Env protein. This binding results in conformational changes in 
Env, permitting membrane fusion and viral penetration of the cell to proceed. The majority 
of retroviruses do not require exposure to low pH for cell entry, and are expected to fuse 
directly with the plasma membrane, as observed for the paramyxoviruses (Hunter, 1997). 
However, infection of most cell lines by ecotropic MLV can be prevented by raising 
endosomal pH (Andersen and Nexo, 1983; McClure et a l, 1990). This suggests that, like 
influenza virus, this retrovirus may enter these cells via receptor mediated endocytosis. It 
has been suggested that other retroviruses may also make use of the endocytic pathway 
even though they do not require low pH for membrane fusion (Marsh and Pelchen- 
Matthews, 1994).
Following entry of the viral particle into the cytoplasm, reverse transcription takes place. 
This occurs in a ribonucleoprotein complex containing the diploid RNA genome, RT and 
other viral proteins. RT possesses two enzymatic activities, DNA polymerase and 
ribonuclease H (RNase H), both of which are required for the reverse transcription process. 
The current model for this process is illustrated in Fig. 1.2. Initially, the virus-specific 
primer tRNA binds to the primer binding site and minus-strand DNA synthesis progresses 
until the 5’ end of the RNA genome is reached. This DNA intermediate is known as the 
minus-strand strong stop DNA (-sssDNA). The RNA strand of the RNA:-sssDNA duplex 
is then degraded by the RNase H, and the -sssDNA transfers to the 3’ end of the genomic 
RNA, annealing to the identical R sequence. It is not yet certain whether this first strand 
transfer involves the use of the same or a switch to the second copy of the genomic RNA. 
Panganiban and Fiore (1988) found that the transfer was intermolecular while Jones et al. 
(1994) found that it was intramolecular. A combination of both forms of transfer has also 
been observed (Hu and Temin, 1990). Minus-strand DNA synthesis then continues, 
accompanied by RNase H digestion of the RNA template. Within this template there is a 
short polypurine tract (PPT) which is resistant to RNase H digestion. This sequence acts as 
a primer for plus-strand DNA synthesis. This synthesis proceeds until a portion of the 
primer tRNA is reverse-transcribed, producing another DNA intermediate termed the plus-
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strand strong-stop DNA (+sssDNA). The termination point for the +sssDNA is a 
methylated adenine residue within the tRNA. Following digestion of the tRNA, sequences 
in the +sssDNA anneal to complementary sequences in the 3’ end of the minus-strand 
DNA. This transfer is believed to be intramolecular (Hu and Temin, 1990; Jones et al, 
1994; Panganiban and Fiore, 1988). Synthesis of both DNA strands is then completed with 
each strand acting as a template for the other (Luciw and Leung, 1993; Telesnitsky and 
Goff, 1997).
The next step in the retroviral life cycle is integration of the viral DNA into the host cell 
genome. The ends of this DNA molecule consist of short inverted repeats that function as 
the attachment site. The terminal four nucleotides of these sequences are highly conserved 
between retroviruses (Varmus and Brown, 1989). The viral enzyme IN cleaves 2 or 3 bases 
from each of the 3’ termini, generating recessed free 3’ hydroxyl (-OH) groups. Either just 
before or after this cleavage the nucleoprotein complex enters the host cell nucleus. Most 
retroviruses enter the nucleus during mitosis, which probably explains their requirement for 
an actively dividing host cell. In contrast, HIV can also enter the nucleus during interphase 
by active transport through nuclear pores (Bukrinsky et al., 1992). Following binding of the 
IN:viral DNA complex to the host DNA, the IN catalyses a reaction between the 3’ -OH 
groups at the ends of the viral DNA and the phosphodiester bonds on opposite strands of 
the host DNA. These bonds are separated by four to six bases, and are positioned on either 
side of a major groove in the helix. The energy released from the broken bonds is used to 
form fresh bonds between the cellular DNA and viral 3’ends. DNA synthesis is then 
carried out to fill the gaps at the junctions and replace the mismatched viral 5’ ends. 
Integration is essential for the replication of retroviruses. It is required for efficient 
transcription of the viral genome and of mRNAs. Also, once the virus is integrated it is 
replicated with the host DNA and transmitted to progeny cells (Temin, 1976). The sites of 
retroviral integration appear to be fairly non-specific. As a result the process is often 
mutagenic due to insertions within host genes or in areas that affect transcriptional control 
(Brown, 1997; Luciw and Leung, 1993).
Transcription is carried out by the host cell RNA polymerase II (Sawadogo and Sentenac, 
1990; Young, 1991) and also depends on a variety of host cell transcription factors 
(Johnson and McKnight, 1989; Mitchell and Tjian, 1989). These include both constitutive
and tissue-specific factors, and are specific to the particular retrovirus. While the simple 
retroviruses rely entirely on these cellular factors (Majors, 1990), the complex retroviruses 
also encode transactivators involved in the control of transcription and RNA processing 
(Green and Chen, 1990; Haseltine, 1991). The particular transcription factors employed by 
a virus can affect tissue tropism and may also have a role in pathogenesis (Luciw and 
Leung, 1993; Rabson and Graves, 1997). The primary transcripts from the pro virus 
resemble cellular mRNA. They are capped at the 5’ end, polyadenylated at the 3’ end, and 
methylated at several internal sites. These transcripts can be divided into two groups, one 
unspliced and one spliced. The unspliced group consists of genomic RNA and mRNA for 
gag, pro and pol. The spliced group forms the mRNA for env. The splicing process 
removes the gag, pro and pol genes as an intron, and joins the 5’ end of the RNA to the env 
gene. The ratio of these two groups is controlled by cw-acting sequences in simple 
retroviruses, and transactivators in complex retroviruses (reviewed by Luciw and Leung, 
1993; Vogt, V.M., 1997).
Translation of the Gag, Pro and Pol proteins takes place on free polyribosomes. This 
translation produces both Gag and Gag-Pro-Pol polyproteins. Approximately 10 to 20 
times more Gag is made than Gag-Pro-Pol. The full length polyprotein is produced when 
the gag termination codon is bypassed. There are two mechanisms by which this is 
achieved. The mammalian C-type retrovimses employ readthrough suppression, which 
allows the amber termination codon to be occasionally misread as a sense codon. For 
example, the pro coding region of Moloney MLV (MoMLV) and feline leukaemia vims 
(FeLV) starts four codons upstream of the gag termination codon. This amber UAG 
termination codon is occasionally read as the glutamine codon CAG, and translation is 
continued (Yoshinaka et al., 1985a; Yoshinaka et al., 1985b). This suppression mechanism 
is regulated by viral cis-acting sequences. Most other retrovimses use ribosomal 
frameshifting. This occurs when the downstream genes are in a different reading frame to 
gag, and requires a seven nucleotide sequence, known as the slippery or shifty sequence, 
within the region of overlap (Jacks et al., 1988a; Jacks et al., 1988b). When two tRNAs are 
bound to this sequence, they are able to slip back one nucleotide, thereby leaving the gag 
reading frame to follow that of pro-pol (Swanstrom and Wills, 1997).
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As mentioned above, the Env polyprotein is translated from a spliced mRNA. It is initially 
translated on free ribosomes until the hydrophobic leader sequence is made. This sequence 
enables binding to a signal recognition particle which targets the protein to the membrane 
of the rough endoplasmic reticulum (RER). Here the polyprotein is further translated, 
passing through the membrane into the lumen of the RER. It remains anchored in the 
membrane via a hydrophobic region close to the carboxyl terminal (reviewed by Vogt, 
V.M., 1997). During translation the leader sequence is removed by a cellular protease and 
the Env protein is glycosylated. Folding and oligomerisation of Env also occur within the 
RER and are required for transport to the cell surface. Cleavage of the polyprotein into the 
SU and TM proteins takes place within the Golgi apparatus and is probably carried out by a 
cellular protease, such as furin (reviewed by Swanstrom and Wills, 1997).
Once all the viral proteins are synthesised, virion assembly can proceed. The budding 
process, which relies on the Gag protein, is not well understood. The cores of B- and D- 
type retroviruses assemble in the cytoplasm and then bud through the plasma membrane 
which contains the Env proteins. The core formation and budding of other retroviruses 
occur simultaneously. It is thought that high affinity lipid-particle interactions allow 
coating and then separation of a growing spherical structure built from the interacting Gag 
proteins. Intermediate budding particles have also been observed on narrow stalks, which 
could suggest an alternative mechanism. The Gag-Pro-Pol is incorporated as a polyprotein, 
and is probably targeted to the assembly site by the Gag portion (reviewed by Luciw and 
Leung, 1993; Swanstrom and Wills, 1997). The mechanism of Env protein incorporation is 
not yet understood. It is generally thought to involve an interaction with a Gag protein, 
probably MA, although this is not required for virion budding (Dickson et al., 1982; Kawai 
and Hanafusa, 1973). This is discussed in greater detail in section 1.5.1. Selective 
packaging of viral genomic RNA is controlled both by signals present in the viral proteins, 
particularly NC (Berkowitz et al., 1995), and a signal in the RNA (\j/). The \j/ signal of 
MLV is approximately 300 bases long and situated between the splice donor site and the 
start codon for gag (Mann et a l, 1983). The subgenomic env mRNA is not packaged since 
this signal is removed during splicing. Following budding, maturation of the viral particle 
takes place. Gag and Gag-Pro-Pol are cleaved by the viral protease, PR, into their 
respective proteins. This results in an observable change in the structure and morphology of 
the virion. This mature structure is less stable and is required for infectivity. The Env
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1protein of at least some retroviruses is also cleaved by PR after budding. This involves 
removal of a carboxy-terminal peptide, known as the R peptide. This cleavage renders the 
Env protein fusion active (Luciw and Leung, 1993; Swanstrom and Wills, 1997).
1.1.5 Genetic diversity and recombination of retroviruses
As a consequence of the nature of their replication cycle, retroviruses are able to evolve 
rapidly, allowing adaptation to changing environments. Viruses, such as HIV-1, that have 
high rates of replication tend to exist as polymorphic populations within the host (Coffin, 
1995). Neither the host RNA polymerase II nor the viral RT have a proof-reading activity, 
and are therefore both likely to contribute to the introduction of errors into the genome. The 
error rate of RT is estimated to be approximately 10-4 errors per base in vitro (Telesnitsky 
and Goff, 1997). This is equivalent to one error per genome in each replication cycle.
_3
Depending on the system used, error rates in vivo have been estimated as 5 x 1 0  , 2 x 1 0  
and 1.4 x 10~4 per base (Dougherty and Temin, 1986; Dougherty and Temin, 1988; Leider 
et al., 1988; Monk et al., 1992).
During the process of reverse transcription a single DNA provirus is made from a virion 
containing a diploid genome (Hu and Temin, 1990; Panganiban and Fiore, 1988). Although 
the RNA molecules are usually identical, heterozygous virions can be released from a cell 
infected by two different viruses. Reverse transcription of heterozygous genomes can result 
in the production of a recombinant provirus containing portions of both sequences. Hu and 
Temin (1990) estimated that homologous recombination between two markers lkb apart 
occurs in about 4% of the DNAs produced in one cycle of reverse transcription by such 
virions. The majority of recombinations are thought to occur through intermolecular strand 
transfer during minus-strand DNA synthesis, although it may also occur during plus-strand 
synthesis (Telesnitsky and Goff, 1997). Recombination between genomes derived from 
different retroviruses constitutes a form of sexual replication, and therefore contributes to 
the genetic diversity and adaptation of viral populations (Temin, 1993).
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1.1.6 Endogenous retroviruses
As mentioned above (section 1.1.4), an important step in the life cycle of infectious 
exogenous viruses is the permanent integration of the provirus into the host cell genome. 
As a consequence of this process, insertion of proviruses into the host germ line has 
occurred on several occasions throughout evolution. These proviruses are then inherited as 
a mendelian trait, and are known as endogenous retroviruses (ERVs). During the 
evolutionary process these viruses have adapted to this form of transmission. The selective 
pressure to produce infectious viral particles is removed resulting in the accumulation of 
mutations in the viral genes. Such defective proviruses are less pathogenic to the host and 
therefore more likely to be maintained in the genome. Many are also transcriptionally silent 
as a result of host methylation of the viral sequences. ERV sequences have been found in 
all vertebrate species so far studied. They are often found in groups of highly homologous 
sequences that differ in their site of integration in the genome (Boeke and Stoye, 1997; 
Patience et a l, 1997b). It is believed that each group of closely related ERVs resulted from 
an initial cross-species infection by an exogenous retrovirus. The different proviruses in a 
group were produced by reinfection, or perhaps by intracellular retrotransposition, and are 
separated by only a few rounds of replication (King et a l, 1987; Stoye and Coffin, 1987). 
Generation of new proviruses ceases when the accumulation of mutations renders them 
noninfectious, or when the host develops mechanisms to prevent further infection, such as 
the selection of a receptor allele not recognised by the virus (Boeke and Stoye, 1997).
Occasionally the retention of a functional ERV gene can confer a selective advantage. For 
example, the human ERV-3 virus possesses a functional env gene. This is expressed in the 
syncytiotrophoblast within the placenta where it may have a role in cell fusion or 
immunosuppression (Boyd et a l, 1993; Harris, 1991; Venables et a l, 1995). It has even 
been suggested that the acquisition of such an ERV enabled evolution of placental 
mammals to proceed (Harris, 1991; Villareal, 1997). Infection of early embryos may have 
resulted in cell fusion and the formation of an invasive syncytial plate that expressed 
immune-suppressing viral Env protein. ERV expression may also provide the host with 
resistance to infection by related exogenous viruses (Boeke and Stoye, 1997). For example, 
endogenous Env proteins can block common receptors, causing receptor interference 
(described in section 1.2.1). The murine Fv-1 gene provides resistance to certain strains of
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MLV. It is believed to have evolved from an endogenous gag gene (Best et al., 1996), and 
probably acts by preventing proviral integration (Brown, 1997).
The presence of ERVs can alter the structure and functioning of the host genome. Every 
proviral integration has the potential to result in insertional mutagenesis or changes in gene 
expression. As a consequence, the germ line insertions of ERVs can have a significant 
effect on the evolution of the host genome. An interesting example of this is the insertion 
of a C-type ERV upstream of a duplicated pancreatic amylase gene of an ancestor of 
humans, Old World monkeys and apes (Meisler and Ting, 1993; Samuelson et al., 1990; 
Ting et al., 1992). This insertion appears to have resulted in expression of amylase in 
saliva, and may therefore reflect the importance of starch in the human diet. The presence 
of these retroviral sequences can also influence evolution of infecting exogenous 
retroviruses, since their expression provides material for recombination. This may also 
have consequences for the host since the resulting recombinant viruses often show 
increased pathogenicity (Ott et al., 1990; Stewart et al., 1986).
ERVs have entered genomes at various times during evolution, and are usually described as 
ancient or modem (Boeke and Stoye, 1997). Ancient viruses were acquired prior to 
speciation and are found in the same location in the genomes of all individuals of a species, 
and often of related species. A few species possess modem viruses that were acquired 
relatively recently in evolution and may still retain the ability to release infectious virions. 
The production of these virions can occur spontaneously or be induced with chemicals such 
as 5-aza-cytidine or 5-bromo-2-deoxyuridine that reverse DNA methylation (Patience et 
al., 1997b). These modem ERVs are closely related to exogenous retrovimses, and often 
vary in their insertion site in individual hosts. Many of these vimses are unable to infect 
cells of the host organism. This is thought to be the result of selection of mutations in the 
cellular receptor which protect the host from reinfection and the potentially pathogenic 
effects of ERV viraemia. The receptor for xenotropic MLV (X-MLV) is expressed by 
several strains of wild mice but is absent from inbred mice, suggesting that a non­
functional receptor has been selected (Kozak, 1985). Other organisms will not have 
evolved such resistance mechanisms and therefore can be susceptible to infection (Boeke 
and Stoye, 1997). This is illustrated by the infection of human tumour xenografts with 
murine and feline ERVs (Tralka et al., 1983; McAllister et al., 1972). It seems possible that
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transfer of ERVs from the xenograft to the host could also occur. This may prove to be a 
problem if animal organs and tissues are used in the treatment of human patients.
It has been proposed that retroviruses have evolved from transposable elements, mobile 
DNA sequences that replicate via an RNA intermediate (Doolittle et al., 1989; Doolittle et 
a l, 1990; Doolittle and Feng, 1992; Temin, 1980; Temin, 1985). If this is the case then it 
seems likely that at least some defective ERV sequences are not products of ancient 
infections, but instead represent stages in the evolution of retroviruses. This evolutionary 
pathway could have begun with the juxtaposition of a reverse transcriptase gene with a 
simple transposable element. This element could then become gradually more complex 
through the acquisition of further coding sequences that would have evolved into gag-like 
genes. Finally, the incorporation of an env gene would allow infection of other cells, and 
perhaps other species. However, it is also possible that transposable elements are the 
remnants of ancient viral infections (Finnegan, 1983). As there have been many cases of 
exogenous retroviruses entering genomes and endogenous retrovimses ‘escaping’ to infect 
alternative hosts throughout evolution it is very difficult to discern which was the original 
mode of transmission.
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1.2 Host range and receptors
The host range of a virus is largely dependent upon the interaction between a specific cell 
surface receptor molecule and the envelope proteins. For many viruses, these receptors are 
not only necessary for viral attachment, but are also involved in the process of infection. A 
large variety of molecules appear to be able to act as receptors, including proteins, 
carbohydrates and lipids. Some are also involved in recognition and adhesion processes 
between cells. While the interaction with a vims often has little effect on the normal 
function of the receptor, this is not always the case. For example, the viral protein may 
block the normal interactions of the receptor or mimic the activity of a ligand. The 
distribution of receptors determines the range of cells susceptible to infection and is 
therefore important in pathogenesis. Consequently, the identification of viral receptors is a 
necessary step towards understanding virus-host relationships. Knowledge of receptors and 
their tissue distribution is also useful when designing and choosing viral vectors for gene 
transfer (Weiss, 1993; Haywood, 1994).
1.2.1 Retroviral receptors
Most animal viruses within the same genus show little, if any, variation in receptor usage. 
However, closely related retrovimses have been found to use different receptors. The 
vimses in the avian and mammalian C-type genera both show a high degree of 
polymorphism both in receptor usage and receptor expression within the host (Hunter, 
1997). These vimses have been placed into subgroups on the basis of host range, 
neutralisation and receptor interference (Weiss, 1993). The murine C-type viruses have 
been classified into four subgroups. Ecotropic vimses are restricted to murine and rat cells, 
while xenotropic vimses will only infect cells from other species. Amphotropic and 
polytropic vimses infect both cell groups but do not interfere with one another indicating 
that they use different receptors. The FeLVs have been divided into three subgroups. FeLV- 
A infects only feline cells while FeLV-B and -C both have wider host ranges (Jarett et al, 
1973; Sarma and Log, 1973; Sarma et al., 1975).
Receptor interference occurs when the receptors of an infected cell are blocked or 
downregulated, thereby preventing superinfection by another vims recognising the same
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receptor. The actual mechanism involved is not yet fully understood, but it probably 
involves a direct interaction between the Env protein and the receptor. This interaction 
could occur on the cell surface or within the RER (Hunter, 1997; Weiss, 1993). Infection 
interference can also occur as a result of the expression of endogenous env sequences. The 
murine Fv-4 gene which confers resistance to Friend-MLV has been found to express an 
ecotropic Env (Ikeda and Sugimura, 1989). This form of infection interference is likely to 
be advantageous to the host, providing protection from infection by exogenous virus and 
also prevention of ERV viraemia. As a consequence, such genes would be expected to be 
preserved within the genome. Several defective ERV proviruses retain a functional env 
gene (Hunter, 1997). Receptor interference is usually reciprocal, however there are a few 
notable exceptions. For example, the murine 10A1 virus blocks infection by the related 
amphotropic MLV, but is able to infect cells releasing this virus (Rein and Schultz, 1984). 
The MLVs also have unexpected interference patterns when tested on Mus dunni cells. 
Certain xenotropic strains are blocked by preinfection with ecotropic and amphotropic 
viruses (Chesebro and Wehrly, 1985). In addition, the viruses placed within the same 
interference group may display small differences in host range. Takeuchi et al. (1992b) 
have shown that simian sarcoma associated virus (SSAV) will infect rat cells, which are 
resistant to FeLV-B.
Analysis of interference between retroviruses infecting human cells has revealed the 
existence of eight receptor groups (Sommerfelt and Weiss, 1990). These are listed in Table 
1.2. To date the receptors corresponding to three of these interference groups have been 
identified. These are Ram-1 (GLVR-2 or Pit-2) for group 2: amphotropic MLV (A-MLV, 
Miller et a l, 1994; van Zeijl et a l, 1994); GLVR-1 (Pit-1) for group 5: gibbon ape 
leukaemia virus (GALV, O'Hara et a l, 1990), the closely related SSAV (Takeuchi et a l, 
1992b), and FeLV-B (Takeuchi et a l, 1992b); a 70kD membrane glycoprotein for group 6: 
bovine leukaemia virus (BLV, Ban et a l, 1993); and CD4 for group 8: the human and 
simian immunodeficiency viruses (HIV and SIV, Dalgleish et a l, 1984; Hoxie et a l, 1988; 
Klatzman et a l,  1984; Sattentau et a l, 1988). The ecotropic MLV (E-MLV) receptor 
mCAT-1 (Albritton et a l, 1989), and the avian sarcoma and leukosis virus (ASLV) -A 
receptor, a protein related to the low density lipoprotein (LDL) receptor (Young et a l, 
1993; Young et a l,  1994), have also been cloned. The known receptors of the mammalian 
C-type viruses are described below.
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Receptor group Virus Receptor
1 RD114
BaEV
SRV-1
SRV-2
MPMV
SRV-4
SRV-5
PO-l-Lu
SMRV
unknown
2 A-MLV Ram-1 (GLVR-2/Pit-2)
3 X-MLV unknown
4 FeLV-C unknown i
5 FeLV-B
SSAV
GALV
GLVR-1 (Pit-1)
6 BLV 70kD membrane glycoprotein
7 HTLV-1
HTLV-2
ChTLV
STLV
unknown
8 HIV-1
HIV-2
SlVmac
SIVsmm
S IV a g m
CD4
Table 1.2. Receptor interference groups of retroviruses infecting human cells (based on Sommerfelt and 
Weiss, 1990)
36
The E-MLV receptor was identified by transfecting resistant human cells with murine 
DNA (Albritton et a l, 1989). These cells were then tested for their susceptibility to 
infection with a recombinant E-MLV virus carrying a neomycin resistance gene. Cells 
expressing the murine receptor were infected by this virus and could then be selected by 
their resistance to neomycin. The DNA clone obtained by this process was found to encode 
a 622 amino acid membrane protein that contains at least 14 transmembrane domains 
connected by short hydrophilic loops. Expression of this protein, now termed mCAT-1, in 
Xenopus oocytes produces an increase in sodium-independent uptake of L-arginine, L-lysine 
and L-ornithine, indicating that it is a cationic amino acid transporter (Kim et a l, 1991; 
Wang et al., 1991). Chronic infection of mink fibroblasts with E-MLV has been shown to 
result in only a 50-70% reduction in transporter activity (Wang et a l, 1992), suggesting 
that bound mCAT-1 remains capable of transporting amino acids. Substitutions of amino 
acid sequences with those from the nonpermissive human homologue have identified a 
region of 29 residues within the third extracellular domain of the receptor that is necessary 
for the interaction with E-MLV (Albritton et a l, 1993). This is illustrated in Fig. 1.3. 
Sequence variations within this region can affect strains of E-MLV differently. For 
example, a single amino acid change in the Mus dunni receptor prevents infection by 
MoMLV, but has no effect on the Rauscher or Friend E-MLV strains (Eiden et a l, 1993).
A similar method to that of Albritton et a l (1989) was used to identify and clone the 
receptor for GALV (O’Hara et a l, 1990). This receptor contains 679 amino acids and a 
series of 10 potential transmembrane domains connected by hydrophilic loops. The cross 
interference between GALV, SSAV and FeLV-B implied that these viruses all use GLVR- 
1 as a receptor (Sommerfelt and Weiss, 1990; Takeuchi et a l, 1992b). Takeuchi et a l 
(1992b) have shown that expression of GLVR-1 in resistant murine cell lines confers 
susceptibility to infection by SSAV and FeLV-B, indicating that these viruses do all 
recognise this receptor. The sequence between residues 550 and 558 of GLVR-1, illustrated 
in Fig. 1.3, has been shown to be necessary for infection by each of these viruses (Johann et 
a l, 1993; Tailor et a l, 1993). This region is highly divergent between species, and the 
different viruses exhibit different sequence requirements (Tailor et a l, 1993). These 
differences are thought to reflect the small variations in host cell range.
37
NHj
Fig. 1.3. Schematic representations of the structures of mammalian C-type retrovirus receptors (modified 
from Weiss, 1993). A) mCAT-1. B) GLVR-1. The regions thought to be required for viral infection are 
indicated by the arrows.
In an attempt to isolate further retroviral receptors, van Zeijl et al. (1994) screened a human 
cDNA library for clones related to GLVR-1. They found that expression of one such clone, 
GLVR-2, allowed infection of nonpermissive Chinese hamster fibroblasts with A-MLV. 
This 652 amino acid protein shares 62% overall homology with GLVR-1. The rat 
homologue of this receptor has been identified by Miller et al. (1994) and designated Ram- 
1. Certain hybrid molecules between the two related receptors can function for both GALV 
and A-MLV (Miller and Miller, 1994). These hybrids contain the amino-terminal of 
GLVR-2/Ram-l and the carboxy-terminal of GLVR-1, including the critical region 550- 
558. The 10A1 virus, a recombinant between 1504A A-MLV and an endogenous murine 
retrovirus, can use both receptors (Miller and Miller, 1994). The expanded host range of 
10A1 can be obtained with only a small number of changes in the amino acid sequence of 
A-MLV Env, presumably a reflection of the homology between these receptors.
The GALV and A-MLV receptors both function as sodium-dependent phosphate 
symporters (Kavanaugh et al., 1994; Olah et al., 1994). Kavanaugh et al. found that 
expression of the receptors in Xenopus oocytes or rat fibroblasts resulted in an uptake of 
phosphate in the presence of sodium ions. They were also able to show that expression of
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A-MLV Env in murine fibroblasts reduces phosphate transport by 50-60%. Although these 
two receptors are very similar they have distinct patterns of tissue expression. While both 
can be detected in most rat tissues, GLVR-1 is highly expressed in bone marrow and Ram- 
1 in heart (Kavanaugh et a l, 1994).
FeLV-B recognises the same receptor as GALV, but shows a much higher level of 
homology with A-MLV within the SU protein, including the variable regions VRA and 
VRB (Tailor and Kabat, 1997). These regions have been implicated in the receptor 
recognition of MLV SU proteins (Battini et a l, 1992; Battini et a l,  1998; Morgan et a l,
1993). The similarities between the FeLV-B and A-MLV proteins therefore suggest that 
they may bind to equivalent domains in their individual receptors. By comparing the 
infectivities of pseudotype vectors bearing FeLV-B/A-MLV SU chimaeras on cells 
expressing GLVR-1/Ram-1 chimaeras, Tailor and Kabat were able to identify such 
domains. The VRA of each SU protein was found to bind to the extracellular loops 4 and 5 
of the respective receptors, and VRB to loop 2. The critical region defined by Johann et al
(1993) between residues 550 and 558 of GLVR-1 is situated on loop 4. It therefore seems 
likely that this loop is also involved in the binding of GALV and SSAV.
The similarities between the receptors so far described for mammalian C-type retroviruses 
suggest that only a limited number of cell surface proteins are suitable for this function. 
This suitability could be due to tissue distribution or an ability to permit virus entry into the 
cell. It is also possible that the interaction between the virus and its receptor confers a 
growth advantage to the cell, thereby enhancing viral spread (Takeuchi et a l, 1992b). 
These restrictions may be peculiar to the viral genus since the CD4 receptor recognised by 
HIV and SIV is unrelated to the transporter molecules described here. This protein is a 
member of the immunoglobulin (Ig) superfamily, containing a single transmembrane 
domain (Maddon et a l, 1985). Although the receptors of the C-type viruses are related they 
vary in their distribution. This is likely to explain why relatively minor changes in Env 
proteins can result in significant differences in host range. It seems quite possible that other 
mammalian C-type retroviruses will also be found to recognise similar receptors 
(Cunningham and Kim, 1994). It is tempting to speculate that the receptors for FeLV-A 
and -C are related to the GLVR-1 recognised by FeLV-B. The FeLV-B Env appears to have 
arisen as a result of recombination of FeLV-A with endogenous env sequences (Stewart et
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a l, 1986), and the FeLV-C from a mutation of FeLV-A (Neil et a l, 1991). Although the 
host range of FeLV-C is much wider than that of FeLV-A, the receptor binding regions of 
the two Env proteins differ only slightly. The sensitivity of mammalian C-type viruses to 
minor differences in their receptors can at least partly explain the unexpected patterns of 
receptor interference observed among MLVs (Chesebro and Wehrly, 1985; Rein and 
Schultz, 1984). Although two viruses may recognise the same receptor in certain cell types, 
species specific changes in the receptor sequence could differentially affect viral 
recognition.
1.2.2 Rhabdoviral receptors
Other viruses, such as rhabdoviruses, have less restricted host ranges than the retroviruses. 
The envelope protein of vesicular stomatitis virus (VSV) is thought to interact with a 
phospholipid constituent of the cell membrane. Schlegel et a l (1983) tested solubilised cell 
membrane components for their ability to inhibit VSV binding. They found that the 
phospholipid phosphatidylserine (PS) inhibited the specific binding of the virus to Vero 
monkey cells. VSV binding to chicken embryo-related (CER) cells is also inhibited by PS 
and, to a lesser extent, sphingomyelin (Superti et a l, 1984b). Partial inhibition is seen with 
phosphatidylethanolamine (PE) and phosphatidylinositol (PI). The apparent ability to enter 
cells without relying on the presence of a specific protein receptor allows VSV to infect a 
very broad host cell range, including fish and insect cells.
The receptor usage of rabies virus, another rhabdovirus, has also not yet been fully defined. 
This virus has a very wide host range in vitro, but has a strong tropism for the nervous 
system in vivo. It has been found to concentrate at neuromuscular junctions (NMJ), areas 
rich in nicotinic acetylcholine receptors, nAchRs (Lentz et a l, 1982). Detection of bound 
rabies virus using immunofluorescence staining revealed that the pattern of binding at NMJ 
and on cultured chick myotubes is very similar to that of a-bungarotoxin (otBtx), an 
antagonist of the AchR. The presence of antagonists such as ocBtx and d-Tubocurarine 
inhibits infection of myotube cells, presumably by competing for binding to AchR. Rabies 
G is also capable of blocking the binding of otBtx (Bracci et a l, 1988). In addition, a region 
of homology has been found between the nAchR binding site of curaremimetic neurotoxins 
and a segment of the G protein. Further supporting evidence for this receptor comes from
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the observation that a monoclonal anti-idiotype-antibody directed against a neutralising 
anti-G antibody will also bind to purified nAchR, NMJ and some cells of the central 
nervous system (CNS, Hanham et a l, 1993). It seems likely that the antigen binding site of 
the anti-idiotype-antibody mimics the neutralising epitope of rabies G, and that this epitope 
is involved in the binding of nAchR. This antibody itself elicited a response in mice which, 
although low in titre, was protective against virus challenge.
Although these studies all indicate that nAchR is a receptor for rabies vims a wide range of 
cell lines are susceptible to infection in vitro, many of which do not express this receptor 
(Reagan and Wunner, 1985; Seganti et a l, 1990; Thoulouze et a l, 1998; Wunner et a l, 
1984). While rabies G is able to fully block binding of ocBtx, the reverse is not observed 
(Bracci et a l, 1988). Also, the neutralising antibody used by Hanham et a l to raise the 
anti-idiotype did not prevent rabies infection of culture cells that lacked the nAchR. 
Therefore, it appears that rabies vims utilises multiple receptors. It has been suggested that, 
like VSV, rabies vims binds to a lipid component of the cell membrane (Seganti et a l, 
1990; Superti et a l, 1984a; Superti et a l, 1984b; Wunner et a l, 1984). Binding to specific, 
saturable sites on hamster BHK-21 cells has been observed (Wunner et a l, 1984), which is 
not affected by predigestion of the cells with trypsin or chymotrypsin. Protease digestion 
also does not prevent binding to CER cells (Superti et a l, 1984a; Superti et a l, 1984b). In 
contrast, phospholipase treatment does have an effect, although only phospholipase A2 acts 
in a dose-response manner (Seganti et a l, 1990; Superti et a l, 1984a; Superti et a l, 1984b; 
Wunner et a l, 1984). Membrane lipid extracts will also inhibit rabies vims binding. Like 
VSV, binding is prevented by PS, and to a lesser extent by PE and PI (Superti et a l, 
1984b). However sphingomyelin, or treatment of cells with sphingomyelinase, has no 
effect. Seganti et a l (1990) found no noticeable difference between the inhibitory effects of 
phospholipids and total membrane lipids. In this study the most significant inhibition of 
rabies vims binding to CER cells was observed in the presence of the glycolipid fraction 
from mosquito cells. Digestion with neuraminidase at 5-20U/ml reduces binding to most 
cells, apart from a mosquito line (Seganti et a l, 1990; Superti et a l,  1984a). Wunner et al 
(1984) were unable to reduce binding to BHK-21 cells, but this is likely to be due to the 
low concentration of enzyme (lU/ml) used. Treatment of the membrane lipid extracts with 
this enzyme abolishes their inhibitory effect with all cell lines tested.
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It has been suggested that gangliosides could act as receptors for rabies virus (Superti et al., 
1986). These are a group of glycosphingolipids that carry one or more sialic acid residues 
in their oligosaccharide chain. They are present on membranes of eukaryotic cells, and are 
particularly abundant on nervous cells. Superti et al. found that exogenous addition of 
gangliosides can restore susceptibility to neuraminidase treated CER cells. Certain 
gangliosides are more efficient than others, depending on the number and position of sialic 
acid residues. The most significant restoration of susceptibility is seen with combinations 
of different gangliosides.
The ability of rabies virus to infect a wide variety of cell types in vitro via an interaction 
with a lipid does not explain its clear neurotropism in vivo. It seems likely that a high 
affinity receptor(s) is expressed on neural cells. Although nAchR does appear to be such a 
receptor, it has been shown that in vivo spread also involves non-cholinergic neurons 
(Kucera et al., 1985; Thoulouze et al., 1998; Tuffereau et al., 1998). In addition, Tuffereau 
et al. (1998) found that insect cells expressing rabies G on their surface will bind 
specifically to several cholinergic and adrenergic neuronal cell lines. Infection of the target 
cells with rabies blocks binding, presumably by downregulation or masking of a receptor. 
The presence of a monoclonal antibody raised against nAchR did not prevent binding in 
this study suggesting that another receptor is involved. Escape mutants involving 
substitution of Arg 333 have been shown to be non-pathogenic, and display a different host 
cell range to the wild type (Seif et al., 1985). While Tuffereau et al. were unable to affect 
binding activity by mutating this residue, a double mutation also involving residue 330 did 
suppress cell binding.
The neural cell adhesion molecule (NCAM) has been proposed as another receptor for 
rabies virus (Thoulouze et al., 1998). This is a cell adhesion glycoprotein of the Ig 
superfamily. It has been found to be expressed on the surfaces of highly susceptible cell 
lines, but not on more resistant cells. Specific blocking of NCAM with antibody or ligand 
significantly reduces viral infection, as does preincubation of the virus with soluble 
NCAM. Cells transfected with the NCAM gene show enhanced susceptibility to rabies 
infection. Thoulouze et al. also found that infection of NCAM deficient mice resulted in 
restricted brain invasion by the virus, and a slower disease progression. While it is possible 
that nAchR and NCAM could act together as receptors, the majority of evidence appears to
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suggest that they act independently. Rabies can infect nAchR negative cells expressing 
NCAM, and can also infect brain tissue in the absence of NCAM. The regions infected in 
the NCAM negative mice include those known to be binding sites for aBtx. It seems 
possible that rabies virus uses at least two high affinity receptors to spread in vivo, while a 
lower affinity receptor, such as a ganglioside, allows infection of a wider range of cell 
types in vitro. Another interpretation is that the virus uses the same ganglioside mediated 
mechanism to enter cells, but the ability to bind high affinity receptors such as nAchR and 
NCAM allows targeting of particular cell types.
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11.3 Virus-cell fusion
The cell entry of all enveloped viruses involves membrane fusion. This procedure is 
effected by the viral fusion protein. These proteins consist of one or two subunits and are 
often arranged as trimers. They are usually also responsible for binding to the cell surface 
receptor. Most fusion proteins are thought to undergo a conformational change, exposing a 
hydrophobic fusion peptide which interacts with the target membrane. For some viral 
fusion proteins, including those of influenza virus and the rhabdoviruses, this 
conformational change is triggered by low pH. The fusion peptides that have been so far 
identified consist of short hydrophobic sequences, often arranged as an a-helix with a 
highly hydrophobic face. They tend to show high conservation within but not between virus 
families (White, 1992). Most of the information available on the viral fusion process has 
been obtained from the well studied influenza virus.
1.3.1 Retroviral cell fusion
Very little is known about the actual mechanisms involved in retroviral cell fusion. 
However, these mechanisms are expected to be similar to those employed by influenza 
virus. Although there are some significant differences between the processes employed by 
retroviruses and influenza, for example the majority of retroviruses do not require a low pH 
step, there appear to be sufficient similarities for this model to be a useful aid to 
understanding retroviral fusion. The hemagglutinin (HA) protein of influenza is 
functionally equivalent to the Env of retroviruses. Each protein is composed of two 
subunits: HA1 which is equivalent to SU, and HA2 which is equivalent to TM. These 
complexes are arranged as trimers on the surface of the virion. The receptor binding 
domain is formed from folds of the HA1 polypeptide chain, and binds with high specificity 
but low affinity to the sialic acid residues present on most glycoproteins and glycolipids. 
Following receptor binding the virus enters the cell via endocytosis. The drop in pH inside 
the endosome induces a conformational change within the protein, initiating the fusion 
process. The HA2 protein contains a long carboxy-terminal a-helix and a shorter amino- 
terminal a-helix. These lie near each other, connected by a loop, in a hairpin-like structure. 
Just before the shorter a-helix, near the amino-terminal, there is a hydrophobic, fusogenic 
peptide, thought to be directly involved in membrane insertion. In the inactive state this
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peptide is positioned inside the stem of the complex, approximately 35A from the viral 
membrane and 100 A from the receptor binding domain. It is held by a system of hydrogen 
bonds. During the pH-dependent conformational change the hairpin is predicted to 
straighten out to form a single long a-helix, which along with the other molecules in the 
trimer creates a triple helix coiled-coil. This brings the fusogenic peptide out into a position 
where it is able to insert into the target cell membrane. At the same time the binding 
domains of HA1 dissociate from one another (Bullough et a l, 1994; Hunter, 1997; White, 
1992). The low pH also causes seven residues near the carboxy-terminus of the coiled-coil 
to refold into a 180° turn, bending the remainder of the carboxy-terminal end of the helix 
and three short (3-strands up towards the fusion peptide end (Bullough et a l, 1994). A 
representation of the structure of HA is shown in Fig. 1.4.
fusion peptide
triple helix 
coiled-coil
Fig. 1.4. Schematic representation of the structure of the influenza virus HA protein (modified from Hunter, 
1997). A) Neutral pH form. B) Activated low pH form.
The ectodomain of the retroviral TM protein is also predicted to contain two a-helices 
(Zhao et a l, 1998). Analysis of the crystal structure of a 55 residue fragment of the 
MoMLV TM (Fass et a l, 1996) has shown that the a-helix immediately downstream of the 
fusion peptide forms a trimeric coiled-coil, similar to that formed by the equivalent a-helix 
in the low pH form of HA2. The carboxy-terminal residues at the end of this fragment 
reverse direction, and extend back up towards the amino-terminus. The crystal structure of 
a larger fragment of the HIV-1 TM (gp41) ectodomain is also available (Weissenhom et 
a l,  1997). This structure contains the proposed leucine zipper region and the carboxyl-
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terminal helical region. Like HA2 and the MoMLV fragment, the zipper region forms a 
trimeric coiled-coil. The second a-helix forms an outer layer, running antiparallel to the 
core, approximately following the groove between two helices. The complex is stabilised 
by a system of hydrogen bonds and salt bridges. This structure is very similar to that 
described for the low pH conformation of influenza HA2. The reversal of direction of the 
polypeptide chain also agrees with the change in direction observed with the MoMLV 
fragment. The turn is at the same position, and is followed by a glycine rich stretch of 8 
amino acids and a disulphide loop in both proteins. These similarities strongly suggest that 
the two a-helices of the MoMLV ectodomain will also run antiparallel to each other in a 
similar trimeric stmcture. Such a structure would be compatible with the theory that a 
functional interaction occurs between these two a-helical regions during the fusion process 
(Zhao et al., 1998).
These envelope fragments were expected to represent the fusion active forms of the 
complete protein since they are likely to have adopted their lowest energy states when 
produced in the absence of SU and gpl20 (Fass et al., 1996; Weissenhom et al., 1997). 
This assumption appears to have been justified judging by the similarities with the structure 
of the presumed fusion active form of HA2. Unfortunately no information is available at 
present on the crystal stmcture of the inactivated forms of these proteins. Incubation of 
HIV-1 with soluble CD4 results in a structural rearrangement in Env, characterised by 
dissociation of gpl20 and antigen epitope exposure (Hunter, 1997). A conformational 
change can also be induced in the ASLV Env by the binding of a soluble form of its 
receptor (Hernandez et al., 1997). This change renders the ectodomain hydrophobic, 
allowing it to bind liposomes. The binding has been shown to be mediated by the TM 
protein. These receptor-induced changes appear to be analogous to the low pH-induced 
changes in HA, although further investigations of the process should be carried out before 
definite conclusions can be made.
The processes by which these proteins actually cause membrane fusion are unknown at 
present. The structures described above are all trimeric a-helical rods, organised so that the 
fusion domain and membrane anchor are positioned at the same end of the rod. Similar 
configurations have been described for the fusion proteins of SV5, a paramyxovirus (Joshi 
et al., 1998), and the Ebola vims, a filovims (Weissenhom et al., 1998), suggesting that a
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common mechanism may be employed by these viruses. One possibility is that the 
positioning of the fusion domain and membrane anchor allows close apposition of the 
cellular and viral membranes, thereby promoting fusion. The rod-shaped molecules may 
cluster together at their hydrophobic ends, forming an oligomeric pore (Weissenhom et al., 
1997; Weissenhom et al., 1998). The cellular SNARE protein complexes involved in 
vesicle membrane fusion are also composed of a-helical rods with the membrane anchors 
of the vesicle and plasma membrane proteins localised at one end. The viral fusion peptide 
may be equivalent to the membrane anchor of the plasma membrane SNARE protein 
(Skehel and Wiley, 1998). A second possibility is that the observed stmctures of the viral 
proteins represent a stable postfusion state (Joshi et al., 1998; Weissenhom et al., 1998). 
Insertion of the fusion peptide into the cellular membrane could occur while the 
ectodomain is in a transient state, and the membranes are then brought together as the rod 
conformation is formed. The disulphide loop-containing linker present in the MoMLV 
fragment (Fass et al., 1996) and predicted for gp41 (Weissenhom et al., 1997) is also found 
in the Ebola vims protein (Weissenhom et al., 1998). The conservation of this stmcture 
implies that it has a function beyond reversing the polypeptide chain direction, and it has 
been proposed to act as a hinge between the two a-helices (Weissenhom et al., 1998). This 
model is supported by the fact that peptides corresponding to both a-helices of gp41 will 
inhibit fusion, probably by preventing the protein folding into the rod-shaped 
conformation. This inhibition only occurs when the peptides are present at the time of 
fusion. However, other studies have suggested that these peptides exert their effects by 
dismpting the rod after it has formed (Chan et al., 1997; Rimsky et al., 1998; Weissenhom 
et al., 1997), or by preventing pore assembly (Munoz-Barroso et al., 1998). Peptides 
corresponding to the equivalent a-helices of SV5 will also inhibit fusion activity of the 
envelope protein (Joshi et al., 1998).
1.3.2 Rabies virus cell fusion
Relatively little is known about the fusion process of rhabdovimses. Like retroviral Env 
proteins, rabies G protein undergoes a conformational change which promotes membrane 
fusion. However, this change results from exposure to low pH during endocytosis of the 
vims. The rabies G protein is thought to adopt three different conformational states: native 
(N), active (A) and inactive (I) (Gaudin et al., 1991a; Gaudin et al., 1993). The N state is
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that normally observed on the surface of virions. Shortly after acidification (pH 6.7) the A 
state can be detected by an increase in hydrophobicity (Gaudin et al., 1993). This state is 
transitory, and is thought to be the conformation required for fusion activity. The I state is 
reached following prolonged incubation at low pH. In this conformation the protein is 32A 
longer than the N state, it becomes sensitive to proteases such as bromelain, and differs 
antigenically from the other states. While in the I conformation G is unable to promote 
membrane fusion. However, reincubation at pH 7.15 restores fusogenicity indicating that 
the conformational changes are reversible (Gaudin et al., 1991a). The I and N states are in a 
pH-dependent equilibrium. After incubation at pH 6.7 for two hours half of the G 
molecules can be seen by electron microscope to be in the I state. In this situation virions 
are unable to fuse with liposome membranes, indicating that several G trimers are required 
for the fusion process (Gaudin et al., 1993). Gaudin et al. (1995) suggest that G is 
transported in the I state to prevent non-specific fusion activity while in the acidic Golgi 
apparatus. The reversibility would be required to obtain active G on the surface of the 
virion.
The rabies G protein does not possess a typical fusion peptide. A putative fusion domain, 
shown in Fig. 3.1, has been identified between residues 84 and 160 (Durrer et al., 1995). 
The region between residues 360 and 366 has also been suggested to be involved in the 
fusion process, due to its homology with other viral fusion peptides (Morimoto et al., 
1992). These regions are discussed in more detail in section 3.1.5.
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1.4 Retroviral vectors
1.4.1 Vectors
The ability of retroviruses to integrate stably into genomic DNA and be transmitted to 
progeny cells makes them ideal candidates for the production of vectors for gene transfer. 
The processes of viral entry, reverse transcription and integration do not require viral 
protein synthesis. Therefore all viral genes in the vector genome can be replaced with 
foreign sequences. As a result there is no production of viral proteins after infection, and no 
subsequent spread of vector. This makes these vectors suitable for use in gene therapy. 
Vectors can also be used to study retroviral replication since the insertion of a selectable 
marker often simplifies detection of viral replication and infection (Miller, 1997).
The majority of vectors in use have been derived from the murine and avian retroviruses, 
although other viruses may also be used. While all viral genes can be removed from these 
vectors, several cis-acting sequences are required. These include a promoter, a 
polyadenylation signal, the packaging signal \j/, the signals necessary for reverse 
transcription such as the primer binding site, PPT and the R sequences, and the partially 
inverted repeats at the ends of the LTRs that are required for integration (Miller, 1997). It 
has been shown that sequences at the 5’ end of gag increase the packaging of MLV-based 
vectors (Adam and Miller, 1988; Armentano et al., 1987; Bender et al., 1987). This larger 
signal has been designated \j/+. Its retention allows production of high vector titres of 
around 107 colony forming units (cfu)/ml. The original viral promoter present in the LTR 
can be used for the expression of the inserted genes. Alternatively, this can be replaced by 
an internal promoter that may alter the level or tissue distribution of expression (Miller,
1997). Vectors can also be used for the expression of more than one protein. These can be 
expressed from alternatively spliced mRNAs transcribed by one promoter (Cepko et al., 
1984), from separate mRNAs transcribed from multiple promoters (Chen et a l, 1992; 
Hantzopoulos et a l, 1989; Overell et a l, 1988), or from a single mRNA containing 
internal ribosome entry site (IRES) elements which allow translation of downstream open 
reading frames (Adam et a l, 1991; Chen et a l, 1993; Koo et a l, 1992). Two proteins can 
also be expressed together as a fusion protein that displays functions of both (Germann et 
a l,  1990; Lupton et a l,  1991).
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1.4.2 Packaging cell lines
In order to package the vector genome, the viral proteins must be provided in trans in 
packaging cells. In early experiments this was achieved by transfecting cells with a vector 
containing the gene of interest and then infecting the same cells with a wild type helper 
virus. However, this procedure results in the release of contaminating replication 
competent retrovirus (Harris and Sikora, 1993). The release of this virus should be avoided 
if the packaging signal \\t is removed from the helper genome. Mann et al. (1983) 
constructed a MoMLV packaging mutant by deleting 351 base pairs between the left LTR 
and the start codon for gag. Three stable cell lines expressing this construct, \j/-l, \|/-2, and 
VJ/-3, were obtained, and only one of these VJ/-3, was found to release infectious virus. Viral 
RNA from \|/-2 cells was packaged into viral particles with an efficiency of less than 1 % 
that of wild type viral RNA. The cell lines were able to package a vector genome that did 
not encode any functional viral proteins, \j/-2 cells producing a titre of 104 cfu/ml. 
However, during these transfection experiments high levels of RT activity were detected in 
the culture medium 9 days after transfection. Mann et al. suggested that this was a result of 
recombination between the mutant genome and endogenous retroviral sequences present in 
the cellular genome.
There are three major mechanisms that give rise to the production of replication competent 
viruses from packaging cells lines. These are recombination between the packaging 
sequences and the vector, recombination of either of these with endogenous retroviral 
sequences, and the activation of functional endogenous retroviruses (Miller, 1997). The 
first of these mechanisms is thought to be involved in most instances (Miller and 
Buttimore, 1986; Miller et al., 1986). When a vector with homologous sequences 3’ of the 
deletion in the defective packaging genome is used in a cell line such as \|/-2, only one 
recombination event is required to produce wild type virus. Deletion of the \j/ signal does 
not fully prevent packaging of the helper genome. Therefore it is important to reduce 
homology between the packaging construct and the vector in order to lower the risk of 
recombination (Miller, 1997).
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Later packaging cell lines contain further deletions and mutations. In the PA317 cell line 
(Miller and Buttimore, 1986) the \|/ signal and the 5’ end of the 5’ LTR have been deleted, 
and the 3’ LTR and second strand initiation site replaced with the polyadenylation signal 
from simian virus 40 (SV40). As a result any RNA that is packaged cannot be reverse 
transcribed or integrated into a host genome. Two recombination events are required to 
produce infectious helper virus. A further modification involved the separation of the 
gag/pro/pol and env genes onto two different plasmids, both of which had deletions of the 
\|f signal and 3’ LTR (Danos and Mulligan, 1988; Markowitz et al., 1988). In this system 
three recombination events are required to produce replication competent virus. However, 
as the end of the pol gene overlaps with the beginning of env, recombination between the 
two constructs can occur. This can be reduced by using the env gene from another virus 
that contains little sequence homology. An early example of this is the DAN amphotropic 
packaging cell line (Dougherty et al., 1989). This contains the gag/pro/pol genes from 
spleen necrosis virus and the env gene from 4070A A-MLV. Although these cells are very 
effective at preventing helper virus production the vector titre (4 x 104 cfu/ml) is lower than 
that released from other similar packaging cell lines. More recently, similar packaging cell 
lines releasing high titre pseudotyped vectors based on MoMLV and bearing the Env 
proteins of 4070A (Cosset et al., 1995), RD114 (Cosset et al., 1995) or 10A1 (Miller and 
Chen, 1996) have been produced.
Although it is possible to carry out many experimental protocols with low titre vector, high 
titre stocks are required for several applications, including in vivo gene therapy. The 
infection of certain cell types, such as human hematopoietic progenitor cells, depends on 
high titres (Hock and Miller, 1986; Hogge and Humphries, 1987). Titres of around 107 
cfu/ml can now be obtained with several packaging cell lines. Some of these lines have 
now been used for human gene therapy trials. Their use indicates that helper virus 
production occurs at a very low rate in these cell lines, and that it is possible to make large 
stocks of helper-free vectors (Miller, 1997). It has been shown that prolonged passage of 
packaging lines results in a reduction in titre (Bender et al., 1987). However, the use of 
early passage stocks not only prevents this problem, but also reduces the risk of 
recombination leading to the production of replication competent helper virus.
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It is now possible to produce high titre retroviral vector in transient transfection systems 
(Landau and Littman, 1992; Soneoka et al., 1995). These systems rely on the use of cells 
such as Cos-7 or 293T that express the SV40 large T antigen. This antigen induces 
episomal replication of the plasmids, which contain the SV40 origin of replication. 
Following cotransfection of Cos-7 cells with gag/pol, env and vector plasmids, Landau and 
Littman (1992) achieved vector titres of 104 cfu/ml, 30 to 40 fold higher than those 
previously obtained by transient transfection. Soneoka et a l (1995) increased this to 107 
cfu/ml by using the cytomegalovirus (CMV) promoter to drive expression of the packaging 
components and the vector. The use of this system is illustrated in Fig. 1.5.
Fig. 1.5. Use of the HIT system (Soneoka et al. 1995). The three plasmid constructs, encoding the viral 
structural proteins and the vector genome, are cotransfected into 293T cells. Transient expression of these 
constructs then results in the release of high titre vector.
1.4.3 Alteration of the host range of retroviral vectors
Retroviral vectors are restricted to the host cell range of the parental virus. This can be 
changed by making alterations to the Env protein, either to target the vector to a specific 
cell type or to expand the host range. One approach involves the production of chimaeric
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proteins containing an antibody fragment or ligand that will promote specific binding to the 
cell type of interest. These sequences are inserted into the amino-terminal region of the SU 
protein, thought to be involved in normal receptor binding. Antibody fragments have been 
used to target vectors to a tumour antigen (Chu and Domburg, 1995), the human I DT 
receptor (Somia et a l , 1995), and human major histocompatibility complex (MHC) class I 
molecules (Marin et al., 1996). The first two of these studies found that wild type Env was 
also required. Marin et a l reported that their vectors were functional in the absence of wild 
type Env, but titres were only around 50 cfu/ml. The incorporation of wild type Env also 
appears to be required for the majority of ligand chimaeras. For example a chimaeric E- 
MLV Env containing erythropoietin has been shown to target vectors to cells expressing 
the erythropoietin receptor, when incorporated alongside wild type Env (Kasahara et a l, 
1994). Although chimaeric proteins are capable of targeting vectors to specific cell types 
the titres achieved so far are too low to be useful in in vivo gene therapy protocols.
Another method for altering the host range of a vector is the direct chemical or physical 
modification of the Env protein. An example of this is the conjugation of a biotinylated 
antibody to the protein (Roux et a l, 1989). The antibody can then be linked, via a 
streptavidin bridge, to a second antibody bound to a cellular antigen. This method has been 
employed to target E-MLV based vectors to human cells using antibodies against MHC 
molecules (Roux et a l, 1989). These antigens were chosen because they are present on 
several cell types and are efficiently internalised by endocytosis. Although these vectors 
were able to infect a number of human cell types, titres were low and efficiency of 
infection varied. However, it seems possible that this method could be used to target 
several different antigens. Neda et a l (1991) chemically coupled lactose residues to E- 
MLV, which allowed binding to hepatocyte-specific receptors. The modified viruses were 
able to infect these cells, perhaps via receptor mediated endocytosis. The fact that the 
modified virus was capable of introducing its genome into the hepatocyte cells suggests 
that the chemical modification did not hinder the normal fusion of the viral membrane with 
that of the endosome, prior to destruction in lysosomes.
An antibody or ligand can also be directly fused to the Env protein. Russell et a l (1993) 
have shown that a hybrid protein consisting of an antibody fragment and the MoMLV Env 
will bind specifically to the targeted antigen. The vectors used in this study were infectious,
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although it is not known whether membrane fusion was mediated by this protein as wild 
type Env was also incorporated. Nilson et a l (1996) produced a functional targeted protein 
by fusing epidermal growth factor to Env via a linker containing a protease recognition site. 
After binding to the receptor the ligand is proteolitically cleaved, allowing the Env to 
interact with its normal receptor.
The host cell range of a vector can also be altered by replacing the envelope protein with a 
protein from another virus. For example, Rous sarcoma virus (RSV) vectors bearing the 
hemagglutinin (HA) protein of influenza virus have been produced (Dong et al., 1992). 
This envelope protein extended the host range of the vectors, though titres were reduced. 
MLV based vectors bearing a variety of envelope proteins have also been constructed. 
These include GALV Env (Miller et al., 1991), Sendai virus glycoproteins (Spiegel et al,
1998), fowl plague virus HA (Hatziioannou et a l, 1998), and VSV G (Bums et a l, 1993; 
Emi et a l,  1991).
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1.5 Viral pseudotypes
Phenotypic mixing has been observed to occur naturally in cells doubly infected with 
related or unrelated enveloped viruses (Zavada, 1982). The pseudotypes formed in this 
process have incorporated envelope protein of the coinfecting virus. As a result they 
display the host range and neutralisation properties of this virus. The formation of 
pseudotypes indicates that during the budding process, viral particles are able to non- 
selectively incorporate viral envelope proteins while excluding the majority of cellular 
membrane proteins (Simons and Garoff, 1980; Zavada, 1982). The mechanisms that allow 
this to occur remain unclear, and much of the evidence appears contradictory. In 1982, 
Zavada put forward two possible models for enveloped virus assembly, illustrated in Fig. 
1.6. In model A the viral matrix protein attaches to the lipid membrane where it forms a 
crystal-like lattice. The internal domains of viral glycoproteins are accepted into this 
structure while nonviral proteins are rejected. The matrix lattice is essential for viral 
budding and can function in the absence of envelope protein. In model B the attachment of 
the matrix protein results in an alteration of the ultrastructure of the lipid membrane, 
causing cellular glycoproteins to become relatively less soluble and the viral proteins 
relatively more soluble. As a consequence, all viral envelope proteins concentrate around 
the area of bound matrix and cellular proteins are excluded.
lipid bilayer
matrix matrix
lipid bilayer
matrix
matrix
Fig. 1.6. Models of viral envelope incorporation, described in the text. A) Model A (Zavada, 1982). Viral 
proteins are incorporated through an interaction with the matrix protein. B) Model B (Zavada, 1982). The 
matrix protein alters the structure of the lipid bilayer, causing viral proteins to become more soluble than 
cellular. C) Active incorporation of retroviral Env proteins through a specific interaction with the matrix 
protein. D) Passive incorporation of retroviral Env proteins. Cellular proteins are prevented from moving into 
areas of budding by their interactions with other cellular proteins.
VI and V2, envelope proteins from different viruses; V, viral envelope protein; C, cellular membrane protein.
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1.5.1 Envelope protein incorporation by retroviruses
The assembly models proposed by Zavada generally correspond to the active and passive 
models of retroviral Env incorporation (Swanstrom and Wills, 1997). These are also shown 
in Fig. 1.6. In the active model, incorporation is driven by a specific interaction between 
the Env cytoplasmic domain and the viral MA proteins underneath the membrane. In the 
passive model, Env proteins are free to move within the membrane to sites of budding, 
while cellular proteins are immobilised by interactions with other cellular proteins and are 
therefore excluded. Model A and the active packing model imply that recognition of the 
cytoplasmic domain of the Env protein by MA is required for incorporation into the virion. 
However, it has been shown that RSV env mutants lacking this domain yield similar levels 
of infectious vims as the wild type (Perez et al., 1987). Perez et al. claimed that 
preliminary data implied that Env proteins with deletions within the transmembrane 
domain are inefficiently incorporated even though they are expressed at the host cell 
surface. This could mean that this domain, not the cytoplasmic domain, is recognised by 
the matrix protein. It has also been suggested that sequences within the transmembrane 
domain may be involved in the incorporation of MoMLV Env (Ragheb and Anderson,
1994), although other studies (Granowitz et al., 1991; Gray and Roth, 1993; Januszeski et 
al., 1997) have implicated regions of the cytoplasmic tail. The majority of these 
cytoplasmic domain mutants contained insertions or internal deletions. It is therefore 
possible that these prevented Env incorporation by altering the structure of the protein. 
However, Januszeski et al. found that complete truncation of the cytoplasmic domain of 
MoMLV Env reduced its incorporation, suggesting that recognition of this region is 
important. Cytoplasmic tail truncations of the Env proteins of HIV-1 and Mason-Pfizer 
monkey vims, a D-type retrovirus, have also been found to reduce incorporation (Brody et 
al., 1994; Yu et al., 1993).
Although viruses are known to exclude the majority of cellular proteins during the budding 
process the incorporation of human CD4 by avian leukosis vims (ALV) has been reported 
(Young et al., 1990). Two chimaeric proteins, consisting of the extracellular region of CD4 
and the transmembrane and cytoplasmic domains of the Env protein of either ALV or 
MLV, were transiently expressed in quail QT6 cells that had been previously transfected 
with an ALV vector. These proteins were incorporated into the virions, but the control wild
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type CD4 protein was incorporated 5 to 10 times more efficiently. Young et al. suggested 
that the quail cells may lack the proteins that would normally interact with CD4, therefore 
allowing the molecule to move freely within the membrane. This implies that incorporation 
of host cell surface proteins is normally prevented by their interactions with other 
membrane associated and cytoplasmic proteins, as proposed in the passive model 
(Swanstrom and Wills, 1997). The lower level of incorporation of the chimaeric CD4 
proteins may have been a result of competition or other interactions with the retroviral Env 
protein. Young et al. claimed that unpublished data show that an avian sarcoma virus that 
lacks env will incorporate both the wild type and chimaeric CD4 with equal efficiencies.
Dong et al. (1992) found that the influenza HA protein could be inserted into the envelope 
of RSV as efficiently as a chimaeric HA containing the membrane anchor and cytoplasmic 
domain of RSV Env. They concluded that this result indicated that recognition of either of 
these domains is not required for envelope incorporation. Dong et al. also found that the 
presence of influenza neuraminidase (NA) increased the incorporation of HA into RSV 
particles by approximately 70% relative to Gag. They suggested that the action of this 
enzyme may have released the HA protein from interactions with cell surface proteins, 
allowing it to move freely into regions of budding. However, as implied in model A, it is 
possible that a recognition signal is present in both viral envelope glycoproteins. This 
would allow the incorporation of the foreign viral protein at a comparable efficiency. In 
contrast, Lindemann et al. (1997) found that the replacement of the majority of the 
cytoplasmic domain of human foamy virus Env with that of MLV Env increased its 
incorporation into MLV-based vectors.
If there is a specific interaction between Env and MA it would be expected that mutations 
in MA could also affect Env incorporation. This has been found to be the case for certain 
deletions and point mutations within the amino-terminus of HIV-1 MA (Freed and Martin, 
1996; Lee et al., 1997; Yu et al., 1992). While this seems to indicate an interaction 
between the two proteins, it is also possible that a specific structure of MA is required in 
order to contain the long cytoplasmic domain of HIV-1, and that this is disrupted by these 
mutations. Interestingly, at least some MA mutants are able to incorporate HIV-1 Env 
proteins with truncated cytoplasmic domains (Freed and Martin, 1995; Mammano et al.,
1995). These mutants are also able to incorporate A-MLV Env, which has a much shorter
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cytoplasmic domain than HIV-1 Env. The difference in the length of this domain in the two 
proteins may explain why HIV-1 Env is not incorporated by MoMLV (Wilson et a l, 1989). 
Mammano et al. (1997) have shown that truncation of the long cytoplasmic domain does 
permit the incorporation of HIV-1 Env by this vims.
In infected polarised epithelial cells budding of enveloped viruses often occurs specifically 
at either the apical or basolateral membrane. Budding of the avian and mammalian C-type 
retroviruses and of HIV-1 occurs at the basolateral membrane (Lodge et al., 1994; Owens 
et a l, 1991; Roth et al., 1983). Following the expression of HIV-1 Gag in epithelial cells in 
the absence of Env, viral maturation and budding is spread evenly between the two 
membranes. In the presence of Env expression the polarisation of budding is restored 
(Owens et al., 1991). This restriction of budding is due to a basolateral membrane targeting 
signal present in the cytoplasmic domain of Env (Lodge et al., 1997a; Lodge et al., 1997b). 
The ability of Env to direct the budding of virions in this way supports the theory that there 
is a specific interaction between Env and MA, and suggests that such an interaction could 
occur within the cell, prior to assembly at the cell surface. An interaction within the cell is 
also implied by the observation that certain MA mutants affect the cellular transport of 
HIV-1 Env in CD4+ T lymphocytes (Lee et al., 1997). While it may be suggested that the 
high levels of protein expression in these experiments could in itself be influencing the 
intracellular transport of Gag, it has been observed that mutations in MA that normally 
affect Env incorporation can prevent Env-directed polarised budding (Lodge et al., 1994).
The Env proteins of human T-cell leukaemia vims type 1 (HTLV-1) and MoMLV have 
been shown to direct the polarised budding of Env-negative HIV-1 virions in epithelial 
cells (Lodge et al., 1997a), suggesting that the putative incorporation signal is common to 
all Env proteins. However, a higher level of expression was required to achieve 
polarisation compared with that required with the HIV-1 Env. This implies that 
incorporation of the heterologous Env proteins is less efficient. Heterologous envelope 
proteins may also be incorporated less efficiently by MoMLV. Suomalainen and Garoff
(1994) found that Semliki Forest vims spike protein or a tmncated mutant of the human 
transferrin receptor could only be incorporated efficiently when expressed at high density 
on the cell surface. In contrast, MoMLV Env was efficiently incorporated when expressed 
at low density. Further evidence of a virus-specific interaction between Env and the Gag
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proteins comes from the work of Weclewicz et a l (1998). This study found that when 
expressed separately in rat neurons, Env is restricted to the somatic region of the cells 
while Gag is found in both the axonal and somatic regions. When the proteins are 
coexpressed they are both found only in the somatic region. Weclewicz et a l were able to 
show that this was true for both MLV and HIV. However, expression of the Gag proteins 
with the heterologous Env did not restrict the localisation of Gag, indicating that the 
interaction is virus-specific. It seems possible that such an interaction allows the vims to 
preferentially incorporate its own Env protein. However, since this interaction is not 
essential for virion release (Owens et a l, 1991; Ruta et a l, 1979; Smith et al., 1990), 
budding virions are able to incorporate foreign envelope proteins either passively or via a 
low affinity interaction.
1.5.2 Envelope protein incorporation by rhabdoviruses
Much of the evidence obtained from studies of VSV suggests that efficient incorporation of 
the G envelope glycoprotein depends on an interaction with the matrix (M) or other internal 
viral proteins. Several studies investigating the incorporation of VSV G have made use of 
the temperature sensitive mutant ts045 (Flamand, 1970; Lafay, 1974). These viruses 
possess a mutation in the G gene which results in the accumulation of the protein in the 
endoplasmic reticulum at the nonpermissive temperature, 40°C. Whitt et a l (1989) tested a 
series of mutated G proteins for their ability to rescue this mutant at the nonpermissive 
temperature. G proteins that retained 9 or 18 of the membrane proximal cytoplasmic amino 
acids rescued ts045 at levels 3 to 4 fold lower than the wild type. Those that retained only 1 
or 3 of these residues produced just a slight increase in titre compared to the mock- 
transfected control. This suggests that an interaction between this membrane proximal 
region and the internal VSV proteins may be necessary for G incorporation. G proteins 
with internal deletions in the cytoplasmic domain rescued ts045 at near wild type levels, 
indicating that the membrane distal region may also be important. G proteins with foreign 
cytoplasmic domains did not rescue to a significant level. Whitt et a l suggested that the 
low level of rescue obtained with some of the G protein mutants may be the result of 
random incorporation. The cytoplasmic tail of the rabies G protein also appears to contain a 
signal that promotes its incorporation into virions. Mebatsion et a l (1996) found that 
removal of this domain significantly reduces incorporation of G by rabies virus. In addition
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the virion particles varied in their G protein content, suggesting that incorporation of this 
truncated protein is non-specific.
Avian myeloblastosis virus (AMV) has been shown to be capable of rescuing VSV ts045 at 
the nonpermissive temperature (Zavada, 1972). The virus particles released had the 
neutralisation, host range and interference specificity of the retrovirus indicating that the 
Env protein had been incorporated. Weiss and Bennett (1980) were also able to show 
rescue of ts045 by AMV. However, rescue attempts with MoMLV were much less 
successful. As this discrepancy did not appear to be the result of the cell type used the 
authors suggested that these differences were due to the strain of retrovirus. If this is the 
case it is possible that the cytoplasmic domains of the different envelope proteins have 
different affinities for the M protein. This would be in partial agreement with model A 
(Zavada, 1982, Fig. 1.6), since it implies that the different viral envelope glycoproteins 
interact with matrix proteins, albeit with different efficiencies. It would be expected that 
the native proteins would display the highest affinity.
Witte and Baltimore (1977) reported that VSV pseudotypes containing the envelope 
protein of MoMLV could only be produced at permissive and semi-permissive 
temperatures with various G ts mutants, or with wild type VSV. They interpreted this to 
mean that at least some G protein was required for the budding process. Schnell et a l 
(1996) have shown that CD4 or measles virus envelope proteins can be incorporated into 
VSV alongside the G protein. As no reduction in the levels of G was observed, the authors 
suggested that this protein interacts specifically with M while the foreign proteins are 
passively trapped into the budding virions. The spikeless te045 mutant virions do contain 
some truncated G protein, consisting of the transmembrane and cytoplasmic domains 
(Metsikko and Simons, 1986). This may explain why these viruses are able to bud at the 
nonpermissive temperature. Pattnaik and Wertz (1991) also concluded that G is required 
for budding of VSV. In this study the five VSV proteins were expressed in cells in order to 
test their ability to rescue defective interfering particles. These particles are unable to 
replicate independently because they do not code for any functional VSV proteins. The 
expression of the nucleocapsid proteins in the absence of either M or G did not result in 
viral budding, indicating that both proteins are required. However, culture media were only 
tested for the presence of virus following a second infection. Any virus lacking G that was
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produced during the first infection would be unable to infect and replicate in the second set 
of cells, and therefore would not have been detected. The related rabies virus has been 
shown to be able to bud in the absence of its G protein, although particle production is 
reduced approximately 30 fold (Mebatsion et a l, 1996).
Owens and Rose (1993) were unable to rescue ts045 by the expression of the HIV-1 Env 
protein in infected cells. However, the expression of a chimaeric protein, in which the 
cytoplasmic domain had been replaced by that of VSV G, resulted in the release of 
infectious virus. These viruses were specific for CD4+ human HeLa cells and could be 
neutralised by anti-HIV serum. The ability of this chimaeric protein to rescue the VSV 
mutant suggests that the cytoplasmic tail of G provides a positive signal for the 
incorporation of the envelope protein into the virion. Similar results have also been 
obtained with rabies virus. Mebatsion and Conzelmann (1996) have shown that HIV-1 Env 
is only incorporated into a G-negative rabies mutant when the cytoplasmic domain is 
replaced with that of rabies G, indicating that this region is required. Of course, it is also 
possible that replacement of the long HIV-1 Env cytoplasmic domain removed a structure 
that was incompatible with incorporation into rhabdovirus particles. Owens and Rose 
(1993) found that a protein containing part of the HIV-1 Env cytoplasmic domain as well 
as that of VSV G was not incorporated by the ts045 virus. Rabies virus lacking G protein 
can incorporate the G protein of Mokola virus, another Lyssavirus, although the titre of this 
pseudotype is reported to be approximately 30 fold lower than that of the wild type rabies 
virus (Mebatsion et al., 1995). The cytoplasmic domain of Mokola G shares little 
homology with that of rabies G but it is also short, and may therefore be more easily 
accommodated than HIV-1 Env. Schnell et al. (1998) found that recombinant VSV 
expressing a chimaeric G protein containing the cytoplasmic domain of CD4 are able to 
bud efficiently, while those containing a cytoplasmic domain of only 1 amino acid did not. 
Following passage of this latter mutant, a revertant was selected that had acquired an 8 
amino acid cytoplasmic domain. These observations imply that an envelope protein with a 
short cytoplasmic domain is necessary for efficient budding of VSV, but that there is no 
strong sequence requirement within this domain.
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1.5.3 Uses of viral pseudotvpes
The ability of enveloped viruses to incorporate foreign envelope proteins can be exploited 
for several experimental and clinical applications. For example, as mentioned above 
(section 1.4.3), pseudotyping can be employed to alter the properties of viral vectors used 
for gene transfer. The production of vectors containing the VSV G glycoprotein was an 
important advance in the development of retroviral vectors (Bums et a l, 1993; Emi et a l, 
1991). These vectors have a wide host range, and can be concentrated to high titres. 
Pseudotyped viruses can also be used to easily define the host range of viruses for which no 
simple infection assays are available. These pseudotypes bear the envelope protein of the 
virus of interest, and therefore will only infect cells that express the receptor recognised by 
this protein. Pseudotypes of VSV have been used to study the receptor usage of several 
viruses, including hepatitis C vims and HIV (Boettiger, 1979; Dalgleish et a l, 1984; 
Lagging et a l, 1998; Sommerfelt and Weiss, 1990). Infection can be detected by the 
formation of visible plaques. Pseudotyped vectors can also be used for receptor studies as 
the opportunity for the insertion of marker genes into the vector genome allows simple 
detection of infected target cells. Retroviral vectors have been used to investigate the 
function of several viral glycoproteins, for example those of ASLV-A and Ebola (Rong et 
a l,  1997; Wool-Lewis and Bates, 1998).
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1.6 Aims
The aims of this study were two-fold, both of which made use of the possibility of 
producing pseudotyped retroviral vectors that display the host range properties of the virus 
donating the envelope protein.The first part involved attempts to produce a retroviral vector 
bearing the envelope protein of rabies virus. Retroviral vectors bearing the envelope 
protein of VSV have been shown to display increased stability and the wider host range of 
VSV (Bums et al., 1993). Unfortunately high level expression of the VSV protein causes 
cell fusion. It was hoped that the equivalent rabies protein would be more suitable for high 
expression in cell culture, and that its incorporation into a retroviral vector would confer 
similar properties as the VSV protein.
The second part involved analysis of the host ranges of endogenous retroviruses of pigs. 
This is of interest due to the proposed use of porcine organs and tissues for human 
transplants, and the potential risk these viruses pose in such a process. Although host range 
can be investigated through the transfer of infection from virus-releasing cells to target 
cells, the use of pseudotyped vectors allows individual analysis of the Env proteins of each 
ERV strain.
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CHAPTER 2
Chapter 2 Materials and methods
2.1 Materials
2.1.1 Cell lines
Cos-7 is an African green monkey kidney fibroblast line, transformed by an origin- 
defective mutant of SV40. These cells express the SV40 large T antigen (Gluzman, 1981).
293 is a human embryonic kidney line, transformed with sheared human adenovirus 5 
DNA (Graham et al., 1977; Graham et a l, 1978; Harrison et al., 1977).
293T is an SV40 large T antigen expressing line derived from 293 cells (DuBridge et al., 
1987).
293-GP is a FeLV Gag/Pol expressing line derived from 293 cells (a gift from Derek Bain, 
Vet Pathology, University of Glasgow)
BHK TK~ is a Syrian hamster kidney fibroblast line, derived from BHK21 (clone 13) and 
rendered TK negative by selection in BUdR (Littlefield and Basilico, 1966; Stoker and 
Macpherson, 1964).
AH927 is a feline embryonic fibroblast line (Rasheed and Gardner, 1980).
NIH 3T3 is a murine fibroblast line, established from a NIH Swiss mouse embryo 
(Andersson et al., 1979; Copeland and Cooper, 1979; Jainchill et al., 1969).
PK15 is a porcine kidney epithelial line (Armstrong et a l, 1971).
MPK is a minipig kidney fibroblast line, established from a 118 day old foetal minipig 
(ECACC ref. no. 87032604).
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ST is a porcine testicular line established from the trypsinised testis of a normal 80-90 day 
old porcine foetus (McClurkin and Norman, 1966).
Raji is a human Burkitt lymphoma line established from an 11 year old male (Pulvertaft, 
1964).
SupTl is a human T cell lymphoblastomic lymphoma line (Smith et a l, 1984).
J.Jhans is a human T cell line.
RK13 is a rabbit kidney fibroblast line established from a 5 week old rabbit (Beale et a l , 
1963).
TblLu is a bat lung epithelial line established from an adult female bat (ECACC ref. no. 
90020805).
2.1.2 Cell culture media
All media and supplements were purchased from Gibco, UK, unless otherwise stated. 
Media described as 10% contained 10% foetal calf serum (FCS). Cos-7, AH927, NIH 3T3, 
ST, and RK13 cells were all grown in 10% DMEM (Dulbecco’s Modified Eagle’s 
Medium). 293, 293T, 293-GP, PK15, MPK, and TblLu were all grown in 10% DMEM 
supplemented with IX non-essential amino acids. 400pg/ml G418 (Calbiochem, UK) was 
added to stock flasks of 293T cells in order to select for neomycin resistant cells expressing 
the SV40 large T antigen. 50pg/ml zeocin (Invitrogen, UK) was added to stock flasks of 
293-GP cells in order to select for zeocin resistant cells expressing FeLV Gag/Pol. BHK 
TK~ cells were grown in Glasgow MEM (Minimum Essential Medium) supplemented with 
5% FCS. Raji, SupTl and J.Jhans cells were grown in 10% RPMI (Rosewall Park 
Memorial Institute) 1640 medium. All media were also supplemented with 2mM 
glutamine, 100 U/ml penicillin and 10|Hg/ml streptomycin.
66
2.1.3 Bacterial strains
E. coli DH5a: subcloning efficiency DH5a competent cells (Gibco, UK). F  
<j)80d/acZAM15 A(lacZYA-argF)U 169 deoR recA\ end A l h sd R llfa ,  mk+) phoA supE44 
X  thi-\ gyr A96 relAl.
E. coli HB101: subcloning efficiency HB101 competent cells (Gibco, UK). F" mcrB mrr 
/udS20(rB\  me") recA13 supE44 aral4 galK2 lacYl proA2 rpsL20(Smr) xyl5 X  leu mtl\.
E. coli DM1: subcloning efficiency DM1 competent cells (Gibco, UK). Absence of dam 
and dcm methylases prevents methylation at GATC and CC(A/T)GG sites. F  dam 
13::Tn9(CmR) dcm-mcrB hsdR'M+ gall gal2 ara' lac' thr leu tonR tsxR su° X.
2.1.4 Plasmids
The eukaryotic expression vectors used were pcDNA3 (Invitrogen, UK) and pCI-neo 
(Promega, UK).
pcDNA3 carries ampicillin resistance (Ampr), neomycin phosphotransferase (neo) which 
confers resistance to G418, the human CMV immediate-early promoter, the bovine growth 
hormone polyadenylation (poly A) signal, and the SV40 origin of replication (ori) which 
induces transient, episomal replication of the vector in cells expressing the SV40 large T 
antigen.
pCI-neo also carries Ampr, neo, the human CMV immediate-early promoter, and the SV40 
ori. In addition it carries the SV40 poly A signal, and a chimaeric intron downstream of the 
CMV promoter region, believed to increase the level of gene expression.
The HIT system plasmids, pHIT60, pHIT456 and pH IT lll (Soneoka et al., 1995), were 
kindly provided by Yuko Soneoka (University of Oxford). These are MLV based retroviral 
constructs with the CMV promoter and SV40 ori.
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pHIT60 encodes the gag/pol gene.
pHIT456 encodes the amphotropic MLV env gene.
p H IT lll is a vector construct which carries the packaging signal \j/, neo and the LacZ gene 
encoding p-galactosidase.
pMV12 was a gift from Gavin Wilkinson (University of Wales College of Medicine, 
Cardiff). This plasmid carries the LacZ gene under the control of the CMV (strain AD 196) 
promoter (position -299 to +69) and immediate-early poly A signal.
pGT5 was a gift from John Oldfield (Veterinary Pathology, University of Glasgow). This 
plasmid encodes the FeLV gag/pol gene.
2.1.5 Reagents and stock solutions
All reagents and chemicals were obtained from Sigma, BDH, Boehringer Mannheim, 
Pharmacia, Fischer Scientific or Gibco unless otherwise stated, and were of Analar quality.
Agarose gel (TBE): 0.8 or 1% (w/v) agarose, 50ml IX TBE buffer, 0.5|ig/ml ethidium 
bromide.
Agarose gel (TAE): 4% (w/v) agarose, 50ml IX TAE buffer, 0.5|ig/ml ethidium bromide.
Ammonium persulphate (APS): 10% (w/v) in deionised water (dF^O). Stored at 4°C for up 
to a week.
Ampicillin: 50mg/ml stock in dF^O. Filtered through a 0.2|im filter and stored at -20°C.
Denaturing polyacrylamide gel: 4% (w/v) acrylamide (Sequagel XR, National 
Diagnostics), 7M urea, 1.2% (v/v) TBE in dH20. 400^1 of 10% APS and 40^1 of TEMED 
(N, N, N’, N’-tetramethylethylenediamine) was added for each 60ml sequencing gel.
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DNA size markers: <j)X174 RF DNA/Haelll fragments and XDNA/HindlH fragments.
Dithiothreitol (DTT): 1M stock in dH20 . Stored in 1ml aliquots at -20°C.
Ethidium bromide: lOmg/ml stock in dH20 . Stored at room temperature protected from 
light.
G418: 50mg/ml stock in dH20. Filtered through a 0.2pm filter. Stored at -20°C.
Gel loading buffer: 50% (v/v) glycerol, 20mM EDTA, 0.5% (w/v) bromophenol blue, 0.5% 
(w/v) xylene cyanol. Stored at room temperature. Used at a 1/10 dilution.
2X HBS: 280mM NaCl, 50mM HEPES, 1.5mM Na2HP04, pH 7.12. Filtered through a 
0.2pm filter, and stored at 4°C.
Laemmli sample buffer: 2% (w/v) SDS, 10% (v/v) glycerol, 60mM Tris pH 6.8, 0.005% 
(w/v) bromophenol blue. Stored at room temperature. lOOmM DTT was added 
immediately prior to use from a 1M stock.
Laemmli running buffer (IPX): 2.5M Tris, 19M glycine, 1% (w/v) SDS, pH 8.3. Stored at 
room temperature.
LB: 1% (w/v) tryptone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl in dH20 . Sterilised by 
autoclave. Stored at room temperature.
LB-agar: 1.5% (w/v) agar in LB. Sterilised by autoclave. Stored at room temperature.
Low TE buffer: ImM Tris pH 7.5, 50pM EDTA. Filtered through a 0.2pm filter. Stored at 
4°C or at room temperature.
4% paraformaldehyde: 0.1M PBS, 0.12M sucrose, 4% (w/v) paraformaldehyde, pH 7.4. 
Stored at 4°C.
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PBS: 0.1M Na2HP(>4, O.IM NaH2P0 4 , 0.6% (w/v) NaCl, pH 7.4. Sterilised by autoclave, 
and stored at room temperature.
Phenvlmethylsulphonvl fluoride (PMSF): lOOmM stock in ethanol. Stored at -20°C.
Polv-L-lvsine: lmg/ml in 0.1M borate buffer, pH 8.5. Filtered through a 0.2pm filter. 
Stored at 4°C.
Polyacrylamide gel (SDS-PAGE): 10% (w/v) acrylamide mix (Scotlab, UK), 390mM Tris 
pH 8.8, 0.1% (w/v) SDS, 0.1% (w/v) APS, 0.04% TEMED.
PRO-MIX™: 70% L-[35S]Met, 30% L-[35S]Cys. (Amersham Life Science, UK)
Protein markers: Rainbow high molecular weight markers (Amersham Life Science, UK).
RIPA lysis buffer: 1% (w/v) NP-40, 150mM NaCl, 50mM Tris pH7.4, 20mM EDTA pH8. 
Stored at room temperature. ImM PMSF was added immediately prior to use from a 
lOOmM stock.
TAE (50X1: 2M Tris-HCl pH 8.15, 1.5M NaOAc, 1M NaCl, 0.1M EDTA. Stored at room 
temperature.
TBE (10X1: 0.9M Tris-HCl, 0.9M boric acid, 25mM EDTA. Stored at room temperature.
TBS: 137mM NaCl, 3mM KC1, 25mM Tris base, 1.5% phenol red, pH 7.4.
TE buffer: lOmM Tris, ImM EDTA, pH 8. Sterilised by autoclave or by filtration through 
a 0.2pm filter. Stored at room temperature.
Versene: 800pg/ml NaCl, 20pg/ml KC1, 115p,g/ml Na2HPC>4, 20pg/ml EDTA, 1% phenol 
red. Sterilised by autoclave. Stored at room temperature.
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X-gal staining solution: 2.1 mg/ml potassium ferrocyanide, 1.6mg/ml potassium 
ferricyanide, 0.186mg/ml magnesium chloride. Stored at 4°C for up to a week. 1 mg/ml X- 
gal was added immediately prior to use from a 40mg/ml stock.
X-gal: 40mg/ml stock in DMSO.
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2.2 Methods
2.2.1 Eukaryotic cell culture
2.2.1.1 Maintenance of cells
Cells were grown at 37°C in an atmosphere of 5% C 02 in air, in sterile plastic flasks. 
Adherent cells were subcultured by washing in phosphate buffered saline (PBS) and 
incubating for 1 to 5mins in trypsin/EDTA (Gibco, UK). The cells were then washed off 
and resuspended in fresh medium. MPK, PK15 and ST cells were washed in versene prior 
to incubation in trypsin/EDTA. Non-adherent cells were recovered by centrifugation and 
resuspended in fresh medium.
2.2.1.2 Cell storage
PK15 cells were stored in 5% glycerol, 10% FCS, 85% DMEM. MPK cells were stored in 
5% dimethyl sulphoxide (DMSO), 10% FCS, 85% DMEM. All other cell lines were stored 
in 10% DMSO, 10% FCS, 80% medium. Cells were either frozen to -100°C in a controlled 
rate cell freezer (Planer Kryo 10, Series II), or to -70°C in a polystyrene container 
overnight, before being transferred to liquid nitrogen vapour phase.
2.2.1.3 Transfection of cells
Most transfections were carried out using calcium phosphate precipitation (Graham and 
van der Eb, 1973). Cells were seeded the day before transfection to give approximately 
40% confluency in 25cm2 flasks. 5|Lig of each plasmid was added to low TE buffer to a 
final volume of 210|il. 30pl of 2M CaCl2 was added drop-wise and the solution was mixed 
thoroughly. This was then mixed with 240jli1 2X HEPES buffered saline (HBS), left to 
form a precipitate for 30min, and then added to the cells in fresh medium. 16-18 hours later 
the transfection medium was removed, the cells were washed in PBS and fresh medium 
was added.
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The other methods of transfection used were lipofection and DEAE-dextran. Lipofection 
was carried out using L ipofectA M IN E ™  (Gibco, UK). This is a 3:1 (w/w) liposome 
formulation of 2,3-dioleyloxy-N-[2(sperminecarboxamido)ethyl]-N,N-dimethyl-1 - 
propanaminium trifluoroacetate, and dioleoyl phosphatidylethanolamine in water. 
Approximately 1 x 105 cells were seeded in 6 well plates 24 hours prior to transfection. 1 pig 
of plasmid in lOOpl serum free DMEM was added to 6|il L ipofectA M IN E ™  in lOOpJ 
serum free DMEM, and incubated at room temperature for 45min. This was then mixed 
with 800|il serum free DMEM and added to the cells. All medium used was antibiotic free. 
After incubation at 37°C for 5 hours the cells were washed and fresh, complete medium 
was added. For the transfection of cells in 25cm2 flasks, figures were increased by a factor 
of 2.5.
When the DEAE-dextran transfection method was used, 6|Lig of plasmid was mixed with 
2.5pl 50mg/ml DEAE-dextran/Tris buffered saline (TBS) in 500|ll1 serum free DMEM. The 
cells to be transfected were washed twice with serum free DMEM and then incubated with 
the DNA/DEAE-dextran mixture for 4 hours at 37°C. The transfection medium was then 
removed and 10% DMSO in TBS was added for 2min. The cells were washed with PBS 
and complete medium was added.
2.2.2 Preparation of DNA
2.2.2.I Preparation of plasmids
Small scale preparations of plasmids were obtained from 2ml overnight cultures using the 
Quantum Prep Plasmid Miniprep Kit (Bio-Rad, UK), according to the manufacturer’s 
instructions. Briefly the cells were lysed using alkaline lysis, cellular debris removed by 
sodium dodecyl sulphate (SDS) -precipitation, and the remaining solution mixed with a 
DNA-binding matrix. This was washed, and the DNA then eluted with dPUO or TE buffer, 
and stored at 4°C.
Large scale DNA preparations were obtained from 100-500ml overnight cultures using the 
Qiagen maxi-prep kit (Qiagen Ltd., UK), according to the manufacturer’s instructions.
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Briefly the cells were lysed using alkaline lysis, and RNA degraded by RNase A. Cellular 
debris was removed by SDS-precipitation. Plasmid DNA was then bound to an anion- 
exchange resin under low salt conditions, washed with a medium salt buffer to remove 
contaminants, and eluted by a high salt buffer. The DNA was desalted by isopropanol 
precipitation, washed with 70% ethanol, air-dried and redissolved in TE buffer. The 
concentration of DNA was calculated on the basis that 50pg/ml double stranded DNA has 
an OD260 measurement of 1. DNA solutions were stored at 4°C or -20°C.
2.2J2.2 Preparation of genomic DNA
Genomic DNA was prepared using the Nucleon® Genomic DNA Extraction Kit (Scotlab, 
UK), according to the manufacturer’s instructions. Briefly, approximately 5 x 106 cells 
were lysed and then deproteinised with sodium percolate. The DNA was extracted with 
chloroform while a resin was added to bind and remove any cell impurities. The DNA was 
then ethanol precipitated, washed in 70% ethanol, air-dried, and dissolved in low TE 
buffer. The concentration of DNA was calculated on the basis that 50|Lig/ml double 
stranded DNA has an OD26o measurement of 1. DNA solutions were stored at 4°C or - 
20°C.
2.2.2.3 Restriction endonuclease digestion
Restriction endonucleases were used with the buffers supplied, according to the 
manufacturer’s instructions. In general, 10 units of enzyme was used to digest 1 pig of DNA 
at 37°C for 2 hours. The enzyme was then heat inactivated by incubation at 70°C for 
lOmin.
2.2.2.4 Gel electrophoresis
DNA samples were separated by electrophoresis on 0.8 - 4% agarose gels in IX TBE or IX 
TAE buffer. 50ml gels were poured in perspex tanks and wells were cast using the 
appropriate combs. Gel loading buffer was added to the samples which were then loaded
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into the wells and run through the gel at 70 to 100V. Gels were viewed on a short wave UV 
transilluminator (UVP Inc.).
2.2.2.5 Gel purification of DNA
DNA samples were run out on 0.8% agarose TAE gels. The DNA was visualised under 
ultra-violet light and the appropriate band was then excised using a clean scalpel. The DNA 
was purified from the gel using the QIAquick™ Gel Extraction kit (Qiagen Ltd., UK), 
according to the manufacturer’s instructions. Briefly, the gel was dissolved in a high salt 
buffer and the DNA was then bound to a silica membrane. After washing, the DNA was 
eluted from the membrane with dH20.
2.2.3 Cloning of hybrid DNA molecules
2.2.3.1 Ligation of DNA fragments
Fragments of DNA generated by restriction endonuclease digestion were ligated into 
vectors by the following procedure. Firstly, vector plasmid was linearised with an 
appropriate restriction enzyme. To prevent recircularisation of the vector the 5’ phosphate 
groups at the digested ends were hydrolysed by incubation with calf intestinal alkaline 
phosphatase (CLAP, Gibco, UK) at 37°C for 45mins. This enzyme was then heat 
inactivated for lOmin at 70°C. The linearised vector and DNA fragment were gel purified 
(section 2.2.2.5) and then ligated using T4 DNA ligase (Gibco, UK) either at room 
temperature for 4 hours or at 14°C overnight. The ligation reaction was then used to 
transform E. coli.
2.2.3.2 Transformation of E. coli
The majority of plasmids were grown in subcloning efficiency DH5a competent cells 
(Gibco, UK). pHIT60 was grown in HB101 competent cells (Gibco, UK) to avoid deletion 
of the plasmid. l-10ng of DNA was added to 50jil of cells and incubated on ice for 30min. 
The cells were heat-shocked at 37°C for 20s and then returned to ice for a further 2min.
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950jll1 of Lennox L Broth (LB, Gibco, UK) was added and the cells were incubated for 1 
hour at 37°C in an orbital incubator (Stuart Scientific, SI 50). The cultures were then 
spread onto LB agar (Gibco, UK) plates containing 50pg/ml ampicillin (Amp, Sigma, UK) 
and incubated overnight at 37°C. Amp resistant colonies were picked with sterile 
toothpicks and grown up in LB containing 50p.g/ml Amp. Clones containing the plasmid o f  
interest were identified by small scale DNA purification (section 2.2.2.1) and restriction 
digestion (section 2.2.2.3).
2.2.4 Production of pseudotyped vectors
2.2.4.1 Transient production of vectors
Vectors were produced using the HIT system as described previously (Soneoka et al., 
1995). 293T cells were transfected with pHIT60, pH IT lll, and the appropriate envelope 
protein construct, using calcium phosphate precipitation (section 2.2.1.3). One flask was 
transfected with pH IT lll alone as a negative control, and one with pMV12 as a control 
for transfection. Following transfection fresh DMEM was added to the cells. In order to 
measure vector titre, the medium was removed, filtered through 0.45|im filters, and added 
to target cells in 1ml aliquots in the presence of 8jig/ml Polybrene (hexadimethrine 
bromide, Sigma, UK). Samples from pHIT456 transfections were added as a 1/1000 
dilution. The cells were incubated at 37°C for 2 hours and then fresh medium was added. 
48 hours later the cells were stained for p-galactosidase (p-gal) activity. Staining of 
pMV12 transfected cells was carried out when the samples were taken.
2.2.4.2 Detection of B-gal activity
Cells were washed in warm PBS and fixed for 15min in 4% paraformaldehyde. They were 
then washed twice before being permeabilised with 0.3% Triton X-100/PBS for 5min. 
After a further 2 washes staining solution containing 1 mg/ml X-gal (5-bromo-4-chloro-3- 
indoyl p-D-galactopyranoside, Biogene Ltd., UK) was added and the cells were incubated 
at 37°C overnight. Vector titres were then determined by counting the number of blue cell 
colonies.
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CHAPTER 3
Chapter 3 Production of retroviral vectors pseudotyped with the rabies
virus G glycoprotein 
3.1 Introduction
3.1.1 VSV G pseudotyped vectors
A limitation in the use of retroviral vectors for gene transfer is their restricted host cell 
range. This can be altered through the production of pseudotypes. For example, MoMLV 
based vectors bearing the Env protein of GALV are able to infect bovine and hamster cells 
(Miller et a l, 1991). Another advantage in the use of vectors pseudotyped with a foreign 
envelope protein is that it reduces the risk of recombination between packaging constructs. 
Since retroviruses have also been shown to be able to form pseudotypes with 
paramyxoviruses, orthomyxoviruses, togaviruses and rhabdoviruses (Dong et a l, 1992; 
Zavada, 1982), any one of these could be chosen for the production of a pseudotyped 
vector. However, both togaviruses and paramyxoviruses require two proteins for membrane 
binding and fusion. Also the incorporation of influenza virus HA into RSV particles is 
increased by approximately 70% in the presence of NA, an enzyme normally found in the 
envelope of influenza virions (Dong et a l, 1992). Rhabdoviruses such as VSV possess 
only one envelope protein, the glycoprotein G (Wagner, 1990). Emi et a l (1991) showed 
that this protein can be incorporated into MoMLV-based vectors in the absence of any 
other VSV proteins. These vectors were infectious and could be neutralised by anti-VSV 
antibodies.
A major advance in retroviral vector technology was the production of high titres of 
retroviral vectors pseudotyped with this VSV envelope glycoprotein (Bums et a l, 1993). 
These vectors were produced in 293 cells stably expressing the MoMLV gag and pol 
genes, which were further transfected with a vector encoding VSV G. The high titres 
(>109cfu/ml) that can be achieved with these pseudotypes are mainly due to the fact that 
they can be concentrated by ultracentrifugation. Attempts to concentrate retroviruses by 
such means results in a significant loss of infectivity. This is thought to be due to the 
instability of the Env protein (Bums et a l, 1993; Yee et a l, 1994). Since the SU protein is
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noncovalently attached to TM it is prone to detachment. The VSV G protein is a 
homotrimer (Doms et a l , 1987; Doms et al., 1988) and, therefore, more resistant to the 
shearing forces met during ultracentrifugation. This ability to concentrate vector 
preparations is advantageous for many procedures requiring the infection of large numbers 
of cells, including in vivo gene therapy.
VSV enters cells via receptor-mediated endocytosis. The reduction in pH within the 
endosome triggers a conformational change in the envelope glycoprotein, resulting in 
membrane fusion (Wagner, 1990). As discussed in section 1.2.2 the G protein is thought to 
interact with a phospholipid constituent of the cell membrane (Schlegel et a l, 1983; 
Superti et a l,  1984b). As a result the virus has a very broad host range, and this is 
conferred to the pseudotyped vectors (Bums et a l, 1993; Yee et a l, 1994).
Unfortunately VSV G is toxic to cells and high level expression causes cell fusion (Bums 
et a l,  1993). Stable expression of G has been achieved, but only at levels too low for 
efficient vector production. Florkiewicz et a l (1983) isolated a murine C l27 cell line in 
which more than 95% of the cells were found to be positive for G expression using 
immunofluorescence. However, there was a cell to cell variation in expression of at least 
30 fold. Extra G-related proteins were also produced by these cells, possibly as a result of 
aberrant splicing of the mRNA. Madin-Darby canine kidney (MDCK) cells stably 
expressing G have also been obtained (Roman et a l, 1988). The proportion of positive 
cells was enriched from 2 to 74% through the use of immunoselection. However, after 5 to 
10 passages this level decreased to between 13 and 20%, probably because of the toxicity 
of the G glycoprotein. Bums et a l produced their vectors by making use of a period of high 
level expression of VSV G, before accumulation of the protein at the cell surface led to 
syncytium formation and cell death. Since high titres are produced this method is sufficient 
for many experimental techniques. Nonetheless, stable expression would be preferred for 
the large scale production of vectors for gene therapy.
3.1.2 Rabies G
It seems possible that a G protein from another rhabdovirus may also be suitable for the 
production of high titre pseudotyped vector. Like VSV, rabies vims has a very wide host
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range. Although it has a strong neurotropism in vivo, it can infect a large variety of cells in 
vitro, including mammalian, avian, fish, reptile and insect cells (Seganti et a l, 1990). VSV 
and rabies virus belong to two different rhabdovirus genera, the Vesiculoviruses and the 
Lyssaviruses respectively. Viruses from both genera infect vertebrates. The Vesiculoviruses 
also infect insects which may be involved in infection transmission. These viruses infect 
epithelial cells causing vesicular disease. The Lyssaviruses infect the central nervous 
system causing fatal encephalitis (Baer et al., 1990; Wagner, 1990). Vesiculovirus infection 
is characterised by a rapid course, cytopathology, a high density of viral budding from 
plasma membranes, and extracellular accumulation of virus. In contrast, Lyssavirus 
infection follows a slower course. There is a progressive accumulation of inclusion bodies 
in infected cells, and viral budding occurs from internal membranes as well as the plasma 
membrane. Laboratory adapted strains of Lyssaviruses appear to bud mainly from the 
plasma membrane (Murphy and Harrison, 1980). Despite these differences, VSV and 
rabies virus show many similarities in morphology and genomic organisation. The two G 
proteins are approximately the same size; rabies G consists of 524 amino acids, and VSV G 
of 511. They have an overall sequence homology of 20%, with some regions, including a 
glycosylation site, having more than 50%. In addition, 8 out of the 15 cysteine residues 
present in VSV G align with 8 of the 17 in rabies G. These similarities suggest that the two 
glycoproteins have similar secondary structures (Rose et al., 1982).
Rabies G has a slower rate of transport through the cell than VSV G. This can be measured 
by the time taken for acquisition of endoglycosidase H-resistant sugars. The presence of 
these sugars indicates arrival to the medial cistemae of the Golgi complex (Dunphy and 
Rothman, 1985). Rabies G has a half-time of approximately 50 minutes (Whitt et a l, 
1991), which compares to 15-20 minutes for VSV G (Rose and Bergmann, 1983).
An advantage of the rabies G protein is that it has a lower pH threshold for fusion activity. 
HeLa cells transiently expressing VSV G have been shown to form syncytia at pH 6.3 and 
below, while those expressing rabies G did not form syncytia above pH 6.1 (Whitt et al,
1991). In addition, hemolysis of human erythrocytes by rabies virus almost completely 
disappears above pH 6.2, while a low level can be detected with VSV even at neutral pH 
(Mifune et a l, 1982). This property suggests that rabies G may be more suitable for long 
term expression in cell culture. Stable expression of this protein has been reported. Burger
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et a l (1991) have achieved expression in Chinese hamster ovary (CHO) cells without any 
observed cytopathogenicity. The level of G expression remained stable for over 6 months 
in culture.
3.1.3 Structure of rabies G
The rabies G glycoprotein is also believed to form homotrimers on the surface of mature 
virions. Although these trimers cannot be purified under conditions used for VSV G, they 
can be cross-linked with reagents such as dithiobis-succinimidyl propionate (DSP, Whitt et 
a l,  1991). Further evidence for such a structure comes from electron microscopy of 
negatively stained rabies virions (Gaudin et a l, 1992). In micrographs the G protein 
appears as a head on a thin stalk, approximately 8.3nm in length. In an end on view the 
proteins look like triangles containing three dots, which is highly suggestive of a trimeric 
configuration. These trimers are not very stable. Unlike VSV G they are not stabilised by 
low pH, and they seem to be sensitive to most detergents apart from 1%CHAPS, a 
zwitterionic detergent (Gaudin et a l, 1992; Whitt et a l, 1991).
The initial 19 amino-terminal residues of the transcribed protein, which are predominantly 
hydrophobic, act as a signal peptide (Anilionis et a l, 1981). Although the site of 
proteolytic cleavage of this peptide aligns with that of VSV, the two sequences are not very 
homologous. It seems likely that the main constraint is maintenance of hydrophobicity 
(Rose et a l, 1982). Another stretch of 22 hydrophobic amino acids near the carboxy- 
terminus corresponds to the transmembrane domain. This leaves a sequence of 44 residues 
to form the cytoplasmic tail (Anilionis et a l, 1981; Conzelmann et a l, 1990). These two 
regions are highly conserved among some, though not all, strains of rabies virus 
(Conzelmann etal., 1990).
The rabies G protein is palmitoylated (Gaudin et a l, 1991b). This involves the post 
translational addition of long chain fatty acids, and it is frequently observed with the 
glycoproteins of enveloped RNA viruses. These additions are usually linked to threonine, 
serine or cysteine residues on the cytoplasmic face of membrane binding or transmembrane 
domains. Gaudin et a l believe that cysteine 460 and/or 461 are the linkage sites for the 
palmitoylation of rabies G. As would be expected these residues are located at the
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cytoplasmic end of the transmembrane domain. The function of palmitoylation is not yet 
known, although roles in membrane fusion, and the assembly and budding of viral particles 
have been suggested.
There are three potential sites for N-linked glycosylation within the ectodomain of G 
(Anilionis et a l , 1981; Conzelmann et a l, 1990; Shakin-Eshleman et a l, 1992, Fig. 3.1). 
This type of modification involves the cotranslational addition of oligosaccharides to 
asparagine residues by enzymes present in the lumen of the RER. The recognition sequence 
is Asn-X-Ser/Thr, where X is any amino acid apart from proline or tryptophan (Myers, 
1997; Rademacher et a l, 1988). N-linked glycosylation appears to be important in 
intracellular transport, immunogenicity, stability and biological activity (Shakin-Eshleman 
et a l, 1992). Inhibition by tunicamycin prevents expression of G on the cell surface 
(Burger et a l, 1991). It may act through affecting the structure of the protein, providing 
hydrophilicity which helps to stabilise correct folding. The N-linked oligosaccharide 
groups may also function in interactions with calnexin, a molecular chaperone involved in 
the folding process (Gaudin, 1997). Studies have suggested that two forms of G are present 
in intact virions of some strains. These forms are glycosylated at one or two of the three 
potential sites (Wunner et a l, 1985). It has been suggested that the site at Asn 37 is not 
accessible to glycosylation as it is within a relatively hydrophobic region of the protein. 
However, it has been shown that this site can also be glycosylated although inefficiently. 
This alone is sufficient to support cell surface expression (Shakin-Eshleman et a l, 1992). 
Mutational analysis of this site has revealed that the amino acid following the recognition 
sequence can affect the efficiency of glycosylation, positively charged residues generally 
being the most favourable (Mellquist et a l, 1998). This is less important when the Ser 
residue is replaced with Thr.
The patterns of cross-neutralisation by monoclonal antibodies (mAbs) with selected G 
protein mutants have been used to define antigenic sites (Lafon et a l, 1983). The majority 
of these mAbs recognise sites II and III, shown in Fig. 3.1 (Benmansour et a l, 1991). The 
main antigenic site, site n, is discontinuous, located between residues 34-42 and 198-200 
(Prehaud et a l, 1988). Since most antibodies can be used to select mutants in both regions, 
it seems very likely that they are positioned close together in the mature protein. Site III is 
linear and positioned between residues 330-340 (Seif et a l, 1985). Escape mutants
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signal peptide
-19 MVPQALLFV PLLVFPLCFG KFPIYTIPDK LGPWSPIDIH HLSCPNNLW
site II
31 EDEGCTNLSG FSYMELKVGY ILAIKVNGFT CTGWTEAET YTNFVGYVTT
section containing putative fusion peptide 
81 TFKRKHFRPT PDACRAAYNW KMAGDPRYEE SLHNPYPDYR WLRTVKTTKE
131 SLVIISPSVA DLDPYDRSLH SRVFPSGKCS GVAVSSTYCS TNHDYTIWMP
predicted nAchR binding site 
181 ENPRLGMSCD IFTNSRGKRA SKGSETCGFV DERGLYKSLK GACKLKLCGV
site II
231 LGLRLMDGTW VSMQTSNETK WCPPDKLVNL HDFRSDEIEH LWEELVRKR
2 81 EECLDALESI MTTKSVSFRR LSHLRKLVPG FGKAYTIFNK TLMEADAHYK
*
site III ?fusion site
331 SVRTWNEILP SKGCLRVGGR CHPHVNGVFF NGIILGPDGN VLIPEMQSSL
a-helix a-helix
3 81 LQQHMELLES SVIPLVHPLA DPSTVFKDGD EAEDFVEVHL PDVHNQVSGV
TM region
431 DLGLPNWGKY VLLSAGALTA LMLIIFLMTC CRRVNRSEPT QHNLRGTGRE
481 VSVTPQSGKI ISSWESHKSG GETRL
Fig. 3.1. Amino acid sequence of SAD B19 rabies G (Genbank accession number M31046, Conzelmann et 
a l ,  1990). Features mentioned in the text are in bold type. The positions of the HP hinge and antigenic sites 
are underlined. *, potential site for N-linked glycosylation.
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involving substitution of Arg 333 have been shown to be nonpathogenic, and display a 
different host cell range to the wild type.
The high conservation of cysteine residues and glycosylation sites between rhabdovirus 
glycoproteins implies that these proteins have similar structures. The crystal structure of the 
protein has not yet been obtained, although a hypothetical structural model of the 
glycoprotein head region has been proposed (Walker and Kongsuwan, 1999). This model is 
based on the pattern of conserved cysteine residues, positioning of antigenic sites, predicted 
secondary structural features, and experimental data such as those from cyanogen bromide 
(CNBr) cleavage studies. This head region is believed to contain the domains involved in 
attachment and membrane fusion. Antigenic sites II and m  have been predicted to interact 
with the receptor(s) and are thought to be positioned closely within the glycoprotein head 
(Gaudin, 1997). This model brings the two identified elements of site II into close 
alignment.
3.1.4 Cell attachment
As discussed in section 1.2.2, the receptor usage of rabies virus is not yet fully understood. 
Like VSV, rabies virus is also able to infect a wide variety of cells in vitro. This is again 
thought to be due to an interaction between the G protein and a phospholipid component of 
the cell membrane. In addition, both the nAchR and NCAM have been proposed as neural 
specific receptors. The receptor binding regions of G have not been defined, although a 
region of homology has been identified between rabies G and the snake venom 
curaremimetic neurotoxins. These toxins bind with high affinity to nAchR. Conserved 
residues that are thought to be involved in this binding are located within the second loop 
of the neurotoxin peptides. These residues are also conserved in the region between 
residues 175 to 203 in rabies G, shown in Fig. 3.1 (Lentz et al., 1984). This indicates that 
this region may function as a nAchR binding site. A section of the discontinuous antigenic 
site II is within this putative binding region. The majority of neutralising mAbs are directed 
against this site (Benmansour et al., 1991). Some site II escape mutants, especially those 
with a substitution of residue 198, are less pathogenic (Prehaud et al., 1988). This residue 
is one of the few that are conserved between all of the neurotoxins as well as G.
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Donnelly-Roberts and Lentz (1991) found that two polyclonal antibodies raised against a 
synthetic peptide representing this region of homology showed some cross reactivity with 
ocBtx and native G. This suggests that the two putative binding sites have similar 
conformations. Bracci et al. (1988) found a similar result in a separate study. Although they 
were unable to demonstrate binding of their peptide to the nAchR, certain mAbs raised 
against it were able to recognise, and inhibit the binding of both rabies G and otBtx. Such 
structural similarity was also predicted by circular dichroism (CD) spectroscopy of peptides 
corresponding to the two sites (Donnelly-Roberts and Lentz, 1991). The major structure 
predicted was a p-sheet, which is in agreement with studies undertaken with intact toxin 
proteins. Rustici et al. (1993) suggest that the NSRG sequence within this region of the G 
protein (Fig. 3.1) is responsible for binding to nAchR. This sequence was common 
between a set of peptides which were recognised by monoclonal antibodies, along with 
neurotoxins, native G and acetylcholine (Ach). It corresponds to a peak in the 
hydrophilicity of G, and is therefore likely to be located on the protein surface (Bracci et 
al., 1988). Rustici et al. propose that the side chains of the Argl96 and Asnl94 residues 
mimic the structure of Ach, in a manner similar to that suggested for the Asp and Arg 
residues of the binding site of the snake neurotoxins.
3.1.5 Membrane fusion
Like VSV, rabies vims is believed to enter cells by adsorptive endocytosis. Incubation of 
the vims with human erythrocytes results in high hemolysis and cell fusion at low pH 
(Mifune et al., 1982). Also, the lysosomotropic agents chloroquine and ammonium 
chloride will inhibit infection of CER cells (Superti et al., 1984a), and rabies vims has been 
shown to colocalise with endosome tracers and an acidic probe shortly after vims 
adsorption to IMR-32 human neuroblastoma cells (Lewis et al., 1998). Adsorptive 
endocytosis involves internalisation of the vims in clathrin-coated pits that form 
intracellular vesicles. These then fuse with endosomes to create an acidic interior. The 
acidic environment produces a conformational change within the G protein promoting 
membrane fusion, and delivery of the vims into the cytoplasm (Gaudin et al., 1991a; 
Gaudin et al., 1993).
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As has been described in section 1.3.2, the rabies G protein can adopt three conformational 
states: native (N), active (A) and inactive (I). The transition between these states is believed 
to be necessary for the fusion process, and therefore protein function. These transitions can 
be studied through the characterisation of mutants that escape neutralisation by antibodies 
specifically targeted to a single conformational state of G. Mutations affecting amino acids 
10, 13 and 15 have been found to alter the epitope targeted by a group of antibodies that 
specifically recognise the I state (Gaudin et a l, 1996). This epitope is not accessible in the 
N state on the virion surface, but becomes so when the molecule is solubilised. This 
suggests that it is situated under the head of the structure. The same study found that 
mutations in amino acids 44 and 282 alter the kinetics of the change to I, and in 392 and 
396 affect the thermodynamic equilibrium between I and N. Residues 392 and 396 are 
close to His 397 and Pro 398 which are highly conserved among rhabdoviruses. These 
residues are located between two putative amphipathic a-helices and may act as a hinge 
during the conformational changes. The a-helices are located downstream of a highly 
conserved glycine residue which is though to mark the start of the stalk region. Specific 
mutations within the equivalent a-helical region of VSV G influence the fusogenic activity 
of the protein, possibly by interfering with the necessary conformational changes (Li et al., 
1993; Shokralla etal., 1998).
Neither VSV G nor rabies G possess a typical fusion peptide. A putative internal fusion 
peptide has been identified between residues 123 and 137 of VSV G (Zhang and Ghosh, 
1994). This peptide is not hydrophobic, but contains a sequence of uncharged amino acids. 
It is highly conserved between vesiculoviruses. Mutations within this region can abolish 
fusogenicity or reduce the pH threshold for fusion (Fredericksen and Whitt, 1995; 
Fredericksen and Whitt, 1996; Li et a l, 1993; Zhang and Ghosh, 1994). Certain mutations 
of the acidic residues Asp 137 and Glu 139 at the carboxy-terminal end of the fusion 
domain will lower the pH threshold. Fredericksen and Whitt (1996) suggest that these 
mutations increase the level of protonation required to induce conformational changes, and 
thereby stabilise the fusion-inactive conformation of the protein. The Glu 139 residue is 
conserved in lyssaviruses where it may act in a similar fashion.
Cleverley and Lenard (1998) have shown that a Gly residue within the transmembrane 
domain of VSV G is required for fusion. This amino acid is found in many other viral
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fusion proteins, including rabies G. The authors suggest that the Gly may allow the protein 
to bend during the fusion process, thereby promoting the formation or enlargement of a 
fusion pore.
A region of rabies G considered to be a putative fusion domain is situated between residues 
84 and 160 (Durrer et al., 1995). This region was identified by photolabeling of exposed 
hydrophobic domains following incubation of whole protein or CNBr fragments with 
unilamellar vesicles at low pH. Part of this region does align with the predicted fusion 
peptide of VSV G, although there is little sequence homology. A higher degree of 
homology is found between Val 125 and Trp 178. The sequence between residues 84 and 
160 does not contain an extended hydrophobic domain. Durrer et al. suggest that the region 
which interacts with the target membrane may adopt a sided a-helix or (3 structure. The 
sequence between positions 360 and 366 of rabies G (FNGIILG) shows a high degree of 
homology with the N-terminals of paramyxovirus Fi and HIV-1 gp41. It has therefore been 
suggested that this region may also be involved in membrane fusion (Morimoto et al.,
1992).
3.1.6 Rabies G pseudotyped vectors
The properties that rabies G shares with VSV G suggest that this glycoprotein could also be 
useful for producing pseudotyped vectors for gene delivery. Both proteins are homotrimers, 
indicating that they are robust structures. This property of VSV G allows concentration of 
pseudotyped vectors to the high titres required for many applications. Both proteins are 
also able to mediate entry into a wide range of host cells. This allows infection of many cell 
types not normally susceptible to retroviral infection. The fact that rabies enters cells via a 
different route to the majority of retroviruses is unlikely to pose a problem. It has already 
been shown that VSV G pseudotyped retroviral vectors can survive the acidic conditions 
encountered during endocytosis.
The experiments described in this chapter were carried out in order to test the suitability of 
rabies G for vector production. The availability of efficient transient packaging systems 
such as the HIT system (Soneoka et al., 1995) allows rapid analysis of these pseudotyped 
vectors. In such a way, a proposed envelope protein can be tested without the need for
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stable packaging cell lines. If experiments are successful these cell lines could then be 
produced.
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3.2 Materials and methods
3.2.1 Cloning of the rabies G glycoprotein
The plasmid pT7T-G (Conzelmann and Schnell, 1994), encoding the rabies virus SAD B19 
G glycoprotein (nucleotides 3311-5138), was a gift from Karl-Klaus Conzelmann 
(FRCVDA, Tubingen). The rabies G gene was subcloned into the eukaryotic expression 
vector, pcDNA3. pT7T-G and pcDNA3 were both digested with Eco RI (Gibco, UK) at 
37°C for 2 hours, and the relevant fragments were then ligated as described in section
2.2.3.1. The ligation reaction was used to transform DH5a cells as described previously 
(section 2.2.3.2). The clone obtained was designated pcDNA3.G. A second clone, 
containing G in the reverse orientation was also acquired (pcDNA3.GR). The orientation of 
the rabies G gene in these clones was verified by Hind III (Gibco, UK) digestion.
3.2.2 Cloning of pcDNA3.CAT
The plasmid pUC119.CAT was provided by Takayuki Miyazawa (Veterinary Pathology, 
University of Glasgow). This construct contained the chloramphenicol acetyltransferase 
(CAT) gene cloned into the plasmid pUCl 19, between the Bam HI and Hind EH restriction 
sites. pUC119.CAT and pcDNA3 were digested with Bam HI and Hind ED (Gibco, UK) 
and the relevant fragments were then ligated as described previously (section 2.2.3.1). The 
ligation reactions were used to transform DH5a cells (section 2.2.3.2) and DNA was 
purified from the resulting colonies. The orientation of the CAT gene in the final clones 
was verified by Eco RI digestion.
3.2.3 Cloning of a chimaeric rabies G glycoprotein
The construct pcDNA3.GMAenv was produced by replacing the cytoplasmic domain of 
rabies G with that of amphotropic MLV Env. pHIT456 and pcDNA3.G were both digested 
with the restriction enzymes Xba I (Gibco, UK) and Cla I (Gibco, UK). Prior to digestion 
pcDNA3.G was grown up in the dam~ cells DM1 (Gibco, UK) in order to avoid 
methylation of the Cla E recognition site. The method for transformation of these cells
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differs slightly from DH5a cells. 0.5ng of plasmid was mixed with lOOpl of cells and 
incubated on ice for 30min. The cells were then heat shocked at 42°C for 45s and incubated 
on ice for a further 2min. 900|il of SOC medium was added and the cells were incubated at 
37°C for 1 hour in an orbital incubator. The cultures were then spread onto LB agar plates 
containing 100|ig/ml Amp and incubated at 37°C overnight. Amp resistant colonies were 
then grown up in LB broth containing Amp, as described for DH5a cells (section 2.2.3.2). 
The digests were gel purified (section 2.2.2.5) and the relevant fragments were ligated 
using T4 DNA ligase at 14°C overnight. The ligation reaction was then used to transform 
DH5a cells. The orientation of the insert was tested by Bam HI (Gibco, UK) digestion and 
the sequence was verified by automated sequencing (section 5.2.2.2), using primers 
targeted to the T7 (sense) and SP6 (antisense) promoters.
3.2.4 CAT enzyme linked immunosorbent assay (ELISA)
CAT expression was detected using a commercial CAT ELISA kit (Boehringer 
Mannheim), according to the manufacturer’s instructions. Cell lysates were diluted with 
sample buffer (PBS and blocking reagents) to give a protein concentration of 250|Lig/ml. 
Concentrations were determined using Bradford reagent (Sigma, UK). The lysates were 
then added to a microtiter plate provided with the kit. This had been precoated with sheep 
polyclonal anti-CAT antibody. The wells were washed with PBS/Tween 20 and anti-CAT- 
digoxigenin was added. After incubating at 37°C for 1 hour, the wells were washed and 
anti-digoxigenin-peroxidase was added. All antibodies were supplied with the kit. 
Following incubation at 37°C for another hour the wells were washed and the peroxidase 
substrate was added for 15min until a green colour developed. Absorbance was measured 
at 405nm.
3.2.5 Immunofluorescence (IF) staining
Glass coverslips were sterilised in 100% ethanol and then coated with 1 mg/ml poly-L- 
lysine (Sigma, UK) in 0.1M borate buffer, pH 8.5. This was done by dropping the solution 
onto the coverslip, removing excess fluid, and leaving to dry overnight in a laminar flow
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hood. The coverslips were then washed twice for two hours with sterile dt^O . 0.8-1 x 105 
cells were then plated onto the coverslips in 6 well plates.
When the cells were ready for staining they were washed twice in warm PBS before fixing 
in 4% paraformaldehyde for 15min. They were then washed 4 times in PBS, permeabilised 
in 0.3% Triton X-100/PBS for 5min, washed 3 times in PBS, and incubated for 30min to 1 
hour in a blocking solution consisting of 10% swine serum in PBS. After blocking the cells 
were washed once with 1% swine serum/PBS and then incubated for 1 hour with the 
primary antibody RV1C5 (anti-rabies virus, monoclonal mouse IgG2a, Immunogen 
International Ltd., UK) diluted 1/500 inl% swine serum/PBS. They were then washed 6 
times and incubated for 1 hour with the secondary antibody, rabbit-anti-mouse TRITC 
(tetramethylrhodamine isothiocyanate, Sigma, UK) diluted 1/100 in 1% swine serum/PBS. 
Finally the cells were washed 6 times in PBS and then once in dFUO. The coverslips were 
mounted on slides and viewed under a fluorescence microscope (40x objective).
3.2.6 Testing for cell fusion at low pH
Cos-7 cells were plated onto coverslips as described above and were transfected with either 
pcDNA3.G or with pcDNA3.GR using DEAE-dextran (section 2.2.1.3). 48 hours after 
transfection the cells were incubated for 1 min in PBS at various pH values (pH 7.0, 6.0, 
5.0, 4.5), and then for 1 hour in 10% DMEM. All cells were then fixed and labelled as 
described above, except that 0.25|ig/ml Hoechst stain was added with the secondary 
antibody. Photographs were taken through the lOOx objective of the fluorescence 
microscope.
3.2.7 Radiolabelling of cells
Medium was removed from cells and replaced with Met-free Eagle’s MEM (Gibco, UK). 
After 1 hour’s incubation at 37°C this was replaced with 500pl of medium containing 
approximately 100(iCi L-[35S]Met (PRO-MIX™, Amersham Life Science, UK), and the 
cells were incubated for a further hour. The labelling medium was then removed and 
retained for analysis. Cells were lysed on ice with lysis buffer and the lysates were 
centrifuged for lOmin to pellet debris.
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3.2.8 Radio-immune precipitation assay (RIPA)
50|il of fixed Staph. A. (Sigma, UK), preloaded with normal serum was added to cell 
lysates and incubated for 1 hour. This was then pelleted in a centrifuge and the supernatant 
was transferred to a fresh tube. Antibody was added to the samples, both cell lysates and 
labelling media, and incubated at 4°C for 1 hour. Rabies G samples were incubated with 
RV1C5 (1/500), and the CAT samples with the anti-CAT-digoxigenin (1/250) from the 
ELISA kit. The samples were centrifuged for lOmin to remove any aggregates that may 
have formed, and then incubated at 4°C for 1 hour with IOjllI of either a 50% protein 
A/agarose (Sigma, UK) slurry or anti-digoxigenin-agarose (Sigma, UK). The complexes 
were pelleted by centrifugation at 3000 rpm for lmin, and then washed 4 times with lysis 
buffer and once with 50mM Tris pH 6.8 on ice. 50|il of Laemmli sample buffer was added 
and the samples were boiled for 5min. 10(Lil of each sample was run on a Tris/glycine SDS- 
polyacrylamide (SDS-PAGE) gel, according to the method of Laemmli (1970). The gel was 
then fixed in 25% isopropanol/10% acetic acid for 30min, soaked in fluorographic reagent 
(Amplify™, Amersham, UK) for 15min, vacuum dried and exposed to film (Amersham, 
UK) at -70°C.
3.2.9 Production of vectors
Vectors were produced using the HIT system (Soneoka et al., 1995) as described in section
2.2.4.1. 293T cells in 25cm2 flasks were transfected with pHIT60, p H IT lll, and either 
pHIT456, pcDNA3.G or pcDNA3.GMAenv using calcium phosphate precipitation 
(section 2.2.1.3). One flask was transfected with pHITl 11 alone as a negative control, and 
one with pMV12 as a control for transfection. Following transfection fresh DMEM 
containing lOmM HEPES pH 7.4 was added to the cells. Vector titres were determined by 
staining infected cells for p-gal activity, as described in section 2.2.4.2.
3.2.10 Optimisation of the HIT system
Several conditions were tested in order to optimise the production of pseudotyped vectors. 
The target cell types were BHK TK", AH927 and NIH 3T3. The medium conditions tested
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were complete DMEM, serum free DMEM, serum free DMEM supplemented with SPIT 
(Sigma, UK), serum free DMEM containing 0.2% bovine serum albumin (BSA), and 
serum free DMEM supplemented with SPIT and 0.2% BSA. SPIT is a commercial medium 
supplement containing insulin from bovine pancreas, partially iron saturated human 
transferrin, sodium selenite and sodium pyruvate in Earle’s Balanced Salt Solution. 
pcDNA3.G was added at 0.5|ig, 5pg and lOjug per transfection. The effect of sodium 
butyrate (NaB) induction was tested by adding lOmM NaB to the culture medium after the 
end of transfection. Following incubation for 8 hours the cells were washed in PBS, and 
fresh complete DMEM was added. Incubation of the transfected cells at 32°C for 24 and 48 
hours was also tested. Titrations of samples taken at 24, 48 and 72 hours after transfection 
were also carried out in the absence of 8pg/ml Polybrene. Vector production over time was 
observed by measuring titre at various points on a time scale. Samples were taken from 
cells at 0, 2, 4, 6, 24, 48 and 72 hours after the end of transfection.
3.2.11 Antibody neutralisation
Vectors bearing A-MLV Env, rabies G or GMAenv were produced by transient 
transfection of 293T cells as described above. 1ml of each supernatant was incubated with 
RV1C5 (1/250 dilution) at 37°C for 1 hour in an orbital incubator. 1ml samples were also 
incubated in the absence of antibody. Vectors were then titred on AH927 cells as before.
3.2.12 Titration of G418 sensitivity of 293 cells
Prior to transfection, 293 cells were tested for their sensitivity to G418. Three 96 well 
plates were set up with 0.4 x 104 cells in each well. The following day G418 was added to 
the cells at concentrations of 4mg/ml, 3mg/ml, 2mg/ml, 1.5mg/ml, lmg/ml, 0.75mg/ml, 
0.5mg/ml, 0.375mg/ml, 0.25mg/ml, 0.188mg/ml, 0.125mg/ml, and 0.094mg/ml. 8 wells of 
cells in a fourth plate were also set up in the absence of G418. After 4, 8, and 12 days cell 
viability was determined by MTT (thiazoyl blue, Sigma, UK) staining of the cells on one of 
the plates. MTT dissolved in DMEM was added to the wells to give a final concentration 
of 1 mg/ml, and the plate was incubated at 37°C for 3 hours. The medium was removed
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and the purple formazan crystals were solubilised in 100% isopropanol for 15min. 
Absorbance was then measured at 570nm.
3.2.13 Cloning of a permanent rabies G expressing cell line
Approximately 1 x 105 293 cells were seeded onto 6cm dishes. 24 hours later the cells were 
transfected with pcDNA3.G using calcium phosphate precipitation (section 2.2.1.3). After 
2 days 400|Lig/ml G418 was added to the growth medium and this medium was replaced 
every 3-4 days for a month, until selection of resistant colonies was possible.
3.2.14 RIPA of pelleted vector
A 75cm2 flask of 293T cells was transfected with pHIT60 and pcDNA3.G using calcium 
phosphate precipitation (section 2.2.1.3). A second flask of cells was transfected with 
pHIT60 alone. The cells were then radiolabelled as described above (section 3.2.7), but 
were incubated in the labelling medium containing 100|iCi/ml PRO-MIX™ overnight. 
This medium was then removed and centrifuged at 10 x g. The cells were lysed and 
immune precipitated as before. Vector was pelleted from the medium samples by 
centrifuging through a sucrose cushion. 1ml of 30% sucrose/TBS was pipetted into a 35ml 
clear polypropylene Beckman centrifuge tube. This was overlaid with 1ml of 20% 
sucrose/TBS and then the medium containing the vector. The remainder of the tube was 
filled with TBS. The samples were centrifuged at 35,000 rpm for 1 hour in a SW41 rotor in 
a Beckman L8-70M ultracentrifuge. The pellets were then resuspended in 250pl of lysis 
buffer and immune precipitated.
3.2.15 Time scale comparison of rabies G and Gag expression
293T cells were seeded onto 15 coverslips. 14 of these were transfected with pGT5, 
pH IT lll and pcDNA3.G. pGT5 is a FeLV based gag/pol construct and was a gift from 
John Oldfield (Veterinary Pathology, University of Glasgow). Cells were also seeded into 
one well of a six well plate and transfected with pMV12 as a transfection control. At 0, 2, 
4, 6, 24, 48, and 72 hours after the end of transfection, medium was removed from 2 
coverslips, filtered through a 0.45|im-pore filter, and stored at -70°C. The cells were then
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analysed by IF staining as described above (section 3.2.5), although only one from each 
pair was permeabilised by incubation with 0.3% Triton X-100. The non-transfected sample 
was taken at 48 hours and was permeabilised. ELISA screening for Gag expression was 
carried out by the Feline Virus Unit, Veterinary Pathology, University of Glasgow.
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3.3 Results
3.3.1 Transient expression of the rabies G glycoprotein
Expression of the G protein from pcDNA3.G was verified by transient transfection of Cos- 
7 cells. As shown in Fig. 3.2, IF staining detected expressed G protein in the transfected 
cells. The stronger staining intensity around the cell outline implies that G is localised on 
the cell surface, as would be expected for an envelope protein. No staining of cells 
transfected with pcDNA3.GR was observed, indicating that the positive signal is specific 
for G. Transfection efficiency was tested by transfecting cells in parallel with 
pcDNA3.CAT. The CAT expression level in these cells was consistently above the highest 
standard provided with the ELISA kit, indicating a concentration greater than 0.797ng/ml 
of protein. An example of the typical results obtained in the CAT ELISA is shown in Table
3.1.
Sample Absorbance (405nm)
Standard 0.797ng/ml 0.259 0.335
0.399ng/ml 0.166 0.133
0.200ng/ml 0.133 0.290
O.lOOng/ml 0.109 0.087
Cell lysate 24 hours 1.381 1.283
48 hours 1.599 1.281
72 hours 1.192 1.661
Table 3.1. Typical result obtained from ELISA of lystes taken from cells transfected with pcDNA3.CAT. 
Lysates were taken at 24, 48 and 72 hours after the end of transfection.
G protein expression was also detected by RIPA, as shown in Fig. 3.3. Cos-7 cell lysate 
samples were taken at 24, 48 and 72 hours after transfection and immune precipitated with 
the antibody RV1C5. A protein of approximately 67kD was detected in lysates taken from 
cells 24 and 48 hours after transfection with pcDNA3.G (lanes D and E), but not in those 
from cells transfected with pcDNA3.GR (lanes A, B and C) or pcDNA3.CAT (lane H), nor 
in non-transfected cells (lane G). This protein is the expected size for rabies G.
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Fig. 3.2. IF staining of transfected Cos-7 cells using RV1C5 antibody. A) Cells transfected with
pcDNA3.G. B) Cells transfected with pcDNA3.GR.
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Fig. 3.3. RIPA o f Cos-7 cells using RV1C5. A-C) Lysates o f ce lls transfected with 
pcDNA3.G R, taken at 24, 48 and 72 hours. D-F) Lysates from cells transfected with 
pcDNA3.G, taken at 24, 48 and 72 hours. G) Lysate of non-transfected cells. H) Lysate of cells 
transfected with pcDNA3.CAT, precipitated with anti-CAT antibody. I) Medium sample taken 
at 24 hours
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(Witkor et a l,  1973; Wunner et al., 1985). G protein could not be detected in samples of 
culture media (lane I).
3.3.2 Fusion activity at low pH
In order to show that the G protein expressed on the cell surface was functional, transfected 
Cos-7 cells were incubated in a series of low pH buffers, and then analysed by IF staining. 
The results are shown in Fig. 3.4. At physiological pH the G-expressing cells could be seen 
as separate, intact cells (Fig. 3.4, A and B). Large, multinucleate cells were observed at and 
below pH 6 (Fig. 3.4, C-H), indicating syncytia formation. These cells were positive for G 
expression. No fusion of control cells transfected with pcDNA3.GR was observed under 
identical pH conditions.
AB
Fig. 3.4. Cos-7 cells transfected with pcDNA3.G and then incubated in a series of low pH buffers. A) IF
staining of untreated cells. B) Hcescht staining of the same untreated cells.
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Fig. 3.4. Cont. C) IF staining of cells incubated at pH6. D) Hcescht staining of the same cells incubated at
pH6.
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Fig. 3.4. Cont. E) IF staining of cells incubated at pH5. F) Hcescht staining of the same cells incubated at
pH5.
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Fig. 3.4. Cont. G) IF staining of cells incubated at pH4.5. H) Hcescht staining of the same cells incubated
atpH4.5.
103
3.3.3 Production of pseudotvped vectors
To test the ability of the rabies G protein to form pseudotypes with MLV-based vectors, 
293T cells were co-transfected with 5|Lig each of pcDNA3.G and the HIT system plasmids 
pHIT60 and pH IT lll, described in 2.1.4. Transfections were also carried out replacing 
pcDNA3.G with pHIT456, encoding the A-MLV env. Control cells were transfected with 
p H IT lll alone, and no titre was obtained with these in any experiment. Titres for the A- 
MLV vector were 1-2 x 104 blue cell colony forming units (bcfu)/ml on NIH 3T3 cells, and 
0.4-1 x 105 bcfu/ml on AH927 cells.
In an attempt to optimise the titre of pseudotyped vector several experimental conditions 
were altered (Table 3.2). Of the three target cell types tested the feline fibroblast AH927 
line was the most susceptible to infection by the pseudotyped vector. The replacement of 
serum with 0.2% BSA was tested as this is often used in studies involving the use of rabies 
virus (Seganti et al., 1990; Superti et a l, 1984a; Superti et al., 1984b; Wunner et al., 
1984). This change did result in a slightly higher titre, as did replacement with the SPIT 
supplement. Over the range tested, the optimal concentration of pcDNA3.G used in the 
transfection was 5|Hg per flask, equal to that of the cotransfected plasmids pHIT60 and 
p H IT lll.
Treatment of the transfected cells with lOmM NaB has been reported to increase titres 
obtained using the HIT system (Soneoka et al., 1995). NaB has been found to increase the 
proportion of cells expressing exogenous DNA (Gorman et al., 1983), although the 
mechanism has not been fully defined. It has also been shown to activate certain eukaryotic 
promoters including the CMV promoter (Radsak et al., 1989; Tanaka et al., 1991). 
Therefore the effect of NaB induction on the titre of these pseudotyped vectors was tested. 
Cells were incubated in lOmM NaB for 8 hours after the end of transfection. However, no 
improvement in titre was detected.
It has been shown that harvesting of retroviral vector from packaging cell lines at 32°C 
instead of 37°C results in higher titres (Kaptein et al., 1997; Kontani et al., 1994). Kaptein 
et al. found that vector half-life was greatly increased at this lower temperature (37-39 
hours compared to 9 hours), and that production rate was approximately 3 to 4 fold higher.
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A
Condition Target Cell Type Titre (bcfu/ml)
standard (5|ig pcDNA3.G, BHK TK" 3.1 x 10'
10% FCS, 37°C, 24hr) AH927 7.0 x 10'
NIH 3T3 1.0 x 10°
serum free medium BHK TK" 0
serum free + 0.2% BSA BHK TK" 7.1 x 10‘
serum free + SPIT BHK TK" 1.0 x 102
serum free + SPIT + BSA BHK TK" 4.4 x 101
0.5jig pcDNA3.G BHK TK" 1.0 x 10°
10pg pcDNA3.G BHK TK" 1.3 x 10'
sodium butyrate BHK TK" 1.2 x 10'
32°C 24hr BHK TK" 4.0 x 10°
48hr BHK TK" 1.0 x 10°
B
Condition Titre (bcfu/ml) 1 on BHK TK" Titre (bcfu/ml) 2 on BHK TK
Polybrene 24hr 
48hr 
72hr
3.3 x 101 2.7 x 101
8.6 x 10° 3.9 x 10°
0 0
no Polybrene 24hr 
48hr 
72hr
0.7 x 10° 3.0 x 10°
4.8 x 10° 9.0 x 10°
0 0
C
Time point Titre (bcfu/ml) on BHK TK- Titre (bcfu/ml) on AH927
0-6hr ND 0
24hr 3.1 x 10' 7.0 x 101
48hr 7.0 x 10° 1 x 10'
72hr 0 2.5 x 10°
Table 3.2. Optimisation of HIT system vectors pseudotyped with rabies G. A) Effects of target cell type, 
media composition, pcDNA3.G concentration, NaB, temperature of incubation of transfected cells. B) Effects 
of Polybrene (8pg/ml) and length of incubation. As duplicate titres were taken in this experiment both results 
are shown. C) Effect of length of incubation of transfected cells. (ND - not done). Unless otherwise stated, 
infections were carried out in the presence of 8|ig/ml Polybrene).
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They suggest that this higher production rate is due to more efficient protein folding, which 
results in increased surface expression of Env. In this case, the pseudotyped vector 
produced from cells incubated at 32°C had a lower titre than that from cells at 37°C at both 
time points tested.
The polycation Polybrene is used in the majority of retroviral vector protocols. Its presence 
improves efficiency of infection, probably by neutralising electrostatic repulsion between 
the virus and cell via an interaction with the cell membrane (Toyishama and Vogt, 1969). It 
is not believed to be able to mediate infection in the absence of an envelope-receptor 
interaction (Porter et al., 1998). Since Bums et a l (1993) found that infection efficiency of 
VSV G pseudotyped vectors is optimal in the presence of 8|ig/ml Polybrene this 
concentration was also used with these rabies G pseudotypes. As can be seen in Table 
3.2B, the addition of Polybrene does improve titres on BHK TK- cells.
Vector titres were taken at various time points after transfection from cultures incubated at 
32°C or 37°C, in the presence or absence of Polybrene, and titrated on either BHK TK“ or 
AH927 cells. On each occasion, the highest titres were obtained from samples taken 24 
hours after the end of transfection.
The highest titre obtained in these experiments was 1 x 102 bcfu/ml. This was on BHK TK” 
cells in the presence of Polybrene, and was with vector produced by cells grown for 24 
hours after the end of transfection, in serum free medium supplemented with SPIT. These 
conditions were therefore used in subsequent experiments. AH927 cells were used as target 
cells since a higher titre was obtained on these than on BHK TK“ cells. However, it is clear 
that none of the conditions tested produced a significant increase in the titre of the 
pseudotyped vector. The low titres are unlikely to be due to poor transfection efficiencies 
since parallel transfections with pMV12 showed a consistent efficiency of approximately 
50 to 70%.
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3.3.4 Specific neutralisation of vectors pseudotyped with rabies G
To ensure that the titres obtained with the pseudotyped vectors were due to the 
incorporation of rabies G, medium samples from transfected cells were incubated with the 
antibody RV1C5. After incubation for 1 hour the samples were titred on AH927 cells as 
before. As shown in Table 3.3, this antibody specifically neutralised the vector 
pseudotyped with G.
Vector Conditions Titre (bcfu/ml)
A-MLV no incubation 2.2 x 105
lhr at 37°C 2.7 x 105
lhr at 37°C with RV1C5 2.5 x 105
G pseudotype no incubation 2.6 x 101
lhr at 37°C 3.1 x 101
lhr at 37°C with RV1C5 0
Table 3.3. Specific neutralisation of vectors pseudotyped with rabies G, by incubation with RV1C5.
3.3.5 Cloning of a permanent rabies G expressing cell line
Bums et al. (1993) increased titres of their VSV G pseudotyped vector by selecting cell 
clones expressing high levels of the vector proteins. It therefore appears possible that the 
use of a cell line expressing rabies G along with the Gag and Pol proteins would also 
improve vector titres. As a first step towards producing such a packaging cell line, 293 
cells were transfected with pcDNA3.G. The 293 cells had been found to be sensitive to 
400|ig/ml G418 and therefore this concentration was used for selection. Following 
selection with G418 for one month, two resistant colonies were picked, expanded for 5-6 
passages, and then analysed for G expression by IF staining. Only single, isolated, G 
positive cells were found, approximately 1% of the total cell number. The number of 
positive cells was not increased by passage in 800|ig/ml G418. No cell fusion was
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observed. As the number of positive cells was so low these cell lines were not pursued any 
further.
3.3.6 Efficiency of G incorporation
A possible explanation for the low titres of pseudotyped vector is that G is not incorporated 
into the envelope very efficiently. In an attempt to look at this, radiolabelled vector 
released from transfected 293T cells was purified through a sucrose cushion and then 
analysed by immune precipitation with RV1C5. As can be seen in Fig. 3.5 a protein of a 
similar size to rabies G is present in this sample (lane A), and absent from the negative 
control (lane B). However, the signal was very weak - this result was obtained after 10 
days’ exposure. This suggests that G may be poorly incorporated into the vectors.
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Fig. 3.5. RIPA of vector pellets using RV1C5. A) Cells transfected with pHIT60 and pcDNA3.G. 
B) Cells transfected with pHIT60 alone.
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There is some evidence that signals in the cytoplasmic tail of retroviral Env proteins are 
involved in their incorporation into virion envelopes (section 1.5.1). The construct 
GMAenv was produced to test whether the replacement of the cytoplasmic domain of G 
with that of A-MLV Env could improve its incorporation. The vector titres obtained with 
this envelope construct, 2-3 x 10° bcfu/ml, were consistently lower than those obtained 
with wild type rabies G (Table 3.4A). These pseudotyped vectors were also neutralised by 
incubation with RV1C5 (Table 3.4B), indicating that entry of these vectors was mediated 
by the G domains of the glycoprotein, as would be expected.
A
Vector Titre (bcfu/ml) 1 Titre (bcfu/ml) 2
GMAenv pseudotype 2 x 10° 3 x 10°
G pseudotype 1 x 10' 2.6 x 101
A-MLV 5.4 x 104 6.6 x 103
B
Vector Conditions Titre (bcfu/ml)
GMAenv pseudotype no incubation 3 x 10°
lhr at 37°C 2 x 10°
lhr at 37°C with RV1C5 0
Table 3.4. Titres of vectors pseudotyped with GMAenv. A) Comparison of titres obtained with vectors 
pseudotyped with GMAenv, G or A-MLV Env, on AH927 cells. B) Specific neutralisation of vectors 
pseudotyped with GMAenv, by incubation with RV1C5.
3.3.7 Time scale comparison of rabies G and Gag expression
It is possible that the poor incorporation of G results from a low level of glycoprotein on 
the cell surface during the budding process. It has been reported (Whitt et a l, 1991) that 
rabies G has a slower rate of transport through the cell than VSV G. This implies that the 
rabies protein accumulates less rapidly on the plasma membrane. If this rate of surface 
accumulation is also significantly slower than that of the Gag and Pol proteins, 
incorporation of G by the vectors would be expected to be affected. This could be tested by 
comparing the expression of these proteins at various time points after transfection.
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293T cells were co-transfected with pcDNA3.G, pGT5 and pH IT lll. At 0, 2, 4, 6, 24, 48 
and 72 hours after the end of transfection, these were analysed for G expression by IF 
staining, and for Gag expression by ELISA. pGT5 was used because an ELISA test for 
FeLV Gag was readily available. G protein could be detected in cells immediately after the 
end of transfection (Fig. 3.6, B) and was present on the cell surface by 2 hours (Fig. 3.6, C). 
The IF staining was most intense at 6 and 24 hours (Fig. 3.6, G-J), and began to fade at 
later time points (Fig. 3.6, K-N). Some possible localised cell fusion was observed at 72 
hours. The ELISA results obtained in this experiment were very poor (Table 3.5). The 
readings taken at 24 to 72 hours were slightly higher than the nontransfected control, but 
they remained approximately 10 fold lower than the positive control consisting of pooled 
serum/plasma samples from FeLV-positive cats. This low level of detected Gag may have 
been the result of a reduced transfection efficiency of 20-30%.
Sample Absorbance (450nm)
0 hours 0.048 0.064
2 hours 0.055 0.060
4 hours 0.045 0.053
6 hours 0.070 0.067
24 hours 0.096 0.091
48 hours 0.101 0.065
72 hours 0.116 0.131
nontransfected cells 0.070
positive control 1.223
Table 3.5. ELISA of FeLV Gag expression at various time points after the end of transfection.
I l l
Fig. 3.6. Expression of rabies G by 293T cells at various time points after transfection with pcDNA3.G.
A) IF staining of nontransfected cells. B) EF staining of permeabilised cells 0 hours after transfection.
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DFig. 3.6. Cont. C) IF staining of cells 2 hours after transfection. D) IF staining of permeabilised cells 2
hours after transfection.
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aFig. 3.6. Cont. E) IF staining of cells 4 hours after transfection. F) IF staining of permeabilised cells 4
hours after transfection.
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HFig. 3.6. Cont. G) IF staining of cells 6 hours after transfection. H) IF staining of permeabilised cells 6
hours after transfection.
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Fig. 3.6. Cont. I) IF staining of cells 24 hours after transfection. J) IF staining of permeabilised cells 24
hours after transfection.
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Fig. 3.6. Cont. K) IF staining o f cells 48 hours after transfection. L) IF staining of permeabilised cells 48
hours after transfection.
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MFig. 3.6. Cont. M) IF staining of cells 72 hours after transfection. N) IF staining of permeabilised cells 72
hours after transfection.
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3.4 Discussion
The major conclusion that can be drawn from these experiments is that rabies G can be 
incorporated into retroviral vectors. The infectivity of these vectors was dependent on the 
incorporation of the foreign glycoprotein as demonstrated by their specific neutralisation by 
an antibody directed against the rabies G protein. Unfortunately, despite confirmation of 
the cell surface expression and fusion activity of G, these pseudotypes had very low titres. 
These titres were ^102 bcfu/ml, while those for the A-MLV Env vector were 104-105 
bcfu/ml. In contrast, Emi et a l  (1991) found that transiently produced VSV G pseudotyped 
vectors had titres comparable to those of similar vectors containing A-MLV Env.
The attempts to optimise these titres, described in Table 3.2, show that they cannot easily 
be improved, at least in this transient system. The replacement of serum in the culture 
medium did appear to increase titres marginally. This could be due to the removal of 
proteins which promote aggregation of the vectors. Despite the fact that NaB is reported to 
increase expression from the HIT system plasmids (Soneoka et al., 1995), its addition did 
not increase the titres of the pseudotyped vectors. Altering the dosage of pcDNA3.G in the 
transfections appeared to decrease vector titre, suggesting that the favoured concentration is 
one that is equal to those of the other two plasmids. However, as only three alternatives 
were tried it is possible that another concentration would be optimal. The failure to increase 
titres of G pseudotyped vector by harvesting at 32°C suggests that the factors affected by 
this incubation temperature are not relevant to the production of these pseudotypes. 
However, Kaptain et al. were also able to show that the improved vector stability observed 
at 32°C is not seen at 30°C nor 34°C. Therefore it is possible that poor temperature control 
could have prevented the potential improvement in titre.
Although the RIPA analysis of the vector was not quantitative, the weakness of the G 
signal in Fig. 3.5 suggests that little of the protein was present. This weak signal was only 
detected after samples were taken from cultures grown in 75cm flasks rather than 25cm . 
It seems likely, therefore, that the low titres of pseudotyped vector were due to poor 
incorporation of the rabies glycoprotein, although a control in which Env or VSV G was 
precipitated from vector would have made this conclusion more reliable. Replacement of 
the cytoplasmic domain of rabies G with that of A-MLV Env did not increase titres. This
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could indicate that any possible recognition sequences present in the retroviral Env 
cytoplasmic domain are not sufficient to promote incorporation of the chimaeric protein. 
However, it is also possible that the presence of this domain somehow interferes with the 
functioning of G. Although rabies G can mediate infection in the absence of a cytoplasmic 
domain (Mebatsion et a l, 1996), the addition of a foreign sequence could disrupt 
secondary structure or alter interactions between the monomers.
One probable cause of inefficient G incorporation is the low rate of transport of the protein 
within the cell. This implies that rabies G accumulates at the plasma membrane more 
slowly than the VSV protein and is probably, therefore, present on the cell surface at a 
lower concentration. If the level of rabies G protein on the cell surface can be shown to be 
lower than that of VSV G, data presented here would appear to support a model of 
pseudotype formation in which foreign proteins are passively incorporated into the virion 
envelope (section 1.5.1). If this is the case it would be expected that increasing the level of 
expression of G with respect to Gag would increase the production of pseudotyped vectors. 
Rose and Bergmann (1983) have shown that certain mutations of the VSV G cytoplasmic 
domain result in a reduced rate of acquisition of endoglycosidase H-resistant sugars, 
implying a reduced rate of transport through the cell. It is possible that GMAenv is affected 
in a similar fashion, thereby further reducing cell surface expression and, therefore, 
incorporation.
Despite the fact that the optimised conditions were used in subsequent experiments titres 
were not always as high as 102 bcfu/ml. This could mean that the production of this 
pseudotype is very sensitive to small variations in experimental procedure, such as 
transfection efficiency, cell number and rate of growth. This might be expected if there is 
no interaction between the retroviral proteins and the G protein. Incorporation would be 
passive and, therefore, relatively random.
Further support for the theory that the low level of surface expression of G produces the 
low titres of pseudotype comes from the observations of Whitt et al. (1991). They found 
that the titre of VSV ts045 rescued by rabies G is 50 to 100 fold lower than that rescued by 
VSV G. Whitt et a l suggest that this is due to the low rate of transport of the rabies protein 
since they found similar loss of titre in a previous study with certain mutant VSV G
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proteins that are transported more slowly than wild type (Whitt et a l, 1989). Another 
possibility is that the rabies protein is incorporated less efficiently. Several studies have 
indicated that the cytoplasmic domains of the VSV and rabies G proteins contain a signal 
that promotes incorporation (Mebatsion et a l, 1996; Owens and Rose, 1993; Whitt et a l, 
1989). The cytoplasmic domain of rabies G shares little homology with the corresponding 
sequences of VSV G, suggesting that this signal is virus-specific. VSV G proteins with 
certain foreign cytoplasmic tails have been shown to be incapable of rescuing VSV ts045 
(Whitt etal., 1989).
It is difficult to conclude much from the data obtained from the comparison of rabies G and 
Gag expression over time. Although G can be detected on the surface of cells soon after 
infection, it is impossible to tell whether the expressed levels are high enough to support 
pseudotype formation. The intensity of the IF staining does suggest that G expression peaks 
at around 24 hours and then falls. A more quantitative approach such as an ELISA would 
provide a better picture of this pattern of expression, and would also facilitate comparison 
with that of the Gag proteins. The failure of the Gag ELISA on this occasion appears to 
have been the result of a poor transfection efficiency. However, without repeating the 
experiment this cannot be concluded with any certainty.
The analysis of cell clones permanently transfected with pcDNA3.G revealed that only a 
very few cells expressed rabies G. This is perhaps surprising since others have reported 
stable expression without any obvious cytotoxicity (Burger et a l, 1991). However, these 
studies were carried out with different cell lines and G proteins from different strains of 
rabies virus. It may be possible that cytotoxicity is increased in this system. Possible cell 
fusion was observed 72 hours after the end of transfection (Fig. 3.6), and Mebatsion et a l 
(1999) have reported that high accumulation of the SAD B19 G protein on the cell surface 
following infection by a mutant rabies virus results in syncytia formation. Also, it has 
recently been reported that expression of G is associated with rabies virus induced 
apoptosis of lymphocytes, possibly as a result of oxidative stress caused by accumulation of 
the protein in intracytoplasmic structures (Thoulouze et a l, 1997). The low level of 
expressing cells could also be due to the expression plasmid used. If this is the case, the use 
of a plasmid that contains the G protein and selector genes in the same reading frame may 
be more appropriate. In such a system expression of the selector gene occurs as a result of
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continued transcription from the G gene, reducing the risk of downregulation of G 
expression.
If it can be assumed from the work of Emi et a l (1991) that a VSV G pseudotyped vector 
would have a titre comparable to that of the A-MLV Env vector if used in this system, this 
would be up to 1000 fold greater than that achieved with the rabies G pseudotype. This is a 
much larger difference than would be expected from the variation in rate of protein 
transport. Another possible factor influencing the abilities of these proteins to form 
pseudotypes with retroviruses involves their role in virion budding. Mebatsion et al. (1996) 
found that the presence of the G protein results in an approximately 30 fold increase in the 
budding efficiency of rabies virions. Their conclusion that this indicates an exocytotic 
activity of G is supported by the work of Rolls et a l (1994). This study showed that the 
expression of VSV or rabies G from a Semliki Forest virus replicon RNA results in the 
release of self-propagating infectious vesicles containing the glycoprotein and the RNA 
replicon. Presumably the G protein induces vesiculation of the plasma membrane and the 
high concentration of the vector in the cell allows it to be randomly incorporated. Although 
these infectious vesicles were produced with both VSV and rabies G, those containing the 
rabies protein had titres at least 100 fold lower. Rolls at a l suggested that this could be 
explained by the slower transport rate of rabies G. However, Mebatsion et a l claim that 
their unpublished data indicate that the efficiency of the exocytotic activities of the two 
glycoproteins differ. If this is the case it could be proposed that the efficient activity of the 
VSV G protein promotes budding of retroviral particles in the same region of the plasma 
membrane, thereby producing high titres of pseudotyped vectors. In contrast, the weaker 
activity of rabies G has little effect on retroviral budding, and therefore the protein is only 
incorporated by chance. It would be interesting to test whether pseudotyping with VSV G 
can increase the titre of rabies virus, as would be predicted by this model.
Although the G protein is the only VSV protein required to produce functional 
pseudotyped retroviral vectors (Emi et a l , 1991) this does not necessarily hold true for 
rabies G. Infection of cells with a mutant rabies virus lacking the M protein results in cell 
surface accumulation of G protein, presumably as a result of a low level of incorporation 
into budding virions (Mebatsion et a l , 1999). This suggests that rabies G requires M for 
efficient incorporation. Data from the same study reveal that a specific interaction between
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these two proteins can be detected. This interaction may also be required for the efficient 
functioning of the G protein. It is thought that the VSV matrix protein M stabilises the G 
trimers (Lyles et al., 1992). It seems possible that a similar interaction occurs between the 
M and G proteins of rabies, and as the trimers of rabies G are less stable (Gaudin et al., 
1992; Whitt et al., 1991) the requirement for such an interaction may be increased. 
Although the G protein appeared to be functional in the cell fusion assay, this might not be 
truly relevant to the fusion of the viral and cellular membranes.
This work was carried out in the hope that rabies G would provide a useful alternative to 
VSV G in the production of stable, high titre pseudotyped retroviral vector. These results 
clearly show that this is not the case. However, further work with these pseudotypes may 
provide interesting insights into the processes governing virion budding and the 
incorporation of viral envelope proteins.
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CHAPTER 4
Chapter 4 Infectivity of porcine endogenous retroviruses
4.1 Introduction
The genomes of many, if not all vertebrates contain endogenous retroviral sequences 
(section 1.1.6). Some of these proviral sequences still retain the capacity to produce 
infectious virus capable of replicating in the cells of other species. This property of ERVs 
has recently become of interest due to the problems it poses for xenotransplantation. This 
involves the transplantation of organs or tissues from one species to another, and has the 
potential to provide an ideal environment for the transmission of these viruses. It has 
therefore become important to identify infectious ERVs present in the genomes of 
proposed donor animals, and to determine their host range.
4.1.1 Xenotransplantation
Transplantation is currently the best, if not the only, treatment for several conditions such 
as end-stage organ failure and hepatic disease. Consequently the demand for organs is 
continually rising. According to UNOS there are currently 65,204 patients waiting for a 
transplant in the USA. At the end of 1988 this number was 16,026. In contrast to this 
increasing demand the most reliable sources of organ donors are declining, mainly through 
improvements in road safety and in the treatment of strokes. As a result only 20,967 
transplants were performed in the USA in 1998. (Data published by UNOS 
[www.unos.org]).
One potential solution to this problem is xenotransplantation, the transplantation of an 
organ, tissue or cells from another species. Such transplants could be used either as a 
permanent treatment or as a bridging therapy until a suitable human organ becomes 
available. The use of animal cells or tissues may also allow the development of new 
procedures for treating illnesses such as AIDS, diabetes and Parkinson’s disease (Groth et 
al., 1994; Isacson and Breakefield, 1997; Nowak, 1994). The breeding of animals 
specifically for transplants would provide almost unlimited numbers of organs. Imaddition,
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the use of quarantined, specific pathogen free (SPF) animals would improve the quality 
control of organs and tissues.
Of course there are ethical objections to the use of animals in this way. Many people 
disapprove of the practice of breeding animals specifically for their organs, especially when 
this involves raising in an unnatural, sterile environment and the possibility of genetic 
manipulation. However, the large demand from patients, coupled with the potential 
benefits of xenotransplantation and probable large commercial returns, has provided strong 
motivation for research in this area.
The first attempts at xenotransplantation used baboon organs (Bailey et al., 1985; Starzl et 
al., 1993; reviewed by Taniguchi and Cooper, 1997). This approach has now been virtually 
abandoned due to strong ethical objections, the high risk of disease transmission including 
human tropic baboon endogenous retrovirus (BaEV), and the impossibility of breeding the 
large numbers that would be required (Allan, 1996; Butler, 1999). Most work now 
concentrates on the use of pigs, since their organs are also approximately the same size as 
those of humans. These animals are thought to present a lower risk of infection than 
baboons, due to their being less closely related to humans. Further advantages of pigs over 
baboons are that they breed quickly and have been domesticated for hundreds of years 
(Sachs, 1994).
4.1.2 Porcine endogenous retroviruses
Although the breeding of SPF animals is intended to remove infectious agents, this process 
is not infallible. The pathogens most likely to pose a potential risk of infection from 
xenotransplantation are those that are undetectable, or impossible to eliminate from the 
donor animals. ERVs are carried in the germ line and therefore cannot be removed from the 
animals. Since some of these proviral sequences still code for functional vims, it is 
plausible that they could be transmitted as a xenozoonosis (Chapman et al., 1995; Smith, 
1993; Stoye and Coffin, 1995). Xenozoonosis is the term used to describe the transfer of 
infections through xenotransplantation (Michaels and Simmons, 1994). A potential danger 
in the use of any transplant is the introduction of infectious agents, and the transmission of 
pathogens via allotransplantation often occurs. In this situation no vector is required for
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disease transmission and migration of infected cells throughout the body can occur. In 
addition, the use of immunosuppression can result in the absence of the usual symptoms of 
inflammation, thereby delaying diagnosis (Bach et a l, 1998). The risks associated with 
xenotransplantation are probably higher. Novel, as yet unidentified, organisms could be 
present, and the higher levels of immune suppression and graft rejection are likely to 
increase activation of any latent pathogens (Bach et a l, 1998). The prolonged close contact 
between the animal and human tissues, in the absence of the normal barriers to infection, 
will probably greatly increase the possibility of pathogen transmission (Brown et al., 1998). 
In addition, organisms present in the graft may not be known human pathogens, but may be 
xenotropic and therefore non-pathogenic in the pig (Bach et a l, 1998). Many ERVs are 
xenotropic, and it has already been shown that viruses from baboons, cats and mice are 
able to infect and replicate in human cells (Stoye and Coffin, 1995). The feline ERV 
RD114 was first detected in a human tumour xenograft in a foetal cat (McAllister et a l, 
1972). Although ERVs tend not to be harmful to their hosts, and are likely to be selected at 
least partly on the basis of low pathogenicity, they cannot be assumed to remain harmless if 
transferred to a new host (Boeke and Stoye, 1997). While the majority of these viruses 
cannot replicate in their natural host they are often able to grow to high titres on cells of 
other animals (Stoye and Coffin, 1995). There are also documented cases of cross species 
infections by ERVs. RD114 is believed to have originated from the transfer of BaEV, and 
GALV from an endogenous C-type retrovirus found in mice (Benveniste and Todaro, 1974; 
Lieber et a l, 1975b). Pathogenic effects of retroviral infection often appear to result from 
replication in an unnatural host where the normal evolved balance between viral replication 
and host cell damage is lost (Coffin et a l, 1997).
Cultured porcine cell lines, such as kidney PK15, MPK and lymphoma V 38A-1, have been 
known for some time to release C-type retroviral particles which are thought to be 
endogenous (Armstrong et a l, 1971; Lieber et a l, 1975a; Moennig et al., 1974; Todaro et 
al., 1974). Evidence from DNA hybridisation experiments suggests that this porcine 
retrovirus (PoERV) evolved from an endogenous murine virus introduced into the pig 
genome 5 to 10 million years ago (Benveniste and Todaro, 1975). Transmission is thought 
to have occurred prior to the divergence of the murine species Mus musculus and Mus 
caroli, and the original murine ERV sequences no longer appear to code for functional 
virus. Early reports (Lieber et al., 1975a; Todaro et al., 1974) suggested that PoERV had a
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narrow ecotropic host range, since productive infection was only achieved in the porcine 
ST-IOWA cell line. However, rescue of Kirsten murine sarcoma virus from nonproducer 
cell lines could be attained by cocultivation. Both serological (Moennig et al., 1974) and 
sequence (Q-One Biotech Ltd. and Imutran Ltd., 1997) data show that PoERV is closely 
related to GALV. This is illustrated by the phylogenetic tree in Fig. 4.1, constructed from 
the alignment of Pol amino acid sequences. GALV is horizontally transmitted between 
gibbons, and causes lymphoid and myeloid malignancies (Kawakami et al., 1972; 
Kawakami et al., 1980). It is thought to have recently evolved from an endogenous 
retrovirus of the Asian mouse Mus caroli or a closely related species (Lieber et al., 1975b). 
This cross species transmission will have occurred under less permissive conditions than 
those presented by xenotransplantation (Brown et al., 1998).
Both RD114 and GALV have been shown to be in the same interference groups, with the 
majority of cell types, as their ancestral viruses, BaEV and the Mus caroli ERV 
respectively (Sommerfelt and Weiss, 1990; Lieber et al., 1975b). This indicates that the 
viruses recognise the same receptors (section 1.2.1). Therefore, it is possible that the 
PoERVs recognise a receptor related to that of the original parent murine ERV, and could 
display a host range wider than that so far observed. As a result, the PoERVs must be 
considered as a potential risk in xenotransplant procedures. As described in section 1.1.5, 
retroviruses are able to evolve rapidly, adapting to an altered host environment or changing 
their tissue tropism. This implies that, during exposure to human cells, a PoERV with low 
infectivity could adapt to replicate in the new host, either through mutation or by 
recombination with a human retrovirus. Such changes could also increase the pathogenicity 
of the virus. Both FeLV-B and -C are more pathogenic than the FeLV-A from which they 
are derived, by recombination and mutation respectively (Neil et al., 1991; Stewart et al., 
1986). The highly oncogenic murine 10A1 vims is the result of a recombination event 
between an A-MLV and a MLV-related endogenous env sequence (Ott et al., 1990).
The transplantation of an organ carrying endogenous viruses has been likened to the 
contamination of gene therapy vectors with replication competent vims (Stoye and Coffin,
1995). An example illustrating the potential dangers of such contamination is the case of 
10 immunosuppressed rhesus monkeys that received autologous transplants of bone 
marrow transduced with an A-MLV retroviral vector preparation containing replication
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competent virus (Donahue et a l, 1992; Vanin et al., 1994). Although this virus was 
believed to be non-pathogenic three of the monkeys developed a rapidly progressive T-cell 
lymphoma, probably as a result of insertional mutagenesis. In contrast to the seven 
unaffected animals these three appeared to lack any immunological response to the virus. 
This observation highlights the increased risk of a pathogenic outcome of retroviral 
infection in an immune-suppressed transplant patient.
4.1.3 Hyperacute reiection
One of the major barriers to xenotransplantation is the problem of rejection. Although 
recent advances in this area indicate that it may soon be possible to minimise this, a 
disadvantage in the use of pig organs rather than those of baboons is hyperacute rejection 
(HAR, Dorling et al., 1997; Weiss, 1998). This involves the lysis of vascular endothelial 
cells of the donor organ via a complement-mediated mechanism, and occurs within the first 
few minutes of exposure to human blood. The main antigen recognised in this response is a 
galactose-a(l-3)-galactose (aGal) terminal sugar residue (Vaughan et a l,  1994). Most 
mammals express the enzyme al-3  galactosyltransferase which adds this residue to 
glycoconjugates. Old World primates including humans do not express this enzyme and 
therefore produce antibodies in response to the aGal antigen present on bacteria in the gut 
(Weiss, 1998).
Several approaches are being developed in an attempt to prevent HAR (Dorling et a l, 
1997; Weiss, 1998; White, 1996). The xenoreactive antibodies can be temporarily removed 
by passing patients’ blood through columns containing aGal linkages (Good et a l, 1992) 
or perhaps by intravenous infusion of carbohydrates (Ye et a l, 1994). Anti-complement 
agents can be used to inhibit the cascade, although the clinical use of these increases the 
risk of serious bacterial infection (Dorling et a l, 1997). Overexpression of a l,2 - 
fucosyltransferase in pig cells reduces the amount of surface antigen since this enzyme 
competes with a l-3  galactosyltransferase (Koike et a l, 1996; Sandrin et a l, 1995). Other 
approaches involve the generation of transgenic pigs expressing human complement- 
regulatory proteins. These regulatory proteins are CD55 (or decay accelerating factor, 
DAF), CD46 (or membrane cofactor protein, MCP-1) and CD59 (or protectin). They act by
130
inhibiting steps in the complement cascade. Several transgenic herds expressing one or 
more of these proteins have been developed, and the approach appears promising (Cozzi 
and White, 1995; Diamond et al., 1996; Fodor et al., 1994; Pino-Chavez et al., 1996; 
Rosengard et al., 1995; Zaidi etal., 1998).
The strategies being undertaken to combat HAR could also confer resistance to viruses 
released from the graft (Weiss, 1998). Enveloped viruses released from animal cells are 
susceptible to lysis by human complement. This has been shown to be due to the presence 
of aGal residues on the viral envelope (Takeuchi et al., 1996). If the same viruses are 
grown in human cells they become resistant to this lysis. It therefore seems very possible 
that viruses grown in transgenic tissues will also be resistant. The presence of CD46, CD55 
and CD59 in the HIV-1 envelope has been shown to be protective (Montefiori et al., 1994; 
Saifuddin et al., 1995). The suppression of the complement cascade is also likely to leave 
the patient more vulnerable to viral infection. Another risk arising from the use of 
transgenic animals is that CD46 and CD55 are known to act as receptors for human viruses 
and would render the pig tissues susceptible to infection by these viruses. It is also possible 
that related viruses that recognise the porcine equivalent of these proteins could adapt to 
use the human protein, thereby becoming potential human pathogens (Weiss, 1998).
4.1.4 Are PoERVs a potential risk?
It is very difficult to assess the risk to a patient since the pathogenicity of an infection can 
change unpredictably when introduced into a new species (Chapman et al., 1995). This can 
be seen in naturally occurring zoonoses. For example, the rodent hantavimses produce no 
detectable mortality or morbidity in their natural hosts. However, human infection can 
result in mortality rates of up to 50% (Chapman and Khabbaz, 1994). The measles vims 
can cause severe, often fatal disease in marmosets, but infection of rhesus monkeys results 
in mild disease comparable to that normally seen in humans (Kalter and Heberling, 1976).
If a xenozoonotic infection is restricted to the transplant recipient, then the risk of such an 
infection can be simply balanced against the benefits of the procedure. However it is quite 
possible that disease could be passed on to other individuals, in which case the risk to the 
population as a whole would need to be taken into account. There are several well known
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cases of zoonotic viruses causing outbreaks of disease in humans. In 1967 the importation 
into Germany of vervet monkeys infected with Marburg virus resulted in human-to-human 
transmission involving 31 individuals (Martini, 1969). Several outbreaks of Ebola virus 
infection in Sudan and Zaire have resulted in multiple generations of transmission with 
fatality rates of 80-90% (WHO, 1978). Although such cases are very dramatic, the 
outbreaks are short lived and fairly contained. Widespread infections are most efficiently 
achieved by the transmission of an agent that establishes long term infection with delayed 
onset of disease (Brown et a l, 1998). Such infections are characterised by retroviruses. The 
human immunodeficiency viruses are generally believed to have resulted from the 
adaptation of simian retroviruses following zoonotic infection. HIV-1 is thought to have 
originated in chimpanzees (Gao et a l, 1999) and HIV-2 in sooty mangabeys (Chen et a l, 
1997; Gao et a l, 1992). Following initial infection of humans transmission continued for 
well over a decade before AIDS was identified (Chapman et a l, 1995).
In order for PoERV to pose a threat to public health several conditions need to be met 
(Stoye, 1998). The virus must first be present in the germline of the pigs bred for 
transplantation and be expressed by the transplanted cells. It must also be able to infect and 
replicate in the recipient’s cells and thereby cause disease. Finally, transmission of the virus 
to other individuals must occur. These viruses are thought to be present in all pigs (Lieber 
et a l,  1975a; Todaro et a l,  1974), and it is quite likely that they will be released from 
transplanted cells. Murine ERVs can be activated through graft-versus-host reactions 
(Hirsch et a l,  1970; Levy et a l, 1977). Therefore the next logical step would be to 
investigate the infectivity of PoERVs in various human cell cultures. It is very difficult to 
experimentally predict pathogenic potential. However, the host range and tissue tropism of 
a virus is an important determinant of this (Hunter, 1997). An environment where cell to 
cell transmission can occur also greatly increases the chance of viral insertion near a proto­
oncogene (Coffin et a l, 1997). If PoERV can be placed into a known interference group it 
will facilitate prediction of this host range and the potential receptor usage of the virus.
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4.2 Materials and methods
4.2.1 Materials
4.2.1.1 Raii 4 cells
The Raji 4 cell clone was a gift from Q-One Biotech Ltd. Raji 4 had been derived from 
human Raji cells cocultivated with irradiated PK15 cells which are reported to release 
PoERV (Armstrong et al., 1971; Lieber et al., 1975a; Todaro et al., 1974). This clone 
tested positive for RT activity, indicating that it had been infected with PoERV released 
from the PK15 cells (Q-One Biotech Ltd. and Imutran Ltd., 1997).
4.2.2 Methods
4.2.2.1 Preparation of Raii 4 cells for electron microscope (EM) study
The Raji 4 cell suspension was mixed 1:1 with paraformaldehyde/glutamine fix and 
immediately centrifuged at 2000 rpm for lOmin in a bench top centrifuge (Beckman). The 
supernatant was removed and fresh fix added. After lOmin the pellet was gently loosened 
and left for a further 2 hours. The sample was then given to the Electron Microscopy Unit, 
Veterinary Pathology, University of Glasgow, for further processing and EM analysis.
4.2.2.2 Polymerase chain reaction (PCR) analysis of Raii 4 cells
Genomic DNA was prepared from Raji 4, SupTl and J.Jhans cells as described in section 
2.22.2. Each PCR was performed with 500ng of template, 30pmol of each primer, 1.5mM 
MgCL, 0.125mM of each dNTP, and 1U Taq DNA polymerase (Perkin Elmer). The 
primers, which were targeted to the pol region of PoERV, were a gift from Christine 
Haworth (Q-One Biotech Ltd.). The cycling parameters used were 30 cycles of lmin at 
95°C, lmin at 55°C, and lmin at 72°C; and a final extension step of lOmin at 72°C. 
Cycling reactions were carried out in 0.2ml reaction tubes in a programmable thermal
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cycler (Perkin Elmer DNA Thermal Cycler). 5jil of each product was analysed by agarose 
gel electrophoresis.
4.2.2.3 Infection interference studies
Approximately 1 x 106 Raji or Raji 4 cells were mixed with 1ml of virus stock in the 
presence of 8|ig/ml Polybrene. The viruses used were A-MLV, X-MLV, FeLV-B and 
FeLV-C. Equal numbers of cells were mock infected with just growth medium and 
Polybrene. After incubation at 37°C for 90min, 4ml fresh medium was added to the flasks, 
and the cells were passaged every 3-4 days. Genomic DNA was extracted as described in 
section 2.22.2 and analysed by PCR.
Each PCR was performed with 500ng of template DNA, 20pmol of each primer, 0.125mM 
of each dNTP, and 2.5U Pfu DNA polymerase (Stratagene, UK). 5% DMSO was also 
added to the FeLV-C reactions to increase the stringency of primer annealing. The primers 
used to amplify the specific envelope regions were as follows:
A-MLV sense 5 ' - CCT CGT TGT CTG AAG TAG TCC - 3 '
antisense 5 ' - CAT GGC TCG TAC TCT ATG GGT - 3 '
X-MLV sense 5 ' - GGA CGA TGA CAG ACA CCT TCC CTA - 3 '
antisense 5 ' - CAA CCA TCC CCA ATA TCG GGT TCT - 3 '
FeLV-B/-C sense 5 ' - CGT GGA ACT TAG TGT TTC TG - 3 '
FeLV-B antisense 5 ' - GAA TGG TTC CTG ATC TGA AG - 3 '
FeLV-C antisense 5 ' - ATA ACG TGC CCA AGA TCT TG - 3 '
The cycling parameters used for A-MLV and X-MLV were 5min at 94°C; 35 cycles of 50s 
at 94°C, 50s at 55°C, and 50s at 72°C; and a final extension step of 7min at 72°C. The 
parameters used for FeLV-B and FeLV-C were 5min at 94°C; 30 cycles of 30s at 94°C, 45s 
at 50°C, and 30s at 72°C; and a final extension step of 7min at 72°C.
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4.3 Results
4.3.1 Presence of PoERV in the Raii 4 culture
Electron microscopy of the Raji 4 cells revealed the presence of virus-like particles roughly 
80nm in diameter, as shown in Fig. 4.2. Recently budded particles can be seen close to the 
plasma membrane, indicated by the small arrows. Mature extracellular particles are also 
visible in B, indicated by the large arrow. These particles have the typical appearance of C- 
type retroviruses (Coffin, 1990; Vogt, P.K., 1997), consisting of a well defined envelope 
surrounding an angular electron dense core. A less condense core is visible within the 
immature particles at the plasma membrane. Env protein spikes are just discernible in B, 
again indicated by the large arrow.
To demonstrate the presence of PoERV proviral DNA in the Raji 4 cells, PCR analysis was 
carried out on genomic DNA prepared from these cells. PCR analysis using PoERV pol 
based primers was expected to produce a band at 468bp in the presence of this provirus. As 
can be seen in Fig. 4.3, a band at this size was obtained from Raji 4 genomic DNA (lane 
D), but not from DNA taken from the other, uninfected, human lymphocyte cell lines 
SupTl and J.Jhans. This suggests that the vims present in the Raji 4 culture may be 
PoERV.
4.3.2 Infection interference
It is possible that PoERV recognises the same receptor as another retrovirus. As mentioned 
previously (section 1.2.1), this would result in infection interference. As an initial attempt 
to place PoERV into an interference group, Raji and Raji 4 cells were both tested for their 
susceptibility to infection by other human-tropic C-type retroviruses. If PoERV is in the 
same interference group as one of these viruses, its presence in the Raji 4 culture would be 
expected to prevent infection.
Raji and Raji 4 cells were incubated with each of the four viruses, A-MLV, X-MLV, 
FeLV-B and FeLV-C. Infection was then detected by PCR, using primers targeted to env 
regions specific to each vims. The results of these PCRs are shown in Fig. 4.4 and
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Fig. 4.3. PCR analysis of human cell lines using primers targeted to the pol region of PoERV. 
A) AHindlll DNA markers (Gibco, UK). B) SupTl cells. C) J.Jhans cells. D) Raji 4 cells. E) 
Water control.
Samples were run on a 1% agarose gel.
Fig. 4.2. Previous page. EM photographs of cells taken from the Raji 4 culture (X45.000). A) 
Recently budded virus particle, indicated by the small arrow. B) Recently budded particles, indicated 
by the small arrow, and mature extracellular virus particles, indicated by the large arrow.
137
4361 bp 
2027bp
(3) A B C D E (4) A B C D E F
Fig. 4.4. PCR analysis of Raji and Raji 4 cells infected with mammalian C-type retroviruses.
(1) PCR with the A-MLV env primers. A) ^Hindlll DNA markers (Gibco, UK). B) Raji 4 cells 
infected with A-MLV. C) Raji cells infected with A-MLV. D) Noninfected Raji 4 cells. E) 
Noninfected Raji cells. F) Water control.
(2) PCR analysis with the X-MLV env primers. A) <j)X174 DNA markers (Gibco, UK). B) Raji 4 
cells infected with X-MLV. C) Raji cells infected with X-MLV. D) Noninfected Raji cells. E) Water 
control.
(3) PCR analysis with the FeLV-B env primers. A) <|>X174 DNA markers. B) Raji 4 cells infected 
with FeLV-B. C) Raji cells infected with FeLV-B. D) Noninfected Raji cells. E) Water control.
(4) PCR analysis with the FeLV-C env primers. A) (|>X174 DNA markers. B) Raji 4 cells infected 
with FeLV-C. C) Raji cells infected with FeLV-C. D) Noninfected Raji cells. E) Positive control 
plasmid containing FeLV-C env. F) Water control
The A-MLV samples were run on a 1% agarose gel, the rest on 4% agarose gels.
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summarised in Table 4.1. For each virus, a band at the expected size was obtained with
DNA taken from infected Raji and Raji 4 cells, but not from uninfected cells. A band at
406bp was obtained in the PCRs for A-MLV env (Fig. 4.4.1 lanes B and C). A band at
96bp was obtained in the PCRs for X-MLV env (Fig. 4.4.2 lanes B and C). A band at
250bp was obtained in the PCRs for FeLV-B env (Fig. 4.4.3 lanes B and C) and FeLV-C 
env (Fig. 4.4.4 lanes B and C). This indicates that all four viruses were able to replicate in 
the Raji 4 cell culture, revealing no obvious interference with PoERV. Since no virus 
specific sequences were detected in the negative controls these results are unlikely to be 
due to DNA contamination. Each PCR was repeated at least three times.
Infection detected
Virus Raji Raji 4 Raji (mock) Raji 4 (mock)
A-MLV yes yes no no
X-MLV yes yes no ND
FeLV-B yes yes no ND
FeLV-C yes yes no ND
Table 4.1. Susceptibility of Raji and Raji 4 cells to infection by mammalian C-type viruses. Infection was 
detected by PCR as described in the text.
O
139
4.4 Discussion
The EM photographs presented in Fig. 4.2 and PCR results presented in Fig. 4.3 imply that 
the Raji 4 cell culture is infected with PoERV. The particles shown in the EM photographs 
have C-type morphology, as expected for this virus (Armstrong et a l, 1971; Moennig et 
al., 1974). The presence of extracellular virions indicate that the virus is transcriptionally 
active in these cells, confirming the previously recorded RT activity (Q-One Biotech Ltd. 
and Imutran Ltd., 1997). Although it is possible that contaminating PK15 cells are still 
present in the cell culture this seems unlikely as these cells were irradiated before the 
coculture was set up. In addition PK15 cells are adhesive and would not be expected to 
grow well in the suspension cell culture. The amplification of a band at the expected size 
during PCR analysis of Raji 4 DNA suggests that PoERV sequences are present. The 
absence of this band in the reactions carried out in parallel with DNA from other human 
lymphocyte cell lines indicates that this result was not due to the primers binding to human 
DNA sequences. The conclusion that PoERV can infect and replicate in human cells has 
been confirmed by studies carried out by other groups. In addition to the Raji cell line, 
PoERV infection of human kidney, lung, muscle and T-cell lines by cocultivation with 
PK15 cells has been demonstrated (Patience et al., 1997a). PoERV has also been obtained 
from mitogenically activated primary blood mononuclear cells taken from miniature pigs 
(Wilson et al., 1998). This virus was reported to be capable of infecting human kidney cells 
in a coculture.
All of the retroviruses tested in the interference assay (Table 4.1) were able to infect both 
the Raji and the Raji 4 cells. As the Raji 4 cells are believed to be infected with PoERV, 
this result indicates that PoERV cannot be placed in any of the four interference groups 
represented by these viruses. However, it is possible that PoERV replication occurs at too 
low a level in the human cells to produce significant receptor interference. A fall in the 
infection efficiency of the superinfecting virus may not have been detected since the PCR 
analysis used here was not quantitative. This experiment would also have been unable to 
detect any non-reciprocal interference as no attempt was made to infect other virus 
producing cells with PoERV. However, the conclusion that PoERV lies outside these four 
interference groups has also been reached by others. Takeuchi et al. (1998) have recently 
shown that MLV based vectors bearing the PoERV Env are able to infect 293 cells infected
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with these four viruses. The same result was obtained with cells infected with RD114, 
GALV or FeLV-C. This lack of interference suggests that PoERV recognises a novel 
receptor(s) on 293 cells not used by other mammalian C-type retroviruses. It still remains 
possible that PoERV will belong to an interference group containing viruses from other 
genera since the RD114 group contains both C- and D-type viruses (Sommerfelt and 
Weiss, 1990).
It is perhaps surprising that no interference is observed with FeLV-B, since this virus 
recognises the same receptor as GALV, a virus that shares close homology with PoERV 
(Q-One Biotech Ltd. and Imutran Ltd., 1997). It is possible that GALV and PoERV 
evolved from the same ancestral murine ERV. However, closely related avian and 
mammalian C-type retroviruses often recognise different receptors (Hunter, 1997). As 
described in section 1.2.1, FeLV-B and A-MLV have highly homologous Env proteins that 
bind to different receptors, the phosphate symporters GLVR-1 and Ram-1 respectively 
(Tailor and Kabat, 1997). As the receptor molecules recognised by mammalian C-type 
retroviruses are often very similar proteins (section 1.2.1), small changes in the viral Env 
proteins can result in a change in receptor recognition, and therefore a potentially 
significant change in host range and pathogenicity. The differences in generation time 
between mice and pigs imply that viruses in the respective genomes will evolve at different 
rates (Benveniste and Todaro, 1975). The porcine ERV is likely to be much more 
homologous to the ancestral virus than the ERVs that remained in the murine genome at 
the time of the cross species infection that gave rise to GALV. It is also likely that, 
subsequent to the initial cross species transfer and germ line insertion, PoERV has evolved 
to adapt to its new host. This may have resulted in a change in receptor recognition. Of 
course it is possible that GALV and PoERV evolved from different, related viruses that 
recognised different receptors.
The observation that PoERV can infect and replicate in human cells in vitro indicates that 
these viruses may indeed pose a threat to xenotransplant recipients. As mentioned in 
section 4.1, such patients are more vulnerable to infections as a result of the transplant 
procedure and the possible suppression of normal complement-dependent viral lysis. 
Although no evidence of infection has yet been found in patients exposed to pig tissues in 
medical procedures (Heneine et al., 1998; Paradis et al., 1999; Patience et al., 1998), it still
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remains possible that rare infections will occur. The risk of infection is likely to be 
increased with actual organ transplants, as the PoERV releasing tissue will remain in close 
contact with human cells for long periods of time, perhaps years. In addition, none of the 
patients included in these studies had been exposed to transgenic pig tissues, which are 
likely to pose a greater risk of virus transmission. It is therefore important to determine the 
host cell range and pathogenic potential of these viruses. Even if PoERV is non-pathogenic 
and does not replicate to high titres in the human body, the ability to enter cells raises the 
possibility of recombination with human exogenous and endogenous retroviral sequences. 
In this way, these viruses could adapt to human tissues and perhaps increase their 
pathogenicity.
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CHAPTER 5
Chapter 5 Sequencing of a novel PoERV env gene
5.1 Introduction
The retroviral envelope glycoprotein recognises and binds to the receptor molecule, and 
mediates fusion of the viral and host cell membranes initiating the infection cycle. The 
binding of the specific receptor molecule is thought to lead to a conformational change 
within the Env protein which enables the fusion process to proceed. Although viruses may 
bind weakly to nonpermissive cells, fusion does not occur in the absence of a specific 
receptor. This means that the host range and tissue tropism of a retrovirus is highly 
dependent upon its envelope glycoprotein. (Hunter, 1997; Vogt, V.M., 1997).
Inbred strains of mice possess closely related MLV-like ERVs that differ in their host 
ranges (Boeke and Stoye, 1997). As would be expected, the major differences between 
these viruses are found within the env gene. It seems possible that porcine genomes also 
contain several strains of PoERV, differing in env and host range. It is therefore important 
to identify and analyse each of these for their potential risk in xenotransplantation.
The function of a protein is dictated by its primary structure. This can be easily predicted 
from the nucleotide sequence of the gene. However, it is difficult to determine the three- 
dimensional structure or activity of a protein just from its amino acid composition. The 
presence of hydrophobic residues can indicate membrane spanning regions, and cysteine 
residues disulphide bonding. Several computer-assisted algorithms such as the Chou- 
Fasman (Chou and Fasman, 1978a; Chou and Fasman, 1978b) have been developed in 
order to predict secondary structure motifs including the a-helix and (3-sheet. Unfortunately 
such predictions are not highly accurate (Myers, 1997). However, obtaining the sequence 
of a protein does allow comparisons to be made with related proteins for which structural 
and functional information has already become available. The most highly characterised 
Env proteins of the mammalian C-type viruses are those of the MLV-related viruses, 
particularly the ecotropic MoMLV.
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5.1.1 Env structure
As mentioned in section 1.1.4, Env is initially translated as a precursor polyprotein. The 
signal peptide at the amino-terminal of the protein binds to a signal recognition particle 
which then targets further translation to the RER. Following cleavage of the signal peptide 
the protein is transferred to the Golgi apparatus. Here the polyprotein is cleaved by cellular 
proteases to form the surface glycoprotein SU and the transmembrane protein TM (Vogt, 
V.M., 1997).
While within the RER Env is cotranslationally N-glycosylated by cellular enzymes present 
in the lumen. These enzymes attach mannose-rich oligosaccharides to the asparagine 
residues in the consensus motifs Asn-X-Ser and Asn-X-Thr (Hunter, 1997), where X is any 
residue except proline and tryptophan (Rademacher et al., 1988). The number and position 
of these residues can vary significantly between virus groups, although a high level of 
conservation may occur within a group. Mutational analysis of the Friend-MLV SU protein 
has shown that only one out of eight glycosylation sites is necessary for viral growth in cell 
culture (Kayman et al., 1991). This site is highly conserved among mammalian C-type 
viruses, and its removal probably interferes with the processing of the precursor protein. 
Glycosylation may have a role in the structure of the protein, providing hydrophilicity 
which helps to stabilise correct folding. It may also reduce immunogenicity and proteolytic 
digestion by masking susceptible amino acid sequences. This would explain why sites are 
conserved even though they appear unnecessary for growth in vitro. Some retroviruses, 
including HIV and MLV are also modified by the addition of O-linked oligosaccharides. 
The role of this is unknown (Hunter, 1997).
The Env proteins are arranged in oligomers on the surface of the virion. These are probably 
trimers, although dimers and tetramers have also been suggested (Hunter, 1997; Tucker et 
al., 1991). The crystal structure of a fragment of the MoMLV TM reveals this protein to be 
trimeric (Fass et al., 1996). The oligomers form in the RER via domains which appear to 
be within the ectodomain of the precursor protein (Hunter, 1997; Tucker et al., 1991). The 
TM proteins of ASLV and HIV will form oligomers when expressed in the absence of SU. 
The formation of oligomers appears to have a role in the intracellular transport of the 
protein, presumably by enclosing hydrophobic sequences within the core of the structure.
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Oligomerisation is probably also important for providing mechanical rigidity, and for 
achieving membrane fusion (Hunter, 1997).
5.1.2 Structure and function of the SU protein
The positions of cysteine residues in the SU proteins of related viruses tend to be conserved 
(Hunter, 1997). The amino-terminal domains of the SU proteins of mammalian C-type 
viruses all contain eight conserved cysteines, suggesting a common structure (Battini et a l, 
1992). Disulphide-bonding patterns have been deduced for Friend-MLV (Linder et a l, 
1992) and Friend mink cell focus-inducing vims (Linder et a l, 1994) in which the bonds 
are found to form between cysteines reasonably close together in the primary sequence. 
There are no bonds linking the amino- and carboxy-terminals. A similar pattern has been 
observed with HIV-1 gpl20 (Hunter, 1997). The loops that are formed by the disulphide- 
bonding tend to contain highly variable amino acid sequences. These regions are thought to 
be involved in the receptor specificity of the mammalian C-type viruses.
Within the amino-terminal region of the mammalian C-type SU proteins there are two 
hypervariable regions, VRA and VRB, believed to be involved in receptor binding. VRA is 
approximately 50 amino acid residues from the amino-terminal, and 35 to 80 amino acids 
long. It contains a peptide of variable length, followed by a hydrophilic region containing 
two conserved cysteine residues. VRB is situated about 40 amino acids after VRA, and is 
22 to 29 amino acids long. It contains one conserved cysteine which is followed by a 
sequence of polar residues (Battini et a l, 1992; Hunter, 1997). VRA can be further 
subdivided into three segments consisting of two disulphide-linked loops and an interloop 
domain (Han et a l, 1998). The first of these loops is highly variable; the ecotropic MLV 
proteins possess two extra disulphide bonds within this region. VRB forms just one 
disulphide loop in the majority of SU proteins, although those of A-MLV, 10A1 and FeLV- 
B contain two more cysteine residues which may form another small loop (Han et a l, 
1998).
The evidence that these regions are involved in receptor interactions comes mainly from 
studies of Env chimaeras. By swapping various lengths of sequences from this region 
between A- and E-MLV SU proteins, Morgan et a l (1993) were able to show that the
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critical sequences for host range are within the first 157 amino acids of the A-MLV SU, 
and the first 88 of the E-MLV SU. These chimaeras lacked full activity, suggesting that 
other regions may also be involved to some extent. Battini et al. (1995) also found that the 
amino-terminal regions of the A- and E-MLV SUs are sufficient for receptor binding and 
interference, although additional sequences are required by the polytropic MLV (P-MLV) 
and X-MLV proteins. In another study Battini et al. (1992) formed chimaeras by swapping 
the VRA, VRB and remaining carboxy-terminal halves of the MLV proteins. They found 
that host range was determined primarily, but not solely, by the specific VRA. A-MLV 
proteins containing a foreign VRB were able to bind to receptors on murine cells but were 
unable to recognise the allelic form present on canine cells. The authors suggest this shows 
that although VRA is the major determinant of host range for A-MLV, VRB also 
contributes to the stability of the receptor recognition complex. This is supported by the 
observation that chimaeras containing only the VRA of A-MLV were inactive. Also, 
although substitutions of segments in the variable regions of A-MLV SU with an epitope 
tag from VSV-G only abolished receptor recognition when they were within the first loop 
of VRA, substitutions in the remainder of VRA and in VRB also affected binding (Battini 
et a l, 1998). While VRB appears to be important for A-MLV, sequences in the carboxy- 
terminal half seem to have a role in the function of the xenotropic and polytropic Env 
proteins. When these regions were replaced with that of the amphotropic protein, the 
resulting chimaeras were inactive. Receptor choice of xenotropic and polytropic based 
chimaeras was unaffected by swapping VRB (Battini et al., 1992). These accessory 
segments may be required for additional binding interactions, or for appropriate folding to 
allow optimal receptor contact (Battini et al., 1998). Mutations within the ectodomain of 
MoMLV TM can affect receptor binding, presumably by influencing the conformation of 
the binding regions of the SU protein (Berkowitz and Goff, 1993).
Analysis of the crystal structure of the receptor binding domain of Friend-MLV SU has 
shown that VRA and VRB form antiparallel a-helices (Fass et al., 1997). The close 
association of these two regions provides some explanation for the inability to produce 
functional chimaeras between ecotropic and non-ecotropic Env proteins. Large differences 
in length and sequence would not be easily tolerated in such a structure.
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Between the amino-terminal receptor binding domain and the more conserved carboxy- 
terminal of SU proteins there is a proline-rich region (PRR), approximately 50 amino acids 
long. This consists of a fairly conserved domain of 14 or 15 amino acids, followed by a 
region that is highly variable both in length and sequence. The positions of the proline 
residues vary between viruses, but they make up about one third of the residues in this 
domain (Hunter, 1997; Wu et a l, 1998). Limited proteolysis of P- and E-MLV SU 
glycoproteins leads to cleavage at both ends of this region, suggesting that it is not just a 
link but a functional domain (Linder et a l, 1994). The presence of the proline residues may 
permit the formation of contiguous p-tum helices (Lavillette et al., 1998). It has been 
suggested that the PRR is necessary for the stabilisation of the receptor binding domain 
(Battini et a l, 1992; Battini et a l, 1995; Tailor and Kabat, 1997). The presence of this 
region has been shown to be required for the binding of P-MLV and E-MLV SUs (Battini 
et a l, 1995) and to increase infectivity of vectors bearing A-MLV SU chimaeras (Tailor 
and Kabat, 1997). Although it is possible that the PRR also interacts with a receptor site it 
seems more likely that it has a role in the induction of appropriate structure of the amino- 
terminal binding domain (Battini et a l, 1995).
Mutation analyses of the PRR have shown that this region is not only important for 
stability of receptor interactions but is involved in the function of the whole Env complex. 
Although the amphotropic PRR can substitute for the differing ecotropic region, and 
truncations of up to 29 amino acids in the variable region have little effect on vector titre, 
further truncations result in decreased levels of precursor cleavage into SU and TM (Wu et 
a l, 1998). These mutants also show low levels of cell-cell fusion and transduction 
efficiency. Deletion of the conserved segment of the PRR produces a protein that is not 
incorporated into virions at any detectable level, despite normal precursor processing. High 
levels of SU are shed into the culture medium suggesting a reduced stability in the 
interaction between SU and TM. This is supported by the observation that the mutant is 
temperature dependent and low levels of protein could be detected on virions produced at 
32°C.
The PRR also appears to have a role in the fusion process. Lavillette et a l (1998) have 
shown that various modifications in this region can result in either high cell-cell fusion 
activity accompanied by decreased SU-TM stability, or low cell-cell fusion and high virus­
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cell fusion accompanied by SU-TM stability. In the same study it was found that chimaeric 
SU proteins in which the PRR is paired with the corresponding binding domain or 
downstream regions are more stable. The authors suggest a model in which the two 
functions of the PRR are to stabilise the structure of the SU, and to mediate the changes 
involved in fusion initiation. The variation among PRRs would therefore be expected to 
reflect the differences in structure required to interact with different receptors. The 
predicted P-tum helical structure is compatible with an ability to transmit the small 
deformations resulting from receptor interactions to the carboxy-terminal fusion domain, 
thereby triggering the necessary conformational changes.
5.1.3 Structure and function of the TM protein
The TM subunit of Env provides the membrane anchor for the protein, and is required for 
fusion. It is connected to SU via noncovalent interactions and, in some viruses such as 
ASLV, by disulphide bonds (Hunter, 1997). The TM protein has several predicted 
structural features. The first 35 amino acids are thought to form the fusion peptide (Jones 
and Risser, 1993). Mutations within this stretch of hydrophobic residues in the TM of 
MoMLV have been shown to influence fusogenicity (Jones and Risser, 1993; Zhao et a l, 
1998). The carboxy-terminal end of this peptide is rich in glycine and threonine residues. 
This is followed by a heptad repeat region containing a putative leucine zipper motif 
(Delwart et a l, 1990), and then a region containing a CX6CC motif highly conserved 
among TM proteins. These cysteine residues are also present in the envelope proteins of 
the filovirus family (Weissenhom et a l, 1998). Three regions of the protein are predicted 
to form a-helices (Zhao et a l, 1998). These are the heptad repeat sequence, a region 
towards the carboxy-terminal end of the ectodomain, and the transmembrane domain with 
the first 16 amino acids of the cytoplasmic tail.
As mentioned previously (section 1.1.4) the TM protein is cleaved by the viral protease 
near the carboxyl-terminus, releasing the 16 amino acid R-peptide. This occurs during and 
after viral budding, and both forms of TM coexist in the virion (Green et a l, 1981; 
Januszeski et a l,  1997). R-peptide cleavage renders the protein fusion competent, and has 
been shown to enhance cell-cell fusion by MoMLV Env (Januszeski et a l, 1997; Rein et 
a l, 1994). Cleavage of the cytoplasmic tails of the proteins from other retroviruses, for
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example Mason-Pfizer monkey virus (Brody et al., 1994), also enhances fusogenicity. 
Removal of the R-peptide is necessary for function as removal of the cleavage recognition 
site renders the protein almost completely defective (Rein et al., 1994). It seems likely that 
Env is synthesised with this peptide intact in order to prevent premature activation of 
fusion potential prior to viral release. A fusogenic protein may be toxic to the host cell or 
may be inactivated by inappropriate interaction with receptor molecules.
Both the ectoplasmic and transmembrane regions of TM are necessary for membrane 
fusion and cell transduction (Ragheb and Anderson, 1994). Mutant proteins in which the 
transmembrane domain has been replaced with glycophospho-lipid-anchoring (GLA) 
sequences can be rescued by the presence of wild type TM in the oligomers. However this 
is not true of mutants lacking the ectodomain, suggesting that necessary intramolecular 
interactions may take place within this region, though it should be noted that the constructs 
used in this study also had altered SU carboxy-terminals.
More detailed analyses of the functional domains of the TM protein have involved the use 
of point mutations and small deletions mapped to specific regions. A number of mutations 
of hydrophobic residues in the leucine zipper region, even conservative changes, have been 
shown to abolish infectivity and cell fusion activity of E-MLV Env (Ramsdale et al.,
1996). The mutation of hydrophilic residues reduces infectivity but has little or no effect on 
rat XC cell fusion. It seems likely that the hydrophobic residues are necessary for the 
formation of a structure required for the fusion process, perhaps forming a fusion pore 
within the trimer (Ramsdale et al., 1996; White, 1992). Zhao et al. (1998) found that 
fusion-defective proteins containing mutations within the predicted helical regions could by 
complemented by a protein with a mutation in the glycine/threonine (GT) rich area, and to 
a lesser extent by one with a mutation in the fusion peptide. However the helix mutants and 
the amino-terminal mutants were unable to complement themselves, indicating that these 
are two separate complementation groups. The authors interpret this as indicative of a 
functional interaction between the three a-helices. Given the ability of R-peptide cleavage 
to enhance fusogenicity in trans, R-less versions of these mutants were tested for their 
ability to produce syncytia when coexpressed with wild type protein. Only the GT rich 
region mutant produced syncytia under these conditions. The same R-less mutant was also 
able to enhance fusion activity of the helix mutants, though reciprocal complementation
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was not observed. This suggests that the trans enhancement of fusion by R-peptide 
cleavage has specific cis requirements. Zhao et al. believe that this cleavage may enhance 
fusion by removing a conformational constraint of the cytoplasmic tail which is then 
transmitted to the rest of the molecule, probably via an interaction between the two 
ectodomain a-helical regions.
After removal of the R-peptide further truncations of the carboxy-terminal end of the 
MoMLV TM protein, even as far as complete removal of the cytoplasmic tail, have very 
little effect on the ability to cause cell-cell fusion (Januszeski et al., 1997; Ragheb and 
Anderson, 1994). In contrast, internal deletions in the membrane proximal region of the 
cytoplasmic tail result in reduced fusogenicity (Januszeski et al., 1997). This suggests that 
residues in this area may be important in the fusion process, particularly since more distal 
deletions can enhance fusion. Januszeski et al. propose that the residues Leu 602 and Val 
603 have an important role. Several substitutions and deletions in this area reduce 
fusogenicity of the full length protein. The fusion defect in some of these could not be 
restored by R-peptide cleavage.
Although truncation of the cytoplasmic tail has little effect on cell-cell fusion, this is not 
always true of vector infectivity (Januszeski et al., 1997; Ragheb and Anderson, 1994). 
This reduction in titre could be due to reduced expression and/or association with virus, or 
it may reflect a role for this region in post fusion events. Certain mutations in the 
cytoplasmic tail, especially in the region amino-terminal to the R-peptide cleavage site, 
permit extensive cell-cell fusion but significantly reduce vector titre (Januszeski et al.,
1997). A group of these mutants in which membrane proximal residues have been deleted 
or substituted are not efficiently incorporated into virions although they are expressed on 
the cell surface. This suggests that the cytoplasmic tail of MoMLV TM has a role in Env 
incorporation (discussed in section 1.5.1). It is also possible that these alterations result in a 
secondary structure that prevents the protein associating with the vector particle.
The observations that several mutations and truncations can be introduced into the 
cytoplasmic tail of MoMLV TM without abolishing infectivity (Granowitz et al., 1996; 
Januszeski et al., 1997; Ragheb and Anderson, 1994) suggests that this domain is not 
absolutely required. However, such mutants have been shown to rapidly revert to the wild
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type during replication (Granowitz et a l, 1996). This implies that the wild type sequence is 
favoured for rapid replication in cell culture.
Several retroviruses, including MoMLV, possess a basolateral membrane targeting signal 
in the cytoplasmic tail of TM (Lodge et a l, 1997a). The consensus for this signal is Y-X- 
X-aliphatic/aromatic. Its conservation may reflect the importance of polarised budding in 
the viral life cycle. Basolaterally targeted viruses also tend to bud at sites of intercellular 
contact. This signal may therefore aid the cell-to-cell transmission of virus.
5.1.4 Sequencing of PoERV env
At the time that this work was undertaken the sequence of only one porcine endogenous 
virus was available. This sequence was obtained at Q-One Biotech Ltd from virions 
released from PK15 cells (Q-One Biotech Ltd. and Immutran Ltd., 1997). As it is quite 
likely that other ERVs are present in the porcine genome, it is important that each 
potentially infectious virus is identified. Since Env is the main determinant of host range 
the cloning and sequencing of PoERV env genes is a useful aid to the assessment of the 
infection risk of these viruses. Sequence analysis also enables determination of functional 
and evolutionary relationships between viral proteins. Although it is very difficult, if not 
impossible at present, to predict receptor usage from a sequence, identification and cloning 
of authentic env genes allows host ranges to be determined using procedures such as 
pseudotyped vector analysis.
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5,2 Materials and methods
5.2.1 Materials
5.2.1.1 Primers
The primers used for cloning and sequencing were as follows:
U5657 5 ' - CGA AGG CGG CCG CAC CTG GAT CCA TGC ATC - 3 '
xhis 5 ' - CTA ATC TTA GAA CGC GGC CGC CTA GAG GTC AGT TT
T7 5 ' - TAA TAC GAC TCA CTA TAG G - 3 '
T3 5 ' - ATT AAC CCT CAC TAA AGG GAA G - 3 '
62 IFOR 5 ' - GTG GAT AAA TGG TAT GAG CT •- 3 '
1869FOR 5 ' - ACA GTT GGG CCT TGC TTA AT ■- 3 '
1316REV 5 ' - GAC CAT GAC ACA GAA ATC TT •- 3 '
5.2.2 Methods
5.2.2.1 Cloning of the env gene from Raii 4 cells
Genomic DNA was extracted from Raji 4 cells as described previously (section 2.2.2.2). 
Primers were designed, based on the PoERV sequence obtained by Q-One Biotech, to bind 
to sequences spanning the start and stop signals for env transcription. These primers were 
U5657 (sense primer) and xhis (antisense primer). Synthetic Not I restriction sites are 
underlined. Each PCR was performed with 500ng of template, 20pmol of each primer, 
0.125mM of each dNTP and 2.5U Pfu DNA polymerase. The cycling parameters used were 
4 mins at 96°C; 30 cycles of 30s at 96°C, 45s at 55°C, and 5 mins at 72°C; and a final 
extension step of 7 mins at 72°C. The PCR product obtained was then gel purified.
The PCR product and the eukaryotic expression vector pCI-neo were both digested with 
Not I (New England Biolabs). The vector was dephosphorylated with CIAP as described 
previously (section 2.2.3.1). Both digests were gel purified (section 2.2.2.5) and ligated 
using T4 DNA ligase at 14°C overnight. The ligation reaction was then used to transform 
DH5a cells as described previously (see 2.2.3.2).
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5.2.2.2 Sequencing of the env gene
Sequencing was carried out using the dideoxy chain termination method (Sanger et a l, 
1977). The reactions were prepared using the Thermo Sequenase fluorescent labelled 
primer cycle sequencing kit with 7-deaza-dGTP (Amersham Pharmacia Biotech, UK), and 
primers labelled with the fluorescent dye IRD-41. Initial sequence was obtained with 
primers targeted to the T7 and T3 RNA polymerase promoters positioned either side of the 
insert in pCIneo. The cycling parameters used were 5 mins at 95°C, and 25 cycles of 30s at 
95°C, 30s at 55°C, and 30s at 72°C. The sequence thus obtained was then used to design 
three more primers which allowed the rest of the gene to be sequenced. These were sense 
primers 621FOR and 1869FOR, and antisense primer 1316REV. The cycling parameters 
used for 62IFOR and 1869FOR were identical to those for the T7 and T3 primers. The 
parameters used for 1316REV were 5mins at 95°C, and 25 cycles of 30s at 98°C, 30s at 
50°C, and 30s at 72°C. The reactions were mn on a 60ml denaturing polyacrylamide gel 
and sequenced using an automated fluorescent sequencer (LI-COR DNA Sequencer model 
4000L, MWG-Biotech).
5.2.2.3 Sequence analysis
Sequence alignments and translations were made using the Wisconsin Package Version 
10.0, Genetics Computer Group (GCG), Madison, Wise. The env sequences used for the 
protein alignment were obtained from Genbank.
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5.3 Results
5.3.1 Cloning of the env gene from Raii 4 cells
In order to obtain an env clone for sequencing, PCR of Raji 4 genomic DNA was carried 
out using primers based on the PoERV sequence already available. This resulted in two 
products, approximately 2kb and lkb in size. As the env product was expected to be around 
2kb, the larger band was gel purified and inserted into pCI-neo.
5.3.2 Sequencing of the env gene
Initial sequencing of the two ends of the insert showed that it was a retroviral env gene. 
Therefore internal primers were designed and the full insert sequenced. The resulting DNA 
sequence is shown in Fig. 5.1. The assembled sequencing fragments are provided in the 
Appendices. Comparison with the Q-One Biotech sequence (Fig. 5.2) reveals that these env 
genes are very similar, but that this new sequence contains a 2 base pair insertion at 
position 572 and an insertion and substitution at 637. These differences do not appear to be 
due to PCR or sequencing errors. The Pfu enzyme used in the PCR has a 3’ to 5’ 
exonuclease proofreading activity, and therefore has the lowest error rate among the 
thermostable DNA polymerases used in PCR (Andre et a l, 1997; Cline et al., 1996). The 
same sequence was obtained from a further 2 clones taken from separate PCR reactions. 
The insertions result in two frameshift events altering the predicted amino acids from 
position 192 to 215 in the SU protein (Fig. 5.2B). This area is downstream of the region 
corresponding to the VRB of MLV Env.
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1 TAGAGTCGAC CCGGGCGGCC GCACCTGGCT CCATGCATCC CACGTTAAGC
51 TGGCGCCACC TCCCGACTCG GGGTGGAGAG CCGAAAAGAC TGAGAATCCC
101 CTTAAGCTTC GCCTCCATCG CCTGGTTCCT TACTCTAACA ATAACTCCCC
151 AGGCCAGTAG TAAACGCCTT ATAGACAGCT CGAACCCCCA TAGACCTTTA
201 TCCCTTACCT GGCTGATTAT TGACCCTGAT ACGGGTGTCA CTGTAAATAG
251 CACTCGAGGT GTTGCTCCTA GAGGCACCTG GTGGCCTGAA CTGCATTTCT
301 GCCTCCGATT GATTAACCCC GCTGTTAAAA GCACACCTCC CAACCTAGTC
351 CGTAGTTATG GGTTCTATTG CTGCCCAGGC ACAGAGAAAG AGAAATACTG
401 TGGGGGTTCT GGGGAATCCT TCTGTAGGAG ATGGAGCTGC GTCACCTCCA
451 AC GATGGAGA CTGGAAATGG CCGATCTCTC TCCAGGACCG GGTAAAATTC
501 TCCTTTGTCA ATTCCGGCCC GGGCAAGTAC AAAATGATGA AACTATATAA
551 AGATAAGAGC TGCTCCCCAT CAGACTTAGA TTATCTAAAG ATAAGTTTCA
601 C TGAAAAAGG AAAACAGGAA AATATTCAAA AGTGGATAAA TGGTATGAGC
651 TGGGGAATAG TTTTTTATAA ATATGGCGGG GGAGCAGGGT CCACTTTAAC
701 CATTCGCCTT AGGATAGAGA CGGGGACAGA ACCCCCTGTG GCAATGGGAC
751 C C GATAAAGT ACTGGCTGAA CAGGGGCCCC CGGCCCTGGA GCCACCGCAT
801 AACTTGCCGG TGCCCCAATT AACCTCGCTG CGGCCTGACA TAACACAGCC
851 GCCTAGCAAC AGTACCACTG GATTGATTCC TACCAACACG CCTAGAAACT
901 CCCCAGGTGT TCCTGTTAAG ACAGGACAGA GACTCTTCAG TCTCATCCAG
951 GGAGCTTTCC AAGCCATCAA CTCCACCGAC CCTGATGCCA CTTCTTCTTG
1001 TTGGCTTTGT CTATCCTCAG GGCCTCCTTA TTATGAGGGG ATGGCTAAAG
1051 AAAGAAAATT CAATGTGACC AAAGAGCATA GAAATCAATG TACATGGGGG
1101 TCCCGAAATA AGCTTACCCT CACTGAAGTT TCCGGGAAGG GGACATGCAT
1151 AGGAAAAGC T CCCCCATCCC ACCAACACCT TTGCTATAGT ACTGTGGTTT
1201 ATGAGCAGGC CTCAGAAAAT CAGTATTTAG TACCTGGTTA TAACAGGTGG
1251 TGGGCATGCA ATACTGGGTT AACCCCCTGT GTTTCCACCT CAGTCTTCAA
1301 CCAATCCAAA GATTTCTGTG TCATGGTCCA AATCGTCCCC CGAGTGTACT
1351 ACCATCCTGA GGAAGTGGTC CTTGATGAAT ATGACTATCG GTATAACCGA
1401 CCAAAAAGAG AACCCGTATC CCTTACCCTA GCTGTAATGC TCGGATTAGG
1451 GACGGCCGTT GGCGTAGGAA CAGGGACAGC TGCCCTGATC ACAGGACCAC
1501 AGCAGCTAGA GAAAGGACTT GGTGAGCTAC ATGCGGCCAT GACAGAAGAT
Fig. 5.1. DNA sequence of the env clone obtained from Raji 4 cells. Vector sequences are in bold type and 
underlined.
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1551 CTCCGAGCCT TAAAGGAGTC TGTTAGCAAC CTAGAAGAGT CCCTGACTTC
1601 TTTGTCTGAA GTGGTTCTAC AGAACCGGAG GGGATTAGAT CTGCTGTTTC
1651 TAAGAGAAGG TGGGTTATGT GCAGCCTTAA AAGAAGAATG TTGCTTCTAT
1701 GTAGATCACT CAGGAGCCAT CAGAGACTCC ATGAACAAGC TTAGAAAAAA
1751 GTTAGAGAGG CGTCGAAGGG AAAGAGAGGC TGACCAGGGG TGGTTTGAAG
1801 GATGGTTCAA CAGGTCTCCT TGGATGACCA CCCTGCTTTC TGCTCTGACG
1851 GGGCCCCTAG TAGTCCTGCT CCTGTTACTT ACAGTTGGGC CTTGCTTAAT
1901 TAATAGGTTT GTTGCCTTTG TTAGAGAACG AGTGAGTGCA GTCCAGATCA
1951 TGGTACTTAG GCAACAGTAC CAAGGCCTTC TGAGCCAAGG AGAAACTGAC
2001 CTCTAGGCGG CCGC
Fig. 5.1. Cont.
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1 —> 50
qlenv AGGAATCCCC ACCTGGATCC ATGCATCCCA CGTTAAGCCG GCGCCACCTC
r4env — GCGGCCGC ACCTGGCTCC ATGCATCCCA CGTTAAGCTG GCGCCACCTC
51  100
qlenv CCGACTCGGG GTGGAGAGCC GAAAAGAcTG AGAATCCCCT TAAGCTTCGC
r4env CCGACTCGGG GTGGAGAGCC GAAAAGAC TG AGAATCCCCT TAAGCTTCGC
101 150
qlenv CTCCATCGCC TGGTTCCTTA CTCTAACAAT AACTCCCCAG GCCAGTAGTA
r4env CTCCATCGCC TGGTTCCTTA CTCTAACAAT AACTCCCCAG GCCAGTAGTA
151 200
qlenv AACGCCTTAT AGACAGCTCG AACCCCCATA GACCTTTATC CCTTACCTGG
r4env AACGCCTTAT AGACAGCTCG AACCCCCATA GACCTTTATC CCTTACCTGG
201 250
qlenv CTGATTATTG ACCCTGATAC GGGTGTCACT GTAAATAGCA CTCGAGGTGT
r4env CTGATTATTG ACCCTGATAC GGGTGTCACT GTAAATAGCA CTCGAGGTGT
251 300
qlenv TGCTCCTAGA GGCACCTGGT GGCCTGAACT GCATTTCTGC CTCCGATTGA
r4env TGCTCCTAGA GGCACCTGGT GGCCTGAACT GCATTTCTGC CTCCGATTGA
301 350
qlenv TTAACCCCGC TGTTAAAAGC ACACCTCCCA ACCTAGTCCG TAGTTATGGG
r4env TTAACCCCGC TGTTAAAAGC ACACCTCCCA ACCTAGTCCG TAGTTATGGG
351 400
qlenv TTCTATTGCT GCCCAGGCAC AGAGAAAGAG AAATACTGTG GGGGTTCTGG
r4env TTCTATTGCT GCCCAGGCAC AGAGAAAGAG AAATACTGTG GGGGTTCTGG
401 450
qlenv GGAATCCTTC TGTAGGAGAT GGAGCTGCGT CACCTCCAAC GATGGAGACT
r4env GGAATCCTTC TGTAGGAGAT GGAGCTGCGT CACCTCCAAC GATGGAGACT
451 500
qlenv GGAAATGGCC GATCTCTCTC CAGGACCGGG TAAAATTCTC CTTTGTCAAT
r4env GGAAATGGCC GATCTCTCTC CAGGACCGGG TAAAATTCTC CTTTGTCAAT
501 550
qlenv TCCGGCCCGG GCAAGTACAA AATGATGAAA CTATATAAAG ATAAGAGCTG
r4env TCCGGCCCGG GCAAGTACAA AATGATGAAA CTATATAAAG ATAAGAGCTG
551
qlenv CTCCCCATCA GACTTAGATT ATCTAAAGAT AAGTTTCACT G 
r4env CTCCCCATCA GACTTAGATT ATCTAAAGAT AAGTTTCACT dA^AAAGGAA
600 
AAAGGAA
601 650
qlenv AACAGGAAAA TATTCAAAAG TGGATAAATG GTATGAGCTG GGGAATAGTT 
r4env AACAGGAAAA TATTCAAAAG TGGATAAATG GTATGAGCTG GGGAATAGTT
qlenv
r4env
651 
TTTTA1
700
______ .TAT ATGGCGGGGG AGCAGGGTCC ACTTTAACCA TTCGCCTTAG
TTTTAl AA AT ATGGCGGGGG AGCAGGGTCC ACTTTAACCA TTCGCCTTAG
qlenv
r4env
701 750
GATAGAGACG GGGACAGAAC CCCCTGTGGC AATGGGACCC GATAAAGTAC 
GATAGAGACG GGGACAGAAC CCCCTGTGGC AATGGGACCC GATAAAGTAC
Fig. 5.2A. Comparison of the PoERV env sequences. The insertions and substitution are boxed, qlenv, 
sequence obtained by Q-One Biotech; r4env, sequence obtained from Raji 4 cells.
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751 800
qlenv TGGCTGAACA GGGGCCCCCG GCCCTGGAGC CACCGCATAA CTTGCCGGTG
r4env TGGCTGAACA GGGGCCCCCG GCCCTGGAGC CACCGCATAA CTTGCCGGTG
801 850
qlenv CCCCAATTAA CCTCGCTGCG GCCTGACATA ACACAGCCGC CTAGCAACAG
r4env CCCCAATTAA CCTCGCTGCG GCCTGACATA ACACAGCCGC CTAGCAACAG
851 900
qlenv TACCACTGGA TTGATTCCTA CCAACACGCC TAGAAACTCC CCAGGTGTTC
r4env TACCACTGGA TTGATTCCTA CCAACACGCC TAGAAACTCC CCAGGTGTTC
901 950
qlenv CTGTTAAGAC AGGACAGAGA CTCTTCAGTC TCATCCAGGG AGCTTTCCAA
r4env CTGTTAAGAC AGGACAGAGA CTCTTCAGTC TCATCCAGGG AGCTTTCCAA
951 1000
qlenv GCCATCAACT CCACCGACCC TGATGCCACT TCTTCTTGTT GGCTTTGTCT 
r4env GCCATCAACT CCACCGACCC TGATGCCACT TCTTCTTGTT GGCTTTGTCT
1001 1050
qlenv ATCCTCAGGG CCTCCTTATT ATGAGGGGAT GGCTAAAGAA AGAAAATTCA 
r4env ATCCTCAGGG CCTCCTTATT ATGAGGGGAT GGCTAAAGAA AGAAAATTCA
1051 1100
qlenv ATGTGACCAA AGAGCATAGA AATCAATGTA CATGGGGGTC CCGAAATAAG
r4env ATGTGACCAA AGAGCATAGA AATCAATGTA CATGGGGGTC CCGAAATAAG
1101 1150
qlenv CTTACCCTCA CTGAAGTTTC CGGGAAGGGG ACATGCATAG GAAAAGCTCC 
r4env CTTACCCTCA CTGAAGTTTC CGGGAAGGGG ACATGCATAG GAAAAGCTCC
1151 1200
qlenv CCCATCCCAC CAACACCTTT GCTATAGTAC TGTGGTTTAT GAGCAGGCCT 
r4env CCCATCCCAC CAACACCTTT GCTATAGTAC TGTGGTTTAT GAGCAGGCCT
1201 1250
qlenv CAGAAAATCA GTATTTAGTA CCTGGTTATA ACAGGTGGTG GGCATGCAAT 
r4env CAGAAAATCA GTATTTAGTA CCTGGTTATA ACAGGTGGTG GGCATGCAAT
1251 1300
qlenv ACTGGGTTAA CCCCCTGTGT TTCCACCTCA GTCTTCAACC AATCCAAAGA 
r4env ACTGGGTTAA CCCCCTGTGT TTCCACCTCA GTCTTCAACC AATCCAAAGA
1301 1350
qlenv TTTCTGTGTC ATGGTCCAAA TCGTCCCCCG AGTGTACTAC CATCCTGAGG 
r4env TTTCTGTGTC ATGGTCCAAA TCGTCCCCCG AGTGTACTAC CATCCTGAGG
1351 1400
qlenv AAGTGGTCCT TGATGAATAT GACTATCGGT ATAACCGACC AAAAAGAGAA 
r4env AAGTGGTCCT TGATGAATAT GACTATCGGT ATAACCGACC AAAAAGAGAA
1401 1450
qlenv CCCGTATCCC TTACCCTAGC TGTAATGCTC GGATTAGGGA CGGCCGTTGG
r4env CCCGTATCCC TTACCCTAGC TGTAATGCTC GGATTAGGGA CGGCCGTTGG
1451 1500
qlenv CGTAGGAACA GGGACAGCTG CCCTGATCAC AGGACCACAG CAGCTAGAGA
r4env CGTAGGAACA GGGACAGCTG CCCTGATCAC AGGACCACAG CAGCTAGAGA
Fig. 5.2A. Cont.
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1501 1550
qlenv AAGGACTTGG TGAGCTACAT GCGGCCATGA CAGAAGATCT CCGAGCCTTA 
r4env AAGGACTTGG TGAGCTACAT GCGGCCATGA CAGAAGATCT CCGAGCCTTA
1551 1600
qlenv AAGGAGTCTG TTAGCAACCT AGAAGAGTCC CTGACTTCTT TGTCTGAAGT
r4env AAGGAGTCTG TTAGCAACCT AGAAGAGTCC CTGACTTCTT TGTCTGAAGT
1601 1650
qlenv GGTTCTACAG AACCGGAGGG GATTAGATCT GCTGTTTCTA AGAGAAGGTG
r4env GGTTCTACAG AACCGGAGGG GATTAGATCT GCTGTTTCTA AGAGAAGGTG
1651 1700
qlenv GGTTATGTGC AGCCTTAAAA GAAGAATGTT GCTTCTATGT AGATCACTCA
r4env GGTTATGTGC AGCCTTAAAA GAAGAATGTT GCTTCTATGT AGATCACTCA
1701 1750
qlenv GGAGCCATCA GAGACTCCAT GAACAAGCTT AGAAAAAAGT TAGAGAGGCG
r4env GGAGCCATCA GAGACTCCAT GAACAAGCTT AGAAAAAAGT TAGAGAGGCG
1751 1800
qlenv TCGAAGGGAA AGAGAGGCTG ACCAGGGGTG GTTTGAAGGA TGGTTCAACA
r4env TCGAAGGGAA AGAGAGGCTG ACCAGGGGTG GTTTGAAGGA TGGTTCAACA
1801 1850
qlenv GGTCTCCTTG GATGACCACC CTGCTTTCTG CTCTGACGGG GCCCCTAGTA
r4env GGTCTCCTTG GATGACCACC CTGCTTTCTG CTCTGACGGG GCCCCTAGTA
1851 1900
qlenv GTCCTGCTCC TGTTACTTAC AGTTGGGCCT TGCTTAATTA ATAGGTTTGT
r4env GTCCTGCTCC TGTTACTTAC AGTTGGGCCT TGCTTAATTA ATAGGTTTGT
1901 1950
qlenv TGCCTTTGTT AGAGAACGAG TGAGTGCAGT CCAGATCATG GTACTTAGGC
r4env TGCCTTTGTT AGAGAACGAG TGAGTGCAGT CCAGATCATG GTACTTAGGC
1951 2000
qlenv AACAGTACCA AGGCCTTCTG AGCCAAGGAG AAACTGACCT CTAGCCTTCC
r4env AACAGTACCA AGGCCTTCTG AGCCAAGGAG AAACTGACCT CTAGGCGGCC
2 0 0 1  
qlenv CA
r4env GC
Fig. 5.2A. Cont.
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qlenv
r4env
qlenv
r4env
qlenv
r4env
s p | s u 50
MHPTLSRRHL PTRGGEPKRL RIPLSFASIA WFLTLTITPQ ASSKRLIDSS 
MHPTLSWRHL PTRGGEPKRL RIPLSFASIA WFLTLTITPQ ASSKRLIDSS
51 100
NPHRPLSLTW LIIDPDTGVT VNSTRGVAPR GTWWPELHFC LRLINPAVKS 
NPHRPLSLTW LIIDPDTGVT VNSTRGVAPR GTWWPELHFC LRLINPAVKS
101 150
TPPNLVRSYG FYCCPGTEKE KYCGGSGESF CRRWSCVTSN DGDWKWPISL 
TPPNLVRSYG FYCCPGTEKE KYCGGSGESF CRRWSCVTSN DGDWKWPISL
151
qlenv QDRVKFSFVN SGPGKYKMMK LYKDKSCSPS DLDYLKISFT E 
r4env QDRVKFSFVN SGPGKYKMMK LYKDKSCSPS DLDYLKISFT E
2 0 0
RKTGKYSK1 
K..GKOENI
20 1   250
qlenv DKW...YELG NSFLlJYGGGA GSTLTIRLRI ETGTEPPVAM GPDKVLAEQG 
r4env QKWINGMSWG IVFYEYGGGA GSTLTIRLRI ETGTEPPVAM GPDKVLAEQG
qlenv
r4env
qlenv
r4env
qlenv
r4env
qlenv
r4env
qlenv
r4env
qlenv
r4env
251 300
PPALEPPHNL PVPQLTSLRP DITQPPSNST TGLIPTNTPR NSPGVPVKTG 
PPALEPPHNL PVPQLTSLRP DITQPPSNST TGLIPTNTPR NSPGVPVKTG
301 350
QRLFSLIQGA FQAINSTDPD ATSSCWLCLS SGPPYYEGMA KERKFNVTKE 
QRLFSLIQGA FQAINSTDPD ATSSCWLCLS SGPPYYEGMA KERKFNVTKE
351 400
HRNQCTWGSR NKLTLTEVSG KGTCIGKAPP SHQHLCYSTV VYEQASENQY 
HRNQCTWGSR NKLTLTEVSG KGTCIGKAPP SHQHLCYSTV VYEQASENQY
401 450
LVPGYNRWWA CNTGLTPCVS TSVFNQSKDF CVMVQIVPRV YYHPEEWLD 
LVPGYNRWWA CNTGLTPCVS TSVFNQSKDF CVMVQIVPRV YYHPEEWLD
451 | TM 500
EYDYRYNRPK REPVSLTLAV MLGLGTAVGV GTGTAALITG PQQLEKGLGE 
EYDYRYNRPK REPVSLTLAV MLGLGTAVGV GTGTAALITG PQQLEKGLGE
501 550
LHAAMTEDLR ALKESVSNLE ESLTSLSEW LQNRRGLDLL FLREGGLCAA 
LHAAMTEDLR ALKESVSNLE ESLTSLSEW LQNRRGLDLL FLREGGLCAA
551 600
qlenv LKEECCFYVD HSGAIRDSMN KLRKKLERRR REREADQGWF EGWFNRSPWM
r4env LKEECCFYVD HSGAIRDSMN KLRKKLERRR REREADQGWF EGWFNRSPWM
601 650
qlenv TTLLSALTGP LWLLLLLTV GPCLINRFVA FVRERVSAVQ IMVLRQQYQG
r4env TTLLSALTGP LWLLLLLTV GPCLINRFVA FVRERVSAVQ IMVLRQQYQG
651
qlenv LLSQGETDL 
r4env LLSQGETDL
Fig. 5.2B. Comparison of the predicted PoERV Env amino acid sequences. The variable region is boxed. SP, 
signal peptide; SU, surface glycoprotein; TM, transmembrane protein; qlenv, sequence obtained by Q-One 
Biotech; r4env, sequence obtained from Raji 4 cells.
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5.3.3 Features of the Env sequence
Alignment of the amino acid sequence with those of several other mammalian C-type 
retroviruses reveals several conserved domains and motifs. These are illustrated in Fig. 5.3. 
As would be predicted, the major sequence differences are seen in the regions 
corresponding to VRA, VRB and the variable PRR. Like the Q-One Biotech sequence, 
greatest homology is seen with that of GALV. The PoERV Env protein contains five 
potential N-glycosylation sites within the SU. Two of these are conserved among the other 
mammalian C-type proteins, and this includes the site reported to be necessary for Friend- 
MLV growth in cell culture (Kayman et a l,  1991). Six of the eight cysteine residues 
normally conserved within the amino terminal of SU are present. The cysteine residues 
throughout the rest of the Env protein are conserved. The VRA is relatively short, 
containing only 28 amino acids. The first cysteine residue usually present in this region is 
missing, although an extra residue is found adjacent to the cysteine towards the carboxy- 
terminal end of VRA. The cysteine residue normally found just after VRB is also missing.
The TM proteins of the mammalian C-type retroviruses are highly homologous. This 
appears to hold true for the PoERV TM. The putative fusion peptide and leucine zipper 
motifs, as well as the conserved CX6CC sequence and basolateral targeting signal, all 
appear to be present. The greatest variation is seen within the fusion peptide. In this region 
the PoERV sequence shows closest homology with GALV. Although the majority of 
features described for TM proteins are conserved, the leucine and glutamine residues in the 
membrane proximal region of the cytoplasmic tail are not present. Residues in this region 
have been reported to be important for fusion and incorporation (section 5.1.3).
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I SU5 0
RGVSTAS..P 
KGARSAA..P 
LGVGMAE... 
IDIGMAN..P 
GGGTS...LQ 
PQASSKRLID
100
LTPDLCMLAH 
LTPDLCMLAL 
LYFDLCDLV. 
MYFDLCDII . 
LKPDVCALAA 
L . .HFCLRLI
101 V R A 150
momlvenv HGPSYWGLEY QSPFSSPPGP PCCS. .G. .G SSPGCSRDCE EPLTSLTPRC
fmlvenv SGPPHWGLEY QAPYSSPPGP PCCS. .GSSG SSAGCSRDCD EPLTSLTPRC
amlvenv .GEE.WDPSD QEPY...VG . . . .YG . . .CK YPAG....R .
felvbenv .GNT.WNPSD QEPF...PG. . . .YG . . .CD QPMR....R .
galvenv SLESWDIPGT DVSSSKRVRP PDSDYTAAYK QITWGAIGCS YPRAR....
r4env N .... . PA. .VKST....P P ..NLVRSY. . .G. .
151
*
200
momlvenv NTAWNRLKLD QTTHKSNEGF YVCP.GPHRP RESKS CGGPD SFYCAYWGCE
fmlvenv NTAWNRLKLD QVTHKSSEGF YVCP.GSHRP REARS CGGPD SFYCASWGCE
amlvenv . . .QRTRTFD .........F YVCP. G.HTV K. .SCCGGPG EGYCGKWGCE
felvbenv ...WQQRNTP .........F YVCP. G.HAN R. .KCCGGPQ DGFCAVWGCE
galvenv ..TRMASSTF YVCPRDGRTL SEARF CGGLE SLYCKEWDCE
r4env .........F YCCP..G.TE KE.Ry CGGSG ESFCRRWSCV
201
★ ★
VRB
★ ★ 
250
momlvenv TTGRAYWK.P SSSWDFITVN . NNL1 S. .DQ AVQV.___C KDN.......
fmlvenv TTGRVYWK.P SSSWDYITVD . NNLT T. .SQ AVQV.... .c KDN.......
amlvenv TTGQAYWK.P TSSWDLISLK . RGNT PWDTG CSKVA.CGPC YDLSKVSNSF
felvbenv TTGETYWR.P TSSWDYITVK . KGVT QGIYQ CSGGGWCGPC Y D .KAVHSST
galvenv TTGTGYW.LS KSSKDLITVK WDQNS EWTQK FQQ. .___c HQT.......
r4env TSNDGDWKWP ISLQDRVKFS FVNSG PGKYK MMKLYKDKSC SPSDLDY...
251
★
300
momlvenv KWCN PLVIRFTDAG RR..VTSWTT GHYWGLRLYV SGQDPGLTFG
fmlvenv KWCN PLAIQFTNAG KQ ..VTSWTT GHYWGLRLYV SGRDPGLTFG
amlvenv QGATRC GRCN PLVLEFTDAG KK. . .ANWDG PKSWGLRLYR TGTDPITMFS
felvbenv TGASEC GRCN PLILQFTQKG RQ. . .TSWDG PKSWGLRLYR SGYDPIALFS
galvenv GWCN PLKIDFTDKG KLS . .KDWIT GKTWGLRFY. VSGHPGVQFT
r4env .LKISFTEKG KQENIQKWIN GMSWGIVFYK YGGGAGSTLT
★
Fig. 5.3. Alignment of mammalian C-type Env peptides. Structural features predicted for ecotropic MLV are 
boxed. The conserved N-linked glycosylation sites in SU and the basolateral targetting signal are in bold type. 
SU, surface glycoprotein; TM transmembrane protein; * conserved cysteine residue; momlvenv, Moloney 
MLV ENV (Shinnick et a l ,  1981; Van Beveren et al., 1981); fmlvenv, Friend MLV Env (Koch et al., 1983); 
amlvenv, 4070A amphotropic MLV Env (Ott et a l ,  1990); felvbenv, Gardner-Arnstein FeLV-B Env 
(Wunsch et a l ,  1983); galvenv, GALV SEATO Env (Ting et a l ,  1998); r4env, sequence obtained from Raji 
4 cells.
l  signal pep tide
momlvenv MARSTLS.......... KPLK NKVNP..RGP LIPLIL . LML
fmlvenv MACSTLP KSPK DKIDP..RDL LIPLILFLSL
amlvenv MARSTLS.......... KPPQ DKINP . . WKP LI. VMGVL . .
felvbenv MESPTHP KPSK DKTLS..WNL VF . LVGILFT
galvenv M ..VLLPGSM LLTSNLHHLR HQMSPGSWKR LIILLSCVFG
r4env M .HPTLSWRH LPTRGGEPKR LRI.PLSFAS IAWFLTLTIT
momlvenv
fmlvenv
amlvenv
felvbenv
galvenv
r4env
51
GSSPHQVYNI 
GSSPHQVYNI 
..SPHQVFNV 
..SPHQVYNV 
NKNPHQPMTL 
SSNPHRPLSL
TWEVTN...G 
TWEVTN...G 
TWRVTNLMTG 
TWTITNLVTG 
TWQVLS.QTG 
TWLIIDPDTG
DRETVWATSG 
DRETVWAISG 
RTANATSLLG 
TKANATSMLG 
D . . WWDTKA 
V ..TVNSTRG
NHPLWTWWPD 
NHPLWTWWPV 
T . .VQDAFPK 
T..LTDAFPT 
VQPPWTWWPT 
VAPRGTWWPE
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301 conserved PRR
momlvenv
fmlvenv
amlvenv
felvbenv
galvenv
r4env
momlvenv
fmlvenv
amlvenv
felvbenv
galvenv
r4env
IRLRYQ.NI 
IRLRYQ.NL 
LTRQVL. NV G 
VSRQVM.TI 
IRLKI.TNM 
IRLRIETGI
PRVPIGPNPV LADC 
PRVPIGPNPV LADC 
PRVPIGPNPV LPDC 
PPQAMGPNLV LPDC 
PAVAVG PDLV LVEC 
PPVAMGPDKV LAEC
_______variable PRR_____ 350
QPLSK............P KPV . . . KSPS
LSLPR............P NPL . . . PKPA
RLPS.............  SPIEIVPAPQ
KPPSR........... Q SQIESRVTPH
GPPRTS LALPPP..LP .PREA...PP 
GPP... .ALEPPHNLP VPQLTSLRPD
351
VTKPPS.GTP ....L S .... PTQLP..PA. .. 
KSPPASNSTP ..TLISPSPT PTQPP..PA. .. 
PPSPLNTSYP PSTTSTPSTS PTS.PSVPQP PP.. 
.HSQGNGGTP GITLVNASIA PLSTPVTPAS PKR] 
PSLPDSNSTA LATSAQTPTV RKTIVTLNTP ..PE
ITQPPSNSTT GLIPTNTP.. R ......NSP GVPMKTGQRL
GTENRL
GTGDRL
GTGDRL
GTGDRL
TTGDRL
400
LNLVDGAYQA
LNLVQGAYQA
LALVKGAYQA
INLVQGTYLA
FDLVQGAFLT
FSLIQGAFQA
momlvenv
fmlvenv
amlvenv
felvbenv
galvenv
r4env
401
LNLTSPDKTQ 
LNLTNPDKTQ 
LNLTNPDKTQ 
LNATDPNRTK 
LNATN PGAT E 
INSTDPDATS
ECWLCLVAGP
ECWLCLVSGP
ECWLCLVSGP
DCWLCLVSRP
SCWLCLAMGP
SCWLCLSSGP
PYYEGVAVLG
PYYEGVAVLG
PYYEGVAWG
PYYEGIAILG
PYYEAIASSG
PYYEGMAKER
TYSNHTSAPA 
TYSNHTSAPA 
TYTNHSTAPA 
NYSNQTNPPP 
EVAYSTD.LD 
KFNVTKEHRN
450
NCSVASQHKL
NCSVASQHKL
NCTATSQHKL
SCLSIPQHKL
RCRWGTQGKL
QCTWGSRNKL
momlvenv
fmlvenv
amlvenv
felvbenv
galvenv
r4env
451
TLSEVTGQGL
TLSEVTGRGL
TLSEVTGQGL
TISEVSGQGL
TLTEVSGHGL
TLTEVSGKGT
CIGAVPKTHQ
CIGTVPKTHQ
CMGAVPKTHQ
CIGTVPKTHQ
CIGKVPFTHQ
CIGKAPPSHQ
ALCNTTQTSS
ALCNTTLKID
ALCNTTQSAG
ALCNETQQGH
HLCNQTLSIN
HLCYSTWYE
RGS..YYLVA 
KGS..YYLVA 
SGS..YYLAA 
TGA..HYLAA 
SSGDHQYLLP 
QASENQYLVP
500
PTGTMWACST
PTGTTWACNT
PAGTMWACST
PNGTYWACNT
SNHSWWACST
GYNRWWACNT
momlvenv
fmlvenv
amlvenv
felvbenv
galvenv
r4env
501
GLTPCISTTI
GLTPCLSATV
GLTPCLSTTV
GLTPCISMAV
GLTPCLSTSV
GLTPCVSTSV
LNLTTDYCVL
LNRTTDYCVL
LNLTTDYCVL
LNWTSDFCVL
FNQTRDFCIQ
FNQSKDFCVM
VELWPRVTYH 
VELWPRVTYH 
VELWPRVIYH 
IELWPRVTYH 
VQLIPRIYYY 
VQIVPRVYYH
SPSYVYGLFE
PPSYVYSQFE
SPDYMYGQLE
QPEYVYTHFA
PEEVLLQAYD
PEEWLDEYD
RSN.RHKF 
KSY.RHKF 
QRT.KYKF 
KAA.RFRF 
NSHPRTKF 
YRYNRPKF
TM
550
EF
EF
EF
EF
EA
EF
551 fusion peptide 600
momlvenv VSLTLALLLG GLTMGGIAAG IGTGTTALMA .TQQFQQ... .LQAA\
fmlvenv VSLTLALLLG GLTMGGIAAG VGTGTTALVA .TQQFQQ... .LHAA\
amlvenv VSLTLALLLG GLTMGGIAAG IGTGTTALIK .TQQFEQ... .LHAAI
felvbenv ISLTVALMLG GLTVGGIAAG VGTGTKALIE .TAQFRQ. . . .LQMAF HTE
galvenv VSLTLAVLL. GL...GITAG IGTGSTALIK GPIDLQQGLT SLQIAI 
r4env VSLTLAVML. GL...GTAVG VGTGTAALIT GPOOLEKGLG ELHAAMTEd
QDE
QDE
QTI
601 leucine zipper motif
momlvenv REVEKSISNL EKSLTSLSEV VLQNRRGLDL LFLKEGGLCA
fmlvenv KEVEKSITNL EKSLTSLSEV VLQNRRGLDL LFLKEGGLCA
amlvenv NEVEKSITNL EKSLTSLSEV VLQNRRGLDL LFLKEGGLCA
felvbenv QALEESISAL EKSLTSLSEV VLQNRRGLDI LFLQEGGLCA
galvenv RALQDSVSKL EDSLTSLSEV VLQNRRGLDL LFLKEGGLCA
r4env RALKESVSNL EESLTSLSEV VLyNRRGLDL LFLREGGLCA
650
ALKEECCFYA
ALKEECCFYA
ALKEECCFYA
ALKEECCFYA
ALKEECCFYI
ALKEECCFYV
Fig. 5.3. Cont.
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momlvenv
fmlvenv
amlvenv
felvbenv
galvenv
r4env
momlvenv
fmlvenv
amlvenv
felvbenv
galvenv
r4env
651 predicted g-helix 700
DHTGLVRDSM
DHTGLVRDSM
DHTGLVRDSM
DHTGLVRDNM
DHSGAVRDSM
DHSGAIRDSM
AKLRERLNQR
AKLRERLTQR
AKLRERLNQR
AKLRERLKQR
KKLKEKLDKR
NKLRKKLERR
QKLFESTC
QKLFESSC
QKLFETGC
QQLFDSQC
QLERQKS
RREREADC
GW
GW
GW
GW
CNW
GW
FEGLFNRSI
FEGLFNRSI
FEGLFNRSI
FEGWFNKSI
YEGWFNNSI
FEGWFNRSI
W FTTLISTIMG 
W FTTLISTIMG 
W FTTLISTIMG 
W FTTLISSIMG 
W FTTLLSTIAG 
W MTTLLSALTG
transmembrane 
IStt domain
PLIVLLMILL FGPCILI 
PLIILLLILL FGPCILI 
PLIVLLLILL FGPCILI
PLLILLLILL FGPCILI RLV
PLLLLLLLLI LGPCIII 
PLWLLLLLT VGPCLII
RLV
RLV
RLV
KLV
RFV
QFVKDRISW 
QFVKDRISW 
QFVKDRI S W  
QFVKDRISW 
QFINDRISAV 
AFVRERVSAV
QAI
QAI
QAI
QAI
KII
R-peptide 750
VLTQQYH
VLTQQYH
VLTQQYH
ILTQQYQ
VLRQKYQ
QIWLRQQYQ
QLKPIEYE.P 
QLKPLEYE.P 
QLKPIEYE.P 
QIKQYDPDRP 
ALENEG..NL 
GLLSQGETDL
Fig. 5.3. Cont.
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5.4 Discussion
The env sequence described here differs slightly from that already reported and therefore 
represents a new gene. It seems likely that this env is associated with a functional provirus 
as it was cloned from an infected human cell line. Its close homology to the env gene 
cloned from PoERV virions indicates that it does belong to an authentic porcine retrovirus. 
This close homology, particularly within the VRA and VRB regions involved in host range 
determination of the MLV Env proteins, also suggests that these viruses will be found to be 
in the same interference group.
Several similarities, as well as some differences, exist between this Env protein and the 
other mammalian C-type sequences shown in Fig. 5.3. The first of the conserved N-linked 
glycosylation sites is probably also important for growth of this virus in cell culture. As 
discussed in section 5.1.2, this site is thought to affect processing of the precursor Env 
protein (Kayman et a l , 1991). The conservation of the majority of the cysteine residues 
within the SU suggests that this protein has a similar structure to the others. However, the 
few changes indicate that there are some differences. The positions of the cysteine residues 
within the region corresponding to VRA seem to imply that the interloop domain is absent. 
The loss of the residue following the VRB region prevents the formation of a disulphide- 
linked loop in this area. These structural differences may indicate that this Env recognises a 
receptor that is unrelated to the transporter molecules recognised by other mammalian C- 
type Env proteins.
As expected, the TM protein shows a high degree of homology to the other proteins 
compared here. This strongly indicates that these proteins function in a similar manner. The 
presence of a basolateral targeting signal suggests that this virus may also use this pathway 
for virion release and cell to cell spread.
It has been reported that certain deletions and substitutions of amino acids in the membrane 
proximal region of the cytoplasmic tail of MoMLV TM reduce fusion activity and 
incorporation of the protein (Januszeski et a l,  1997). These residues are highly conserved 
among the C-type viruses. It is therefore perhaps surprising that the Leu and Gin residues 
are not conserved in the PoERV sequence. The Leu is believed by Januszeski et a l to be
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particularly important in the fusion process. The same study also found that deletion of Leu 
and the adjacent Val, or substitution of Gin with Ala and Phe with Met reduced 
incorporation into virions. While the substitution of Leu with Phe in the PoERV TM is a 
conservative change, that of Gin with Ala is not. However, Januszetski et al. suggested that 
the fusion process requires hydrophobic residues within this region. These substitutions 
result in an overall increase in hydrophobicity. The mutations that affect incorporation of 
the MoMLV protein may be related to structural features that differ in the PoERV protein. 
Although most of the changes are conservative, the sequence of the cytoplasmic tail of the 
PoERV TM shares only approximately 45% homology with those of the other proteins.
The cloning and sequencing of this env gene confirms that more than one transcriptionally 
active strain of PoERV exists. Although this env is highly homologous to the gene 
sequenced previously, it is possible that the two proteins recognise different receptors. This 
can only be tested through infectivity assays. It is now possible to use this env clone in 
pseudotyping experiments utilising the HIT system (Soneoka et al. 1995). Vectors bearing 
this Env protein will be expected to exhibit the host range of the PoERV from which it is 
derived.
167
CHAPTER 6
Chapter 6 Determination of the host range of PoERV
6.1 Introduction
6.1.1 PoERV subgroups
Several closely related ERVs are now known to be present in the porcine genome 
(Akiyoshi et al., 1998; Le Tissier et al., 1997; Q-One Biotech Ltd. and Imutran Ltd., 1997). 
The complete nucleotide sequence of two of these viruses are now available: the PoERV- 
B1 sequence obtained from virions released from PK15 cells (Q-One Biotech Ltd. and 
Imutran Ltd., 1997), and the PERV-MSL sequence obtained from a proviral clone derived 
from miniature swine lymphocytes (Akiyoshi et al., 1998). These viruses share 90.1% 
homology within the gag gene, and 96.8% within the pol gene (Onions et al., 1998). The 
major sequence differences are found within the SU protein, suggesting that they recognise 
different receptors. As discussed in section 1.2.1, closely related retroviruses are placed 
into subgroups on the basis of host range, neutralisation and receptor interference analyses 
(Weiss, 1993). Although these properties have not been fully defined for the PoERVs, 
these viruses have been tentatively placed into three subgroups, PoERV-A, -B and -C 
(Onions et al., 1998). The PoERV-A subgroup Env sequence was first described by Le 
Tissier et al. (1997). A second, related sequence, designated PoERV-A 1 has also been 
placed into this subgroup (G.Langford, pers. com). The PoERV-B subgroup contains both 
PoERV-Bl and the env sequence obtained from the infected Raji 4 cells, described in the 
previous chapter. This sequence was also obtained by Le Tissier et al. Both PoERV-A and 
PoERV-B specific sequences have been detected in PK15 cells and PoERV-infected 
human 293 cells (Le Tissier et al., 1997). Subgroup C contains PERV-MSL, the Tsukuba-1 
virus isolated from a porcine lymphoma cell line (Suzuka et al., 1986; The General 
Hospital Corporation, 1997), and also a sequence obtained recently, designated PoERV-Cl 
(P.Banerjee, pers. com.). Hybridisation analyses have revealed that normal pig tissues carry 
between 10 and 23 copies of PoERV-A sequences and between 7 and 12 of PoERV-B (Le 
Tissier et al., 1997). PoERV-C is present in 8 to 15 copies in the tissues of miniature swine 
(Akiyoshi et al., 1998). This subgroup does not appear to be present in all pigs, and has not
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been detected in ST or PK15 cells (D.Hart, pers. com.). It is not yet known how many of 
these proviral sequences encode functional virus.
Laboratory mice are the only other animals in which groups of closely related infectious 
ERVs with different env genes have been described (Boeke and Stoye, 1997). The genomes 
of all inbred strains of mice contain several xenotropic and polytropic endogenous MLV 
sequences (Hoggan et al., 1983; O'Neill et a l,  1986), and some also contain ecotropic 
sequences (Jenkins et al., 1982). Kozak and O’Neill (1987) have found that the different 
endogenous env sequences are restricted to specific taxonomic groups among wild mice. 
This indicates that they were acquired independently. The presence of the different ERV 
sequences within the laboratory strains is likely to be the result of interbreeding between 
mice of different geographical and taxonomic origins. Ecotropic sequences have only been 
found in a small number of wild and laboratory mouse strains (Jenkins et al., 1982; Lafon 
et al., 1983), suggesting that these were acquired more recently. It seems possible that the 
different subgroups of PoERV were also acquired independently. Although the majority of 
domestic pigs are believed to have been derived from Asian species, European wild boars 
are also likely to have had an influence (Epstein and Bichard, 1984). Later interbreeding 
between pig breeds would have allowed the different PoERVs to become spread 
throughout the population. PoERV-C sequences were first isolated from miniature pig cells 
and do not appear to be present in all pigs (Akiyoshi et al., 1998; Wilson et al., 1998; 
D.Hart, pers. com.). This suggests that, like the endogenous E-MLV, this virus was 
acquired more recently than the other subgroups. It is also feasible that the differences in 
the PoERV env genes arose from recombination with other, as yet unidentified, ERV 
sequences in the porcine genome.
Multiple copies of ERV proviruses are believed to have resulted from additional germline 
infections following replication of the original provirus (King et al., 1987; Stoye and 
Coffin, 1987). The heterogeneity observed in PoERV proviral copy numbers (Le Tissier et 
al., 1997; Akiyoshi et al., 1998; D.Hart, pers. com.) is likely to reflect the lack of 
significant inbreeding (Epstein and Bichard, 1984). It is possible that proviral acquisition is 
still an ongoing process. Studies of inbred strains of laboratory mice have revealed a 
continual movement of endogenous E-MLV sequences between generations (Boeke and 
Stoye, 1997). Novel insertions have been found in the progeny of viraemic females
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(Jenkins and Copeland, 1985; Rowe and Kozak, 1980), probably as a consequence of 
oocyte infection (Lock et al., 1988). This process may also occur with PoERV since these 
viruses are capable of infecting at least some porcine cells (Lieber et al., 1975a; Patience et 
al., 1997a; Wilson et al., 1998), and some pigs may have a low level viraemia -  RT activity 
has been detected in serum although no transfer of infectivity to cultured cells has yet been 
observed (Onions et al., 1999).
6.1.2 PoERV Env proteins
The relationship between the PoERV Env proteins is depicted in the phylogenetic tree in 
Fig 6.1 and a comparison of the four sequences is shown in Fig. 6.2. The four TM proteins 
are highly homologous, although PoERV-C has a divergent R-peptide sequence. PoERV-B 
and B1 Env proteins differ only in the region between residues 192 and 215. The PoERV-A 
and -C proteins show a greater degree of homology with PoERV-B within this region. 
However, PoERV-A and -C show differences within the areas corresponding to VRA, 
VRB and the PRR. As described in section 5.1.2, VRA and VRB are believed to be 
involved in the receptor binding of Env proteins. The most significant areas of divergence 
among the PoERV proteins are within VRB and the variable PRR. It is possible that these 
differences reflect variation in receptor usage, and therefore host range. Five potential N- 
linked glycosylation sites are conserved between all the SU proteins, while PoERV-A and - 
C possess another three. Sixteen conserved cysteine residues are present in all four 
proteins. These include 6 of the 8 residues normally present in the amino-terminal region of 
mammalian C-type SU proteins, and the highly conserved CXgCC motif of the TM protein 
(section 5.1). PoERV-A and -C possess only one of the two cysteine residues normally 
conserved within VRA. This indicates further differences in the structure of the receptor 
binding region.
6.1.3 Analysis of host range and receptor usage of retroviruses
The predicted differences in receptor usage may prove very important when assessing the 
risk the PoERV subgroups pose through xenotransplantation. This is because the receptor 
used by a virus not only determines its host range but also has a large influence on the
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PoERV-C1
PoERV-A
PoERV-A1
PoERVPoERV-B1
10%
Fig. 6.1. Unrooted phylogenetic tree of the PoERV retroviruses based on alignment of SU 
glycoprotein amino acid sequences. The PHYLIP package was used for protein distance calculation 
and tree construction. The solid line below the diagram represents 10% divergence. Constructed by 
Douglas Hart (Veterinary Pathology, University of Glasgow).
1 signal peptide |SU 50
poervB MHPTLSWRHL PTRGGEPKRL RIPLSFASIA WFLTLTITPQ ASSKRLIDSS
poervBl MHPTLSRRHL PTRGGEPKRL RIPLSFASIA WFLTLTITPQ ASSKRLIDSS
poervC MHPTLNRRHL PIRGGKPKRL KIPLSFASIA WFLTLSITSQ TNGMRIGDSL
poervA MHPTLSRRHL PIRGGKPKRL KIPLSFASIA WFLTLSITPQ VNGKRLVDSP
51 100
poervB NPHRPLSLTW LIIDPDTGVT VNSTRGVAPR GTWWPELHFC LRLIjNPAV..
poervBl NPHRPLSLTW LIIDPDTGVT VNSTRGVAPR GTWWPELHFC LRLINPAV..
poervC NSHKPLSLTW LITDSGTGIN INNTQGEAPL GTWWPDLYVC LRSVIPSL..
poervA NSHKPLSLTW LLTDSGTGIN INSTQGEAPL GTWWPELYVC LRSVIIPGLND
poervB
poervBl
poervC
poervA
101 VRA
QATPPDVLRA YGFYVCPGPP NNEE~¥
150
CGGSG ESFCRRWSCV TSNDGDWKWP 
CGGSG ESFCRRWSCV TSNDGDWKWP
KSTPPNLVRS YGFYCCPG . T EKEK’i 
KSTPPNLVRS YGFYCCPG.T EKEK¥
.TSPPDILHA HGFYVCPGPP NNGKPCGNPR DFFCKQWNCV TSNDGYWKWP
CGNPQ DFFCKQWSCI TSNDGNWKWP
151
poervB ISLQDRVKFS FVNS
poervBl ISLQDRVKFS FVNS
poervC TSQQDRVSFS YVNl
poervA VSQQDRVSYS FVNN
VRB 200
.GPGKYKM MKLYKDK................SCSPSD
.GPGKYKM MKLYKDK................SCSPSD
YTSSGQ FNY LT W ....... IR TGSPKCSPSD
PTSYNO FNYGHGRWKD WOORVOKDVR NKOISCHSiJd
201 250
poervB LDYLKISFTE K..GKQENIQ KWINGMSWGI VFYKYGG.GA GSTLTIRLRI
poervBl LDYLKISFTE RKTGKYSKVD KW...YELGN SFLLYGG.GA GSTLTIRLRI
poervC LDYLKISFTE K..GKQENIL KWVNGMSWGM VYYGGSGKQP GSILTIRLKI
poervA LDYLKISFTE K..GKQENIQ KWVNGISWGI VYYGGSGRKK GSVLTIRLRI
poervB
poervBl
poervC
poervA
2 51 conserved PRR variable PRR 300
ETGTEPPVAM GPDKVLAEQG PPALEPPHNL PVPQLTSLRP DITQPPSNST 
ETGTEPPVAM GPDKVLAEQG PPALEPPHNL PVPQLTSLRP DITQPPSNST
. NQLEPPMAI GPNTVLTGQR PPTQ.................. GPGPSS.NIT
ETOMEPPVAI GPNKGLAEGG PPIOEO..............RP SPNPSDYNTT
301 350
poervB TGLIPTNTPR NSPGVPVKTG QRLFSLIQGA FQAINSTDPD ATSSCWLCLS
poervBl TGLIPTNTPR NSPGVPVKTG QRLFSLIQGA FQAINSTDPD ATSSCWLCLS
poervC SGSDPT ESNSTTKMG AKLFSLIQGA FQALNSTTPE ATSSCWLCLA
poervA SGSVPT.... .EPNITIKTG AKLFSLIQGA FQALNSTTPE ATSSCWLCLA
351 400
poervB SGPPYYEGMA KERKFNVTKE HRNQCTWGSR NKLTLTEVSG KGTCIGKAPP
poervBl SGPPYYEGMA KERKFNVTKE HRNQCTWGSR NKLTLTEVSG KGTCIGKAPP
poervC SGPPYYEGMA RRGKFNVTKE HRDQCTWGSQ NKLTLTEVSG KGTCIGKVPP
poervA SGPPYYEGMA RGGKFNVTKE HRDQCTWGSQ NKLTLTEVSG KGTCIGMVPP
Fig. 6.2. Alignment of the PoERV Env peptides so far described. The features indicated are described in 
section 5.1. Predicted structural features are boxed. The conserved N-linked glycosylation signals and the 
basolateral targeting signal are in bold type. SU, surface glycoprotein; TM, transmembrane protein; *, 
conserved cysteine residue; poervB, PoERV-B Env (Chapter 5, Le Tissier et a l ,  1997); poervBl, PoERV-Bl 
Env (Q-One Biotech Ltd, Immutran Ltd, 1997); poervC, PoERV-C Env (Akiyoshi et al., 1998); poervA, 
PoERV-A Env (Le Tissier et al., 1997).
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401 450
poervB SHQHLCYSTV VYEQASENQY LVPGYNRWWA CNTGLTPCVS TSVFNQSKDF
poervBl SHQHLCYSTV VYEQASENQY LVPGYNRWWA CNTGLTPCVS TSVFNQSKDF
poervC SHQHLCNHTE AFNQTSESQY LVPGYDRWWA CNTGLTPCVS TLVFNQTKDF
poervA SHQHLCNHTE AFNRTSESQY LVPGYDRWWA CNTGLTPCVS TLVFNQTKDF
451 | TM
poervB CVMVQIVPRV YYHPEEWLD EYDYRYNRPK f|
poervB 1 CVMVQIVPRV YYHPEEWLD EYDYRYNRPK F
poervC CIMVQIVPRV YYYPEKAILD EYDYRNHRQK F
poervA CVMVQIVPRV YYYPEKAVLD EYDYRYNRPK F
*
500
EPVSLTLAV MLGLGTAVGV 
EPVSLTLAV MLGLGTAVGV 
EPISLTLAV MLGLGVAAGV 
EPISLTLAV MLGLGVAAGV
poervB
poervBl
poervC
poervA
501 fusion peptide
GTGTAALITG PQQLEKGLGE LHAAMTEE 
GTGTAALITG PQQLEKGLGE LHAAMTED 
GTGTAALVTG PQQLETGLSN LHRIV TED
leucine zipper motif 55 0
GTGTAALITG PQQLEKGLSN LHRIVtTEEjLQ ALEKSVSNLE ESLTSLSEW
LR ALKESVSNLE ESLTSLSEW 
LR ALKESVSNLE ESLTSLSEW 
LQ ALEKSVSNLE ESLTSLSEW
poervB
poervBl
poervC
poervA
5 51 predicted a-helix 600
LQNfRRGLDLL FLREGGLCAA LKEECCFYVjD HSGAIRDSMN KLRKKLERRR 
LCJNfRRGLDLL FLREGGLCAA LKEECCFYVD HSGAIRDSMN KLRKKLERRR
D HSGAIRDSMN KLRERLEKRR 
D HSGAIRDSMS KLRERLERRR
LQNfRRGLDLL FLKEGGLCVA LKEECCFYV 
LQNfRRGLDLL FLKEGGLCVA LKEECCFYV
601 transmembrane domain 650
poervB REREADQ SWF EG tfFNRSPWM TTLLSALTGP LWLLLLLTV GPCLIN R.FVA
poervBl REREADQ SWF EG tfFNRSPWM TTLLSALTGP LWLLLLLTV GPCLIN RFVA
poervC REKETTQ SWF EG AfFNRSLWL ATLLSALTGP LIVLLLLLTV GPCIIN K.LIA
poervA REREADQ SWF EG AfFNRSPWM TTLLSALTGP LWLLLLLTV GPCLIN R.FVA
poervB
poervBl
poervC
poervA
651
FVRERVSAVQ
FVRERVSAVQ
FIRERISAVQ
FVRERVSAVQ
R-peptide 679
IM/LRQQYQG LLSQGETDL 
IM/LRQQYQG LLSQGETDL 
IM/LRQQYQS PSSREAGR- 
IM/LRQQYQG LLSQGETDL
Fig. 6.2. Cont.
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pathogenic outcome of infection. Several methods have been employed to investigate the 
host range and receptor usage of retroviruses. Many of the approaches used detect virus 
attachment, membrane fusion or cell entry, and therefore avoid interference from any 
restrictions acting at later stages of replication (Weiss, 1993). Studies of viral attachment 
have attempted to identify cell proteins that bind to purified, soluble SU proteins (DeLarco 
and Todaro, 1976; Moldow et a l,  1979) or virions (Krichbaum-Stenger et a l , 1984; Notter 
et a l, 1982). As monoclonal antibodies that recognise the receptor molecule may compete 
with the virus for binding, they can also be used to investigate attachment. This method 
was used in the identification of the HIV receptor, CD4 (Dalgleish et a l, 1984; Klatzman 
et a l, 1984). Cell-cell fusion can occur when retrovirus-infected cells are mixed with 
uninfected cells expressing the receptor molecule (Weiss, 1993). This property can 
therefore be used to identify susceptible cell types. The mixing of cells infected with 
different viruses can also be used to detect receptor interference (Sommerfelt and Weiss, 
1990). Unfortunately not all viral strains or receptor-expressing cell types readily form 
syncytia (Weiss, 1993). Direct fusion of the viral and cellular membrane can be observed 
through the use of self-quenching dyes (Blumenthal et a l, 1991; Dimitrov et a l, 1991). 
The dye is initially incorporated into the viral envelope. Following fusion, the dye is 
distributed through the plasma membrane and this dequenching results in detectable 
fluorescence. Several of the retrovirus receptors so far identified (section 1.2.1) have been 
found through the use of viral vectors carrying a selectable marker (Albritton et a l, 1989; 
O'Hara et a l, 1990; Young et a l, 1993). This system measures functional penetration of 
the cell, which can be simply detected by the subsequent expression of the selectable 
marker gene. An adaptation of this method involves the use of pseudotyped viruses and 
vectors bearing the Env protein of the virus of interest (Hunter, 1997; Weiss, 1993).
6.1.4 The use of pseudotypes in host range and receptor analysis
Pseudotypes of VSV have been used to study the receptor usage of several viruses, often 
those for which no in vitro assay was available (Boettiger, 1979; Dalgleish et a l, 1984; 
Lagging et a l, 1998; Sommerfelt and Weiss, 1990). These pseudotypes bear the envelope 
protein of the virus of interest, and therefore will only infect cells that express the receptor 
recognised by this protein. Following cell entry the VSV genome replicates as normal, 
forming visible plaques. VSV is normally able to replicate in a wider range of cell types
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than the virus used to form the pseudotype. Therefore, these pseudotypes can be used to 
determine whether host range restrictions occur at the level of cell entry, or at a later stage 
of the infection cycle (Weiss, 1980). For example, the ecotropic MLV virus strains differ in 
their ability to infect the NIH 3T3 and BALB 3T3 cell lines (Hartley et al., 1970; Pincus et 
al., 1975). Experiments with VSV pseudotypes gave the first indication that these 
differences were due to factors acting at a post penetration step (Weiss, 1980).
Pseudotyped retroviral vectors have also been used in studies of host range and receptor 
usage. Such vectors have been used to investigate the function of several viral 
glycoproteins, for example those of ASLV-A and Ebola (Rong et al., 1997; Wool-Lewis 
and Bates, 1998). Their use avoids the need for infectious virus, and the opportunity for the 
insertion of marker genes into the vector genome allows simple detection of infected target 
cells. The transient packaging systems described in section 1.4.2 provide a convenient 
method of producing high titre pseudotyped vectors by replacing the envelope protein 
construct. Since the use of a pseudotype system requires only the env genes to be cloned, it 
enables rapid analysis of a wide variety of cell lines for their susceptibility to infection. 
These vectors also permit investigation of the specific host range of each PoERV Env 
individually. Viral sequences detected in cells infected by wild type virus could have been 
carried by virions bearing the Env protein of another subgroup, or as genomic pseudotypes 
since these have been shown to form between mammalian C-type retroviruses (Takeuchi et 
al., 1992a). Although it is possible that the pseudotyped vectors will be able to infect cells 
that would not normally support replication of the PoERVs, the ability to enter cells may 
still be relevant when assessing the risks posed by these viruses.
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6.2 Materials and methods
6.2.1 Cell free infection
Fresh DMEM medium was added to 75cm2 flasks of subconfluent MPK and PK15 cells, 
and incubated overnight at 37°C. Medium was then removed and filtered through 0.45fim- 
pore filters. 1ml aliquots were added to 25cm2 flasks of target cells, seeded the previous 
day at 5 x 105 cells per flask, in the presence of 8pg/ml Polybrene. The cells were 
incubated at 37°C for 4 hours and 5ml fresh medium was added. The target cells used were 
AH927, 293 and RK-13. MPK medium was also added to ST and PK15 cells. The target 
cells were then subcultured, and after the third and fifth passages, cells were removed and 
genomic DNA was extracted as described previously (section 2.2.2.2). This DNA was then 
analysed by PCR for PoERV env sequences.
Each PCR was performed with 500ng of template DNA, 20pmol of each primer, 2.5mM 
MgCl2, 0.125mM of each dNTP and 1U Taq DNA polymerase. The primers used were 
designed by Douglas Hart (Veterinary Pathology, University of Glasgow) and were as 
follows:
PV2USU 5 ' - ATA AGA GCT GCT CCC CAT CAG AC - 3 '
PV2DSU 5 ' - GCT AGG CGG CTG TGT TAT GTC AG - 3 '
PV3USU 5 ' - CTG ACC TGG ATT AGA ACT GGA AG - 3 '
PV3DSU 5 ' - TAT GTT AGA GGA TGG TCC TGG TC - 3 '
PV4USU 5 ' - GGA GAT GGA AAG ATT GGC AAC AG - 3 '
PV4DSU 5 ' - CAG AGG TTG TAT TGT AAT CAG AG - 3 '
PV2USU and PV2DSU are specific for PoERV-B env, PV3USU and PV3DSU for 
PoERV-C env, and PV4USU and PV4DSU for PoERV-A env. The cycling parameters 
used with the PV2 and PV3 primers were 5 mins at 94°C; 25 cycles of 30s at 94°C, 30s at 
65°C, and 1 min at 72°C; and a final extension step of 7 mins at 72 °C. The parameters 
used with the PV4 primers were 5 mins at 94°C; 25 cycles of 30s at 94°C, 30s at 60°C, and 
1 min at 72°C; and a final extension step of 7 mins at 72°C.
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6.2.2 Cloning of the PoERY-A and -MSL env genes
The PoERV-A env gene was obtained by reverse transcription PCR (RT-PCR) of PK15 
mRNA. mRNA was prepared from PK15 cells using the QuickPrep mRNA Purification 
Kit (Pharmacia Biotech, UK), according to the manufacturer’s instructions. Briefly, cells 
from a confluent 75cm2 flask were homogenised in a buffer containing a high 
concentration of guanidinium thiocyanate, ensuring rapid inactivation of endogenous 
RNase activity. The extract was then diluted, centrifuged, and added to an oligo(dT)-
cellulose matrix in a spun column, supplied with the kit. The mRNA was allowed to bind
to the matrix, washed with a high salt and then a low salt buffer, and then eluted at 65°C. 
The sample was concentrated by precipitation using potassium acetate, glycogen and 95% 
ethanol. Reverse transcription was then carried out using the First-Strand cDNA Synthesis 
Kit (Pharmacia Biotech, UK), according to the manufacturer’s instructions. The mRNA 
solution was heated to 65°C for 10 mins and then placed on ice. To this was added the 
Bulk First-Strand cDNA Reaction Mix (containing MoMLV RT, BSA and dNTPs), DTT, 
and an oligo-dT primer. The mixture was incubated at 37°C for 1 hour, then heated to 95°C 
for 5 mins to denature the mRNA-cDNA duplex, and chilled on ice. PCR was then carried 
out using the U5657 and xhis primers as described for PoERV-B env (section 5.2.2.1). The 
PCR product was then Not I digested and cloned into pCI-neo as before. The clone 
obtained was identified by automated sequencing as described in section 5.2.2.2, using the 
same T7 and T3 primers, along with the sense primer PA878F and antisense primer 
PA1742R shown below:
PA878F 5 ' - GGT ATA TCT TGG GGA ATA GT - 3 '
PA1742R 5 ' - GGA GAT CTT CCG TTA CAA TT - 3 '
The resulting construct was designated pCIneo.penvA.
The PERV-MSL (PoERV-C) env clone (Akiyoshi et a l, 1998) in the pNEB193 vector was 
a gift from Papia Banerjee (BioTransplant Inc., Massachusetts, USA). The env gene was 
removed from the vector by digestion with the restriction enzymes Xba I (Gibco, UK) and
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Sal I (Gibco, UK), and then cloned between the equivalent sites in pCI-neo (section 2.2.3). 
The resulting construct was designated pCIneo.mslenv.
6.2.3 Transient production of pseudotyped vectors
Pseudotyped vectors were produced using the HIT system as described in section 2.2.4.1, 
with the env constructs pCIneo.penvA, pCIneo.penvB (containing the env clone described 
in Chapter 5), and pCIneo.mslenv. Following transfection, serum free DMEM 
supplemented with SPIT was added to the cells (section 3.3). The vectors were titred 24 
hours after transfection on the 293, AH927, TblLu, RK13, ST, PK15 and MPK cell lines. 
Infection was again detected by staining for P-gal activity (section 2.2.4.2).
6.2.4 Production of permanent cell lines releasing pseudotyped vectors
The 293-GP cells were a gift from Derek Bain (Veterinary Pathology, University of
Glasgow). These cells permanently express FeLV Gag, Pro and Pol. 293-GP cells were
transfected with a PoERV env construct, either pCIneo.penvA, pCIneo.penvB or
pCIneo.mslenv, using calcium phosphate precipitation (section 2.2.1.3). 48 hours after
transfection 500|ig/ml G418 was added to the culture medium. Following selection for a
month the resistant colonies were pooled and passaged in G418 medium. In order to titrate
pseudotyped vectors released from these cell lines, approximately 2 x 106 cells were seeded
in 25cm2 flasks and then transiently transfected with pHITl 11 the following day. 48 hours
after transfection the medium was removed, filtered and added to target cells as described
for the HIT system (section 2.2.4.1). In this experiment 8|ig/ml Polybrene was added to the 
•
target cells 24 hours prior to infection. Titres were determined by staining for p-gal activity 
(section 2.2.4.2).
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6.3 Results
6.3.1 Cell free infection
In order to further characterise the host range of PoERV released from PK15 and MPK 
cells, a variety of cell lines from different species were incubated with medium taken from 
cultures of these cells. PoERV infection was then detected by amplification of e«v-specific 
sequences from target cell genomic DNA. Cells incubated with PK15 medium were tested 
for PoERV-A and -B sequences with the PV4 and PV2 primers respectively, and those 
incubated with MPK medium were tested for PoERV-C sequences with the PV3 primers. 
The ST and MPK cell lines were not incubated with PK15 medium in this experiment since 
they are reported to contain A- and B-specific sequences which could have interfered with 
PCR analysis, although they do not appear to encode infectious virus (Patience et al., 
1997a; Le Tissier et al., 1997; D.Hart, pers. com.). The results of the PCRs are shown in 
Fig. 6.3 and summarised in Table 6.1. As can be seen in Fig. 6.3, bands at the expected size 
were amplified from the positive control DNA samples taken from untreated PK15 and 
MPK cells, indicating that the primers were able to recognise the PoERV sequences. A 
band at 336bp was amplified from PK15 DNA using the PV4 primers (Fig. 6.3.1 lane H). 
A band at 302bp was amplified from PK15 DNA using the PV2 primers (Fig. 6.3.2 lane 
H). A band at 282bp was amplified from MPK DNA using the PV3 primers (Fig. 6.3.3 
lanes F and L). The PV3 primers also amplified a faint band at 282bp from DNA taken 
from ST cells incubated with MPK medium (Fig. 6.3.3 lane K), but not from the control, 
untreated ST cells (Fig. 6.3.3 lane E). This indicates that PoERV released from MPK cells 
was able to infect the ST cells. No bands were amplified from the DNA samples taken 
from the other cell lines, and therefore no evidence of infection was detected. No bands 
were amplified from the water control samples (Figs. 6.3.1 lane I, 6.3.2 lane I and 6.3.3 
lane M). Each PCR reaction was carried out at least twice.
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( I ) A B C D E F G H I
( 2 ) A B C D E F G H I
118bp - 
72bp -
Fig. 6.3. PCR analysis of cells incubated with medium taken from PK15 or MPK cell cultures. 
All samples were run on 4% agarose gels.
(1) PCR analysis with the PV4 primers. A) <J)X174 DNA markers (Gibco, UK). B) Untreated 
RK-13 cells. C) Untreated AH927 cells. D) Untreated 293 cells. E) RK-13 cells incubated with 
PK15 medium. F) AH927 cells incubated with PK15 medium. G) 293 cells incubated with PK15 
medium. H) PK15 cells. I) Water control.
(2) PCR analysis with the PV2 primers. A) <j)X174 DNA markers. B) Untreated RK-13 cells. C) 
Untreated AH927 cells. D) Untreated 293 cells. E) RK-13 cells incubated with PK15 medium. F) 
AH927 cells incubated with PK15 medium. G) 293 cells incubated with PK15 medium. H) PK15 
cells. I) Water control.
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Fig. 6.3. Cont.
(3) PCR analysis with the PV3 primers. A) <|)X174 DNA markers. B) Untreated RK-13 cells. C) 
Untreated AH927 cells. D) Untreated 293 cells. E) Untreated ST cells. F) MPK cells. G) PK15 
cells incubated with MPK medium. H) RK-13 cells incubated with MPK medium. I) AH927 cells 
incubated with MPK medium. J) 293 cells incubated with MPK medium. K) ST cells incubated 
with MPK medium. L) MPK cells. M) Water control
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Infection detected
PK15 medium MPK medium
Cell type PoERV-A PoERV-B PoERV-C
RK-13 (rabbit) no no no
AH927 (feline) no no no
293 (human) no no no
PK15 (porcine) ND ND no
ST (porcine) ND ND yes
Table 6.1. Susceptibility of various cell lines to infection with PoERV strains by cocultivation with media 
from the virus releasing cell lines PK15 and MPK. Infection was detected by PCR as described in the text
6.3.2 Pseudotyped vectors
As a more accurate and sensitive method of defining the host range of the PoERV 
subgroups, pseudotyped vectors bearing the different PoERV Env proteins were produced. 
This was initially achieved through the use of the HIT system (Soneoka et a l, 1995), 
previously used to produce the rabies G pseudotyped vectors described in Chapter 3. The 
titres of vectors produced from the HIT system are expected to be higher than those of 
ERVs released from cultured cells. This method also allows investigation of the 
susceptibility of ST and MPK cells to infection with PoERV-A and -B. Vectors bearing the 
Env proteins of PoERV-A, PoERV-B, PERV-MSL or A-MLV were titred on a variety of 
cell lines from different species. Titres were determined by staining for (3-gal activity, as 
described in section 2.2.4.2. The results are shown in Table 6.2.
Both PoERV-A and -B pseudotyped vectors were able to infect 293 cells, although the 
titres of 1-6 x 10° bcfu/ml were approximately 105 times lower than those obtained with the 
control vectors bearing the A-MLV Env, 0.5-2.5 x 105 bcfu/ml. Although neither of these 
vectors appeared to infect porcine cell lines, titres of around 103 bcfu/ml were obtained 
with the PERV-MSL pseudotype on ST and PK15 cells. However, this vector did not infect 
the MPK cells. None of the other cell types tested were susceptible to infection by any of 
the PoERV Env pseudotyped vectors. In addition, no titre was observed on the porcine
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cell lines with the vectors bearing A-MLV Env. Control cells were transfected with the 
vector plasmid pHITl 11 alone, and no titre was obtained from these on any target cell line.
In an attempt to increase the titres of the pseudotyped vectors, and to obtain a continuous 
supply for host range studies, stably transfected cell lines were made. Cells from the 293- 
GP cell line stably transfected with FeLV gag/pro/pol were subsequently transfected with 
the expression plasmid containing the env gene of PoERV-A (pCIneo.penvA), PoERV-B 
(pCIneo.penvB), or PERV-MSL (pCIneo.mslenv), and cells expressing both constructs 
were selected with 500jiig/ml G418. The resulting cell lines were designated 293-GP/A, 
293-GP/B and 293-GP/MSL respectively. Following transient transfection with pHITl 11 
the vectors were titred on human 293T cells. The titres obtained in this way are shown in 
Table 6.3. As expected, these are higher than those obtained in the transient system. A titre 
of 3.5 x 102 bcfu/ml was obtained with the PoERV-A pseudotype, 8.6 x 102 bcfu/ml with 
the PoERV-B pseudotype, and 2.8 x 101 bcfu/ml with the PERV-MSL pseudotype. 
However, a titre of 1.2 x 103 bcfu/ml was also obtained with the negative control medium 
taken from 293-GP cells. These cells were expected to release Env-free vector which 
would be unable to infect the 293T cells. No blue cells were detected in uninfected 293T 
cells, incubated with the X-Gal staining solution. This suggests that the vector producing 
cells were contaminated with a functional env gene or an infectious virus. A sample of 
medium taken from the 293-GP cells gave a negative result in a virus isolation assay, 
carried out by the Feline Virus Unit, University of Glasgow. This assay is designed to 
detect retroviruses that infect feline cells and therefore a negative result does not rule out 
the possibility of contamination with virus possessing a different host range. However, the 
most likely source of contamination of this cell line is FeLV.
Titres on 293T cells (bcfu/ml)
PoERV-A PoERV-B PERV-MSL Env-free vector
3.5 x 102 8.6 x 102 2.8 x 101 1.2 x 103
Table 6.3. Titres obtained on 293T cells with PoERV Env pseudotyped vectors produced from permanent cell 
lines.
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6.3.3 Receptor interference between subgroups of PoERV
As an initial investigation into the patterns of receptor interference between the PoERV 
subgroups, pseudotyped vectors were titred on the vector producing cell lines 293-GP/A, 
293-GP/B and 293-GP/MSL. These titres are shown in Table 6.4. It was expected that the 
Env protein produced in the cell would block its receptor, preventing infection by 
pseudotyped vectors that recognise the same receptor. A lack of interference would imply 
that the Env proteins of the different subgroups recognise different receptors. As shown in 
Table 6.4, infection was detected for all combinations of vectors and cell lines. No obvious 
receptor interference was observed, not even when vector was titred on its equivalent 
pseudotype producing cell line, expressing the same Env protein.
Titres of pseudotyped vectors (bcfu/ml)
Cell line PoERV-A PoERV-B PERV-MSL
293-GP/A 4.4 x 101 1.5 x 102 2.0 x 101
293-GP/B 2.4 x 101 7.6 x 101 2.0 x 101
293-GP/MSL 4.0 x 10' 1.4 x 102 2.0 x 101
Table 6.4. Titres obtained on permanent vector producing cell lines with PoERV pseudotyped vectors 
produced from these cells.
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6.4 Discussion
The results obtained in the cell free infection experiment, shown in Fig. 6.3 and Table 6.1, 
provide little evidence of PoERV infectivity. Transferred PoERV-specific sequences were 
only detected in the ST cells incubated with MPK medium. It is unlikely that the 293 cells 
were resistant to infection with PoERV since Patience et al. (1997a) have reported 
infection of 293 and 293T cells incubated with PK15 medium. It seems possible that the 
number of cells infected with PK15-derived virus was too low to be detected in this 
experiment. This would suggest that these vimses are expressed at a low level or that they 
are unstable and require close contact between virus-releasing and target cells for efficient 
infection. It is also possible that the PoERV Env proteins bind with low affinity to the 
receptor on human cells. The infection of ST cells with PoERV-C indicates that these 
viruses are adapted to infect pig cells. The ability to detect this infection may also imply 
that PoERV-C is more stable, perhaps reflecting a more recent integration into the porcine 
genome (section 6.1.1).
The pseudotyped vectors were produced as a more sensitive method of investigating the 
host range of the PoERV subgroups. The results presented in Table 6.2 show that a wider 
range of PoERV infectivity can be detected by this method. Both PoERV-A and -B 
pseudotypes were able to infect 293 cells, and the PERV-MSL (PoERV-C) pseudotype was 
able to infect PK15 and ST cells. The titres obtained with these pseudotyped vectors were 
much lower than those obtained with the vectors bearing A-MLV Env. This suggests that 
the PoERV Env proteins are less efficient at promoting cell entry, or that they have a low 
affinity for the receptor alleles present on these target cell types. It is also possible that 
these Env proteins are incorporated into the MLV-based vectors with lower efficiency than 
A-MLV Env. No infectivity was detected with the other target cell types tested, as shown 
in Table 6.2. Takeuchi et a l (1998) reported a low susceptibility of TblLu cells to a similar 
PoERV-B pseudotyped vector. However, this was achieved with higher titre vector 
produced from a stably transfected cell line. For comparison, this cell line releases vector at 
titres of 1-5 x 107 infectious units/ml when transfected with an A-MLV Env construct 
(Cosset et al., 1995).
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Although the PERV-MSL (PoERV-C) pseudotype was able to infect ST and PK15 cells, 
no titre was obtained on MPK cells. It seems likely that this was the result of infection 
interference since MPK cells, but not ST or PK15, contain PoERV-C proviral sequences. 
The Env protein expressed by these sequences would be expected to block the receptors on 
the MPK cells. The lack of titre obtained with the PoERV-A and -B pseudotypes on the 
porcine cell lines may also be the result of infection interference. ST and MPK cells do not 
release infectious PoERV-A and -B, but the sequences present in these cells may encode 
Env capable of blocking receptors. It is also possible that these vectors are unable to infect 
these cell lines due to a lack of the necessary receptor. Either situation would imply that 
PERV-MSL recognises a different receptor from the other two subgroups. Although no 
infection of porcine cells by the PoERV-A and -B pseudotypes was detected here, Takeuchi 
et al. (1998) reported that these pseudotypes could infect porcine cell lines with variable 
efficiencies. This could be an effect of the system used for vector production, or it could 
reflect a variability in the level of available receptor, perhaps as a result of changes in 
PoERV or receptor expression by the target cells. Although Takeuchi et a l achieved a titre 
of 2.1 x 103 infectious units/ml for the PoERV-B pseudotype on PK15 cells, these cells 
were resistant in an earlier experiment.
No titre was obtained on the porcine cell lines with the control vectors bearing the A-MLV 
Env. This lack of infectivity was not due to a block acting post entry since vectors 
pseudotyped with PERV-MSL Env were able to infect ST and PK15 cells. This could 
indicate that these cells lack a functional receptor for A-MLV. However, this virus is able 
to infect cells from a large number of species (Miller, 1997). It therefore seems possible 
that infection was prevented by receptor interference with PoERV Env proteins. As 
discussed above, all three cell lines may express PoERV-A and -B Env proteins capable of 
blocking their receptors. Although no interference between PoERV and A-MLV was 
detected in the experiment described in section 4.3.2, this was only tested in human cells, 
perhaps only infected with PoERV-B. It is possible that the interference occurs with 
PoERV-A, or that it is affected by species-specific differences in the receptor. Certain 
xenotropic MLV strains are unable to infect Mus dunni cells preinfected with ecotropic and 
amphotropic viruses (Chesebro and Wehrly, 1985). It would be interesting to test whether 
the porcine homologue of the A-MLV vector, Ram-1, can render non-susceptible cell lines 
sensitive to infection by PoERVs.
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It is difficult to conclude very much from the results obtained with the pseudotyped vectors 
produced by the permanent expression cell lines (Tables 6.3 and 6.4). Although the titres 
were higher than those obtained with the HIT system, a titre of 1 x 103 bcfu/ml was 
obtained from the negative control cells. These control cells were expected to express only 
the FeLV Gag/Pol construct and the vector plasmid pHITl 11, and therefore to release Env- 
free vectors. The addition of Polybrene is unlikely to have been the cause of this 
unexpected titre since it is reported to have no effect on the infectivity of Env-free virus 
(Porter et al., 1998). Although it is possible that the pHITl 11 plasmid may have been 
transferred to the target cells, this has not been observed in any previous experiments. The 
titre obtained from these cells indicates that they were contaminated with an envelope 
protein capable of being incorporated into the vector particles, or a C-type virus capable of 
packaging the vector genome, although no replication-competent virus could be detected 
by virus-isolation assay. It should be noted that the assay used was designed to detect feline 
retroviruses, however these are the most likely source of contamination since they are 
studied in the same laboratory. It appears to be possible that the contamination is derived 
from an endogenous retrovirus present in the genome of the 293 cells used to produce the 
original clones. If this is shown to be the case it will have serious implications for the use 
of such cells for the manufacture of retroviral packaging cell lines. Unless the cause of this 
result can be determined the titres obtained with the pseudotyped vectors in this experiment 
cannot be interpreted. If neutralising antibodies become available these could be used to 
test the specificity of the pseudotype titres, as described in section 3.3.4.
It was expected that the pseudotyped vectors would show reduced infectivity on their own 
producing cell lines, due to the expression of Env protein blocking receptors. However, as 
can be seen in Table 6.4, no significant reduction in infectivity was observed. This lack of 
interference suggests that these samples were contaminated in the same way as the negative 
control vectors. However, it is also possible that the Env expression level of these cell lines 
was too low to significantly block the receptors. These cell lines were not derived from 
single cell clones, and no antibodies have yet become available to analyse the level of Env 
expression. Although no interference was observed between the PoERV subgroups these 
results are not reliable. However, Takeuchi et a l (1998) have also found no evidence of 
interference between these viruses. This supports the prediction that PoERV-A, -B and -C 
recognise different receptors, and can be placed into different interference groups.
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Both PoERV-A and -B pseudotypes have been shown to be able to infect a large number of 
human cell lines in addition to the 293 cells reported here, while the PoERV-C pseudotype 
has only so far been shown to infect HT1080 fibrosarcoma cells (Takeuchi et al., 1998). 
This suggests that the A and B subgroups may pose the greater risk in xenotransplantation, 
particularly since they have been found in all pigs so far tested (Le Tissier et al., 1997; 
Martin et al., 1998; D.Hart, pers.com.). It is possible that the PoERVs may not be able to 
establish a productive infection in all the cells susceptible to these pseudotyped vectors. 
However, the ability of the virus to enter human cells may still be significant since even 
partial expression may allow recombination with human retroviral sequences. While it is 
important to define the cell types susceptible to PoERV, resistant cell lines may also prove 
useful for receptor identification. Following transfection with porcine or human DNA such 
cells could be tested for their susceptibility to the vectors pseudotyped with PoERV Env, in 
a method similar to that used by Albritton et al. (1989) and O’Hara et al. (1990) described 
in section 1.2.1. Identification of the receptors recognised by the PoERV subgroups would 
be a useful step in the ongoing investigation into the risk posed by these viruses in 
xenotransplantation.
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CHAPTER 7
Chapter 7 General discussion
These studies made use of the ability of retroviruses to incorporate the envelope proteins of 
other viruses, and adopt the host range and cell fusion properties of the virus donating the 
envelope protein. In the first section of this work, the process of pseudotype formation was 
exploited in an attempt to produce stable gene delivery vectors with an expanded host 
range, by pseudotyping MLV-based vectors with the rabies envelope glycoprotein G. 
Although high titre VSV G pseudotyped vectors had been produced previously (Bums et 
al., 1993), the vectors produced in this system had low titres, probably as a result of 
inefficient incorporation of the rabies G protein.
As discussed in section 3.4, a likely factor in the inefficient incorporation of rabies G is its 
low rate of transport through the cell compared to the VSV glycoprotein (Whitt et a l, 
1991), resulting in a lower level of expression on the cell surface. This strongly suggests 
that there is no interaction between the rabies glycoprotein and the MLV MA protein, since 
MLV is able to efficiently incorporate its own Env protein when this is expressed at low 
levels on the cell surface (Suomalainen and Garoff, 1994). It seems more likely that the G 
protein is incorporated passively, perhaps as a consequence of alterations in the structure of 
the lipid bilayer, as implied by the model B put forward by Zavada (1982), or because it is 
not prevented from moving into areas of viral budding by interactions with host cellular 
proteins (Dong et al., 1992; Swanstrom and Wills, 1997; Young et al., 1990). Differences 
in the assembly and budding mechanisms of retroviruses and rhabdoviruses may also 
influence the incorporation of rabies G by the MLV-based vector. These are discussed 
further in section 3.4.
In the second section, pseudotyped vectors were used to study the host ranges of the 
PoERV subgroups. The ability of PoERV to infect human cells has been demonstrated by 
cocultivation of virus-releasing cells with target cells (Chapter 4; Patience et al., 1997a). 
However, this was difficult to achieve by exposure to medium taken from cultures of 
PoERV-releasing cells (Chapter 6), indicating that these viruses have low infectivity or are 
unstable. The cloning of the Env genes (Chapters 5 and 6) allowed production of 
pseudotyped vectors with the host ranges of the different PoERV subgroups. These vectors 
provided a more sensitive method of investigating infection and allowed rapid detection of
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infected cells. Their use also allowed individual analysis of the different subgroup Env 
proteins. The results described in section 6.3 show that the vectors pseudotyped with the 
PoERV-A and -B Env proteins are able to infect human 293 cells, implying that these 
viruses may pose a risk to xenotransplant recipients. The vector pseudotyped with PERV- 
MSL (PoERV-C) Env was only observed to infect porcine cell lines, suggesting that these 
may have an ecotropic host range. However, as discussed in section 6.4, other human cell 
lines may be susceptible to this virus.
Although the pseudotyped vectors were found to be a useful method of investigating 
PoERV host range, the titres achieved were, like those of the rabies G pseudotype, much 
lower than those of the control vector bearing the A-MLV Env protein (section 6.3, Table 
6.2). It may be expected that an envelope protein from a closely related virus would be 
more efficiently incorporated by the retroviral vector than the rabies glycoprotein. Like 
MLV, the PoERVs are mammalian C-type retroviruses and, as described in Chapter 5, 
MLV and PoERV Env proteins have very similar structures. It therefore seems likely that 
the low titres were due to the binding and fusion properties of the PoERV Env proteins, or 
the level of available receptors on the target cells. Many ERVs are defective due to the lack 
of selective pressure to produce infectious viral particles (section 1.1.6). As mentioned 
above, PoERVs released from cultured porcine cell lines do not easily infect target cells. In 
addition, Patience et al. (1997a) found that infected 293 and muscle RD cells released 
PoERV at low titres of less than 500 infectious units/ml. While this may be the result of a 
low level of expression, it could also indicate that these viruses have poor infectivity. As 
Env is the only PoERV protein present in the pseudotyped vectors, it seems likely that poor 
infectivity could, at least partly, be due to a defect in Env function. However, it is also 
possible that these Env proteins were inefficiently incorporated.
Several studies have suggested that retroviral Env proteins contain a signal in the 
cytoplasmic domain which is required for efficient incorporation (Brody et a l, 1994; 
Granowitz et a l,  1991; Gray and Roth, 1993; Januszeski et a l, 1997; Yu et a l, 1993). 
Although the PoERV and MLV Env proteins are very similar they do not have identical 
cytoplasmic domains. This may indicate that different sequences are required for the 
specific interaction with the homologous MA protein. As discussed in section 5.4, two of 
the intracytoplasmic residues, Leu 602 and Gin 604, reported to be involved in the efficient
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incorporation of MoMLV Env (Januszeski et al., 1997) are not conserved in the PoERV-B 
Env protein. It is therefore possible that the PoERV Env proteins lack the sequence 
required for specific incorporation into MLV-based vectors. Although both PoERV-A and - 
C Env proteins also lack Gin 604, PoERV-C does contain the conserved Leu residue. It 
may be interesting to investigate whether this residue increases incorporation of this protein 
by the MLV-based vector. These residues are both conserved in the GALV Env protein 
(section 5.3). MLV vectors pseudotyped with this protein have been reported to have 
similar titres to vector bearing A-MLV Env, implying that GALV Env is efficiently 
incorporated (Miller et al., 1991). If the PoERV Env proteins do lack a sequence required 
for an interaction with the MLV MA it would be expected that a high level of expression 
would be required for their efficient incorporation into the MLV-based vector 
(Suomalainen and Garoff, 1994). Takeuchi et a l (1998) observed variations in the titres of 
MLV-based vectors pseudotyped with PoERV Env proteins, plated on human and porcine 
cells. While it is quite likely that these variations were due to changes in levels of available 
receptor, it could also be the result of changes in Env expression and incorporation. In the 
absence of mAbs directed against the PoERV Env proteins, it is not possible to determine 
the level of expression of these proteins. Therefore it is possible that the low titres reported 
here were partly due to low levels of Env expression resulting in poor incorporation. Such 
inefficient incorporation of the Env proteins could prevent detection of infection of cell 
lines with low susceptibility.
The establishment of cell lines releasing high titres of vector pseudotyped with the PoERV 
Env proteins would be useful for further characterisation of the host ranges of these 
viruses, and for the characterisation of potential receptors. The use of a stable cloned 
packaging cell line, such as the TELCeB6 line used by Takeuchi et a l (1998), would be 
expected to result in increased vector titres. If the low titres are a reflection of inefficient 
incorporation of PoERV Env, these should be improved by increasing the expression of 
Env relative to Gag. This could perhaps be achieved by transfecting a higher concentration 
of the env construct, or through the use of a plasmid that contains the env and selector 
genes in the same reading frame. Since expression of the selector gene in such a construct 
occurs as a result of continued expression from env, this should reduce any downregulation 
of Env expression by the cell.
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In conclusion, the results described in this study demonstrate that the pseudotyping of 
retroviral vectors can be used both to target vectors to a defined host range, or to 
investigate the unknown host range of a new virus. Unfortunately, pseudotyping with the 
rabies G protein proved to be inefficient and the resulting vectors are unlikely to be useful 
for gene delivery and gene therapy protocols. However, analysis of the factors influencing 
the production of these pseudotypes should aid investigations into the processes of virion 
assembly and envelope incorporation. The vectors pseudotyped with the PoERV Env 
proteins also had very low titres. However, they still proved to be useful for detection of 
cell lines susceptible to infection by these vectors. The production of higher titre stocks of 
these pseudotypes would allow more confident detection of non susceptible cell lines, and 
also increase the utility of these pseudotyped vectors in receptor studies. As it has been 
established that these viruses are able to infect human cells, further investigation of their 
host range and infectivity is required in order to assess the risk posed to the human 
recipients of xenotransplants.
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Appendices
A .l Arrangement of assembled fragments obtained during the sequencing of PoERV- 
B env
All fragments
t7208 +------------>
t7x2 87 +---------------------->
t7xl98 +------------------------- >
621208 + >
revl98 <------------------------- +
rev2bll8 <---------------- +
rev208 <------------ +
rev2al2 8 <-------------------- +
rev2bl2 8 <-------------------- +
621218 +>
621fal28------------------ +---------------------->
621fbl28------------------ +---------------------->
621198 +------------------------ >
t3109------------------------------- <----------------------+
t3x2 87 <----------------------+
t3208 <------------- +
2 804xhis <--------------------------+
t3148 <----------------------+
1869109 +>
1869208 +>
CONSENSUS +-------------------------------------------------->
0 300 600 900 1200 1500 1800 2100 2400
Fragments sorted by strand
t 7  2 0 8  h------------------------- >
t7x287 +---------------------->
t7xl98 +------------------------- >
621208 + >
621218 +>
621fal28------------------ +--------------------- >
621fbl28------------------ +--------------------- >
621198 +------------------------ >
1869109 +>
1869208 +>
CONSENSUS +-------------------------------------------------->|  |  |  |  |  |  |  |  |
0 300 600 900 1200 1500 1800 2100 2400
t3148  <------------------------------------ +
2804xhis <--------------------------+
t3208 <------------- +
t3x287 <---------------------- +
t3109-------------------------------<---------------------- +
rev2bl2 8 <-------------------- +
rev2al2 8 <-------------------- +
rev208 <------------ +
rev2bll8 <---------------- +
revl9 8 <------------------------- +
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A.2 Alignment of fragments obtained during the sequencing of PoERV-B env
t7208 > TAGAGTCGaCCCGGGCGGCCGCACCTGGCTCCATGCATCCCACGTTAAGCTGGCGCCACC 60
t7x287 > GcGGCCGCRCCTGGCTCCATGCAT.CCACGTTAAGCTGGCGCCACC 46
t7xl98 > CCGGGCgGCCGCACCTGGCTCCATGCATCCCACGTTAAGCTGGCGCCACC 50
CONSENSUS> TAGAGTCGACCCGGGCGGCCGCACCTGGCTCCATGCATCCCACGTTAAGCTGGCGCCACC 6 0
t7208 > TCCCGACTCGGGGTGGAGAGCCGAAAAGACTGAGAATCCCCTTAAGCTTCGCCTCCATCG 12 0
t7x287 > TCCCGACTCGGGGTGGAGAGCCGAAAAGACTGAGAATCCCCTTAAGCTTCGCCTCCATCG 10 6
t7xl98 > TCCCGACTCGGGGTGGAGAGCCGAAAAGACTGAGAATCCCCTTAAGCTTCGCCTCCATCG 110
CONSENSUS> TCCCGACTCGGGGTGGAGAGCCGAAAAGACTGAGAATCCCCTTAAGCTTCGCCTCCATCG 12 0
t7208 > CCTGGTTCCTTACTCTAACAATAACTCCCCAGGCCAGTAGTAAACGCCTTATAGACAGCT 180
t7x287 > CCTGGtTCCTTACTCTAACAATAACTCCCCAGGCCAGTAGTAAACGCCTTATAGACAGCT 166
t7xl98 > CCTGGtTCCTTACTCTAACAATAACTCCCCAGGCCAGTAGTAAACGCCTTATAGACAGCT 17 0
CONSENSUS> CCTGGTTCCTTACTCTAACAATAACTCCCCAGGCCAGTAGTAAACGCCTTATAGACAGCT 18 0
t7208 > CGAACCCCCATAGACCTTTATCCCTTACCTGGCTGATTATTGACCCTGATACGGGTGTCA 240
t7x287 > CGAACCCCCATAGACCTTTATCCCTTACCTGGCTGATTaTTGACCCTGATACGGGTGTCA 22 6
t7xl98 > CGAACCCCCATAGACCTTTATCCCTTACCTGGCTGATTATTGACCCTGATACGGGTGTCA 23 0
CONSENSUS> CGAACCCCCATAGACCTTTATCCCTTACCTGGCTGATTATTGACCCTGATACGGGTGTCA 2 4 0
t7208 >
t7x2 87 >
t7xl98 >
revl9 8 <
CONSENSUS>
TGTAAATAGCACTCGAGGTGTTGCTCCTAGAGGCACCTGGTGCCCTGAACTGCATtTCT 5 9 
 CTGTAAATAGCACTCGAGGTGTTGCTCCTAGAGGCACCTGGTGGCCTGAACTGCATTTCT 3 00
17 2 0 8 > GCCTCCGATTGATTAACCCCGCTGTTAAAAGCACACCTCCCAACCTAGTCCGTAGTTATG 3 60
17x287 > GCCTCCGATTGATTAACCCCGCTGTTAAAAGCACACCTCCCAACCTAGTCCGTAGTTATG 346
t7xl98 > GCCTCCGATTGATTAACCCCGCTGTTAAAAGCACACCTCCCAACCTAGTCCGTAGTTATG 3 50
revl9 8 < GCCTCCGANTGATTAACCCCGCTGTTAAAAGCACACCTCCCAACCTAGTCCGTAGTTATG 119
CONSENSUS> GCCTCCGATTGATTAACCCCGCTGTTAAAAGCACACCTCCCAACCTAGTCCGTAGTTATG 3 60
t7208 > GGTTCTATTGCTGCCCAGGCACAGAGAAAGAGAAATACTGTGGGGGTTCTGGGGAATCCT 42 0
t7x287 > GGTTCTATTGCTGCCCAGGCACAGAGAAAGAGAAATACTGTGGGGGTTCTGGGGAATCCT 406
t7xl98 > GGTTCTATTGCTGCCCAGGCACAGAGAAAGAGAAATACTGTGGGGGTTCTGGGGAATCCT 410 
revl98 < GGTNCTATTGCTGCCCAGGCACAGAGAAAGAGAAATACTGTGGGGGTTCTGGGGAATCCT 17 9 
rev2al28 < CTGgGgAATCCT 12
rev2bl2 8 < AATCCT 6
CONSENSUS> GGTTCTATTGCTGCCCAGGCACAGAGAAAGAGAAATACTGTGGGGGTTCTGGGGAATCCT 42 0
t7208 > TCTGTAGGAGATGGAGCTGCGTCACCTCCAACGATGGAGACTGGAAATGGCCGATCTCTC 48 0
t7x287 > TCTGTAGGAGATGGAGCtGCGTCACCTCCAACGATGGAGACTGGAAATGGCCGATCTCTC 46 6
t7xl98 > TCTGTAGGAGATGGAGCTGCGTCACCTCCAACGATGGAGACTGGAAATGGCCGATCTCTC 47 0 
revl98 < TCTGTAGGAGATGGAGCTGCGTCACCTCCAACGATGGAGACTGGAAATGGCCGATCTCTC 239 
rev2al28 < TCTgTAgGAGATggAgCTGCGTCACCTCCAACGATGGAGACTGGAAATggCCgATCTCTC 72 
rev2bl2 8 < TCTGTAGNANATGGANCTGCGTCACCTCCAACNATGGANACTGGAAATgNCCNATCTCTC 66 
CONSENSUS> TCTGTAGGAGATGGAGCTGCGTCACCTCCAACGATGGAGACTGGAAATGGCCGATCTCTC 480
229
t7208 > TCCAGGACCGGGTAAAATTCTCCTTTGTCAATTCCGGCCCGGGCAA 52 6
t7x287 > TCCAGGACCGGGTAAAATTCTCCTTTGTCAATTCCGGCCCGGGCGAGTACAAAATGATGA 526
t7xl98 > TCCAGGACCGGGTAAAATTCTCCTTTGTCAATTCCGGCCCGGGCAAGTACAAAATGATGA 53 0 
revl98 < TCCAGGACCGGGTAAAATTCTCCTTTGTCAATTCCGGCCCGGGCAAGTACAAAATGATGA 2 99
rev2al28 < TCCAggACCGTgTAAAATTCTCCTTTGTCAATTCCGgCCCGGGCAAGTACAAAATGATGA 132 
rev2bl28 < TCCANGACCGTGTAAAATTCTCCTTTgTCAATTCCGGCCCGGGCAAGTACAAAATGATGA 12 6 
CONSENSUS> TCCAGGACCGGGTAAAATTCTCCTTTGTCAATTCCGGCCCGGGCAAGTACAAAATGATGA 540
 +  +  +  +  +  +
t7x287 > AACTATATAAAGATAAGAGCTGCTCCCCATCAGACTTAGATTATATAAAGATAAGTTTCA 5 86
t7x198 > AACTATATAAAGATAAGAGCTGCTCCCCATCAGACTTAGATTATCTAAAGATAAGTTTCA 590
revl98 < AACTATATAAAGATAAGAGCTGCTCCCCATCAGACTTAGATTATCTAAAGATAAGTTTCA 3 59
rev2bll8 < CAGACTTAGATTATCTAAAGATAA.TTTCA 3 0
rev2al28 < AACTATATAAAGATAAGAgCTGCTCCCCATCAGACTTAGATTATCTAAAGATAAGTTTCA 192 
rev2bl28 < AACTATATAAAGATAAGAGCTGCTCCCCATCAGACTTAGATTATCTAAAGATAA. TTTCA 186 
CONSENSUS> AACTATATAAAGATAAGAGCTGCTCCCCATCAGACTTAGATTATCTAAAGATAAGTTTCA 600
 +  +  +  +  +  +
17x287 > CTGAAAAAGGAAAAcAGGAAAATATTCAAAAGTGGATAAATGGTATGAGCTGGGGAATAG 646
t7xl98 > CTGAAAAAGGAAAACAGGAAAATATTCAAAAGTGGATAAATGGTATGAGCTGGGGAATAG 650
revl9 8 < CTGAAAAAGGAAAACAGGAAAATATTCAAAAGTGGATAAATGGTATGAGCTGGGGAATAG 419
rev2bll8 < CTGAAAAAGGAAAACAGGAAAATATTCAAAANTgGATAAATGNTATGANCTgGAGAATAT 90 
rev2al28 < CTGAAAAAGGAAAACAGGAAAATATTCAAAAgTGGATAAATGgTATGAGCTggtGAATAG 2 52 
rev2bl28 < CTGAAAAAGGAAAACAGGAAAATATTCAAAAGTGGATAAATggTATGAGCTGGgGAATAg 246 
CONSENSUS> CTGAAAAAGGAAAACAGGAAAATATTCAAAAGTGGATAAATGGTATGAGCTGGGGAATAG 6 60
t7x2 87 > TTTTTTATAATTATGGCGGGGGAGCAGGGTAGACTTTAACCATTCGACTTAGGATAGAGA 7 06
17x19 8 > TTTTTTATAAATATGGCGGGGGAGCAGGGTCCACTTTAACCATTCGCCTTAGGATAGAGA 710
62120 8 > GGAGCAGGGTC.ACTTTAACCaKKCGCCTTAGGATAGAcA 40
revl9 8 < TTTTTTATAAATATGGCGGGGGAGCAGGGTCCACTTTAACCATTCGCCTTAGGATAGAGA 47 9
rev2bll8 < TTTTTTATAAATATGNCGGGGGAGCAGGGTCCACTTTAACCATTCGCCTTAGGATAGAGA 150 
rev2al28 < TTTTTTATAAATATAgCGGgGGAgCAGggTCCACTTTAACCATTCgCCTTAGGATAGAGA 312 
rev2bl2 8 < TtTTTTATAAATATAgCGGGgGAGCAGg . TCCACTTTAACCATTCGCCTTAGGATAGAGA 3 06 
621fal28 > GGaG.AGGGTCCACTTTRACCATcCGCSTTAGGATAGAGA 40
621fbl28 > GGaGcAGGGTCCACTTTaACCATcCGCSTTAGGATAGAGA 40
621198 > aCTTTAA.CATTCGCCTTACGATACACA 28
CONSENSUS> TTTTTTATAAATATGGCGGGGGAGCAGGGTCCACTTTAACCATTCGCCTTAGGATAGAGA 72 0
t7x287 
t7xl9 8 
621208 
revl98 
rev2bll8 
rev2 0 8 
rev2al2 8 
rev2bl2 8 
621fal28 
621fbl28 
621198 
CONSENSUS>
CGGGGAgAGAGCCCCCTGTSGCGATGGGACGCGATAGAGTACTGGCTG. AGGGGGGAGCC 7 66 
CGGGGACAGAACCCCCTGTGGCAATGGGACCCGATAAAGTACTGGCTGAACAGGGGCCCC 77 0 
CGGGGACAGAA. CCCCTGTGGCAATGGGACCCGATAAAGTACTGGCTGAACAHGGCCCCC 100 
CGGGGACAGAACCCCCTGTGGCAATGGGACCCGATAAAGTACTGGCTGAACAGGGCCCCC 53 9 
CGGGGACAGAACCCCCTGTRGCAATGGGACCCGATAAAGTACTgGCTGAACAGGGCCCCC 210
AAAGTACTGGCTGAACAGGGCCCCC 2 5 
CGGGGACAGAACCCCCTGTGGCAATGGGACCCGATAAAGTACTGGCTGAACAGGGCCCCC 3 72 
CGGGGACAGAACCCCCTGTGGCAATGGGACCCGATAAAGTACTGGCTGAACAGGGCCCCC 3 66 
CGGGGACAGARCCCCCTGTGGCAATGGGACCCGATAAAGTACTGGcTGAaCARGGCCCCC 100 
CGGGGACAGARCCCCCTGTGGCAATGGGACCCGATAAAGTACTGGCTGAaCARGGCCCCC 100 
CGGGGaCACAA . CCCCTGTCGCAATGGGA. CCGATAAACTACTGGCTGAACAcSG . CCCC 8 8 
CGGGGACAGAACCCCCTGTGGCAATGGGACCCGATAAAGTACTGGCTGAACAGGGCCCCC 7 80
230
t7x287 > GGGCTGGAGCCA.GGCATAACTTGaCGGTGCGCCAGTT.AtCTCGCTGCGG.STGACATA 82 6
t7xl98 > GGCCTGGAGCCACCGCATAACTTGCCGGTGCCCCAATTAACCTCGCTGCGGCCTGACATA 83 0
6212 08 > GGCCTGGAGCCACCGCATAACTTGCCGGTGCCCCAATTAACCTCGCTGCGGCCTGACATA 160
revl98 < GGCCTGGAGCCACCGCATAACTTGCCGGTGCCCCAATTAACCTCGCTGCGGCCTGACATA 599
rev2bll8 < GGCCTGGAGCCACCGCATAACTTGCCGGTGCCCCAATTAACCTCGCTGCGGCCTGACATA 27 0 
rev208 < GGCCTGGAGCCACCGCATAACTTGCCGGTGCCCCAATTAACCTCGCTGCGGCCTGACATA 8 5 
rev2al28 < KGCCTGGAGCCACCGCATAACTTGCCG.TGCCCCAATTAACCTCGCTGCGGCCTGACATA 43 2 
rev2bl28 < GGCCTGGAGCCACCGCATAACTTGCCG.TGCCCCAATTAACCTCGCTGCGGCCTGACATA 42 6 
621fal28 > GGcCTGGaGCCACCGCATAAcTTGCCGGTGCCCCAATTaACCTCGCtGCGGCCTGASATA 160 
621fbl28 > GGCCTGGaGCCACCGCATAAcTTGCCGGTGCCCCAATTaACCTCGCtGCGGCCTGAcATA 160 
62119 8 > GGCCTGGaGCCACCGCATAACTTGCCGGTGCCCCAATTAACCTCGCtGCGGCCTGACATA 14 8
CONSENSUS> GGCCTGGAGCCACCGCATAACTTGCCGGTGCCCCAATTAACCTCGCTGCGGCCTGACATA 840
17x2 87 > AcACAGNCGCCTAGC.ACAGTA.CACT.GATTGATTCTTAc. .ACACGCCTAG.AGCTCC 8 86
t7xl98 > ACACAGCCGCCTAGCAACAGTACCACTGGATTGATTCCTACCAACACGCCTAGAAACTCC 8 90
621208 > ACACAGCCGCCTAGCAACAGTACCACTRGATTGATTCCTACCAACACGCCTAGAAACTCC 22 0
revl98 < ACACAGCCGCCTAGCAACAGTACCACTGGATTGATTCCTACCAACACGCCTAGAAACTCC 659
rev2bll8 < ACACAGCCGCCTAGCAACAGTACCACTGGATTGATTCCTACCAACACGCCTAGAAACTCC 33 0 
rev2 08 < ACACAGCCGCCTAGCAACAGTACCACTGGATTGATTCCTACCAACACGCCTAGAAACTCC 145
rev2al28 < ACACAGCCGCCTAGCAACAGTACCACTGGATTGATTCCTACCAACACGCCTAGAAACTCC 492 
rev2bl28 < ACACAGCCGCCTAGCAACAGTACCACTGGATTGATTCCTACCAACACGCCTAGAAACTCC 486 
621fal28 > ACACAGCCGCCTAGCAACAGTACCACTGGaTTNAKTCCTACCAACACGCCTAGAaACTCC 22 0 
621fbl28 > ACACAGCCGCCTAGCAACAGTACCACTGGaTTNAKTCCTACCAACACGCCTAGAaACTCC 22 0 
62119 8 > ACACAGCCGCCTAGCAACACTACCACTGGAtTCATTCCTACCAACACGCCTAGAAACTCC 2 08
CONSENSUS> ACACAGCCGCCTAGCAACAGTACCACTGGATTGATTCCTACCAACACGCCTAGAAACTCC 900
t7x2 87 
t7xl98 
621208 
revl98 
rev2bll8 < 
rev2 08 <
rev2al2 8 < 
rev2bl28 < 
621fal28 > 
621fbl28 > 
621198 >
CONSENSUS>
C .A .GTG.TGCT 898
C . AGGTGTTCCTGTTAAGACAGGACAGAGACTCTTCAGTCTCATCCAGgGAGCTTTCCAA 95 0 
CCAGGTGTTCCTGTTAAGACAGGACAGAtACTCTTCAGTCTCATCCAGGGAGCTTTCCAA 2 8 0 
CCAGGTGTTCCTGTTAAGACAGGACAGAGACTCTTCAGTCTCATCCAGGGAGCTTTCCAA 719 
CCAGGTGTTCCTGTTAAGACAGGACAGAGACTCTTCAGTCTCATCCAGGGAGCTTTCCAA 3 9 0 
CCAGGTGTTCCTGTTAAGACAGGACAGAGACTCTTCAGTCTCATCCAGGGAGCTTTCCAA 2 05 
CCAGGTGTTCCTGTTAAGACAGgACAGAGACTCTTCAGTCTCATCCAGGGAGCTTTCCAA 552 
CCAGGTGTTCCTGTTAAGACAGGACAGAGACTCTTCAGTCTCATCCAGGGAGCTTTCCAA 546 
CCAGGTGTTCCTGTKAAGASAGGACAGAGACTCTTCAGTcTCATCCAGGGAGCTTTCCAA 28 0 
CCAGGTGTTCCTGTtAAGASAGGACAGAGACTCTTCAGTCTCATCCAGGGAGCTTTCCAA 2 8 0 
CCAGGTGTTCCTGTTAAGACAGGACAGAYACTCTTCAGTCTCATCCAGGGAGCTTTCCAA 2 6 8 
CCAGGTGTTCCTGTTAAGACAGGACAGAGACTCTTCAGTCTCATCCAGGGAGCTTTCCAA 9 6 0
t7xl9 8 
621208 
revl9 8 
rev2bll8 
rev208 
rev2al28 
rev2bl28 
621fal28 
621fbl28 
621198 
2804xhis 
CONSENSUS>
GCCATCAACTCCACCGACCCTGATGC.ACTTCTTCTTGTTGGCTTTGTCTATCCTCAGGG 1010 
GCCATCAACTCCACCGACCCTGATGCCACTTCTTCTTGTTGGCTTTGTCTATCCTCAGGG 3 40 
GCCATCAACTCCACCGACCCTGATGCCACTTCTTCTTGTTGGCTTTGTCTATCCTCAGGG 77 9 
GCCATCAACTCCACCGACCCTGATGCCACTTCTTCTTGTTGGCTTTGTCTATCCTCAGGG 45 0 
GCCATCAACTCCACCGACCCTGATGCCACTTCTTCTTGTTGGCTTTGTCTATCCTCAGGG 2 6 5 
GCCATCAACTCCACCGACCCTGATGCCACTTCTTCTTGTTGGCTTTGTCTATCCTCAGGG 612 
GCCATCAACTCCACCGACCCTGATGCCACTTCTTCTTGTTGGCTTTGTCTATCCTCAGGG 60 6 
GCCATCAACTCCACCGACCCTGATGCCACTTCTTCTTGTTGGCTTTGTCTATCCTCAGGG 3 40 
GCCATCAACTCCACCGACCCTGATGCCACTTCTTCTTGTTGGCTTTGTCTATCCTCAGGG 3 40 
GCCATCAACTCCACCGACCCTGATGCCACTTCTTCTTGTTGGCTTTGTCTATCCTCAGGG 3 2 8 
CATCA.CTC.ACN.ACC.T .A T .cCACT.CT.CTN.TTG.CTTT. .CTATC.TCAGN. 5 8 
GCCATCAACTCCACCGACCCTGATGCCACTTCTTCTTgTTGGCTTTGTCTATCCTCAGGG 102 0
231
t7xl98 
621208 
revl98 
rev2bll8 
rev2 08 
rev2al28 
rev2bl2 8 
621fal28 
621fbl28 
621198 
t3109 
2 804xhis 
CONSENSUS>
C .TCCTTATTATGAGGGGATGGCTAAA 1037
C C TC C TTATTATGAGGGGATGGC TAAAGAAAGAAAATTCAATGTGAC CAAAGAGCATAGA 400 
CCTCCTTATTATGAGGGGATGGCTAAAGAAAGAAAATTCAATGTGACCAAAGAGCATAGA 83 9 
CCTCCTTATTATGAGGGGATGGCTAAAGAAAGAAAATTCAATGTGACCAAAGAGCATAGA 510 
C C TC CTTATTATGAGGGGATGGC TAAAGAAAGAAAATTCAATGTGAC CAAAGAGCATAGA 3 2 5 
CCTCCTTATTATGAGGGGATGGCTAAAGAAAGAAAATTCAATGTGACCAAAGAGCATAGA 672 
C C TC C TTATTATGAGGGGATGGC TAAAGAAAGAAAATTCAATGTGAC CAAAGAGCATAGA 6 66 
CCTCCTTATTATGAGGGGATGGCTAAAGAaAGAaAATTCAATGTGACCAAAGAGCATAGA 4 00 
CCTCCTTATTATGAGGGGATGGCTAAAGARAGAaAATTCAATGTGACCAAAGAGCATAGA 400 
CCTCCTTATTATGAGGGGATGGCTAAAGAAAGAAAATTCAATGTGACCAAAGAGCATAGA 3 8 8 
GATGGCTAAAGAAAGAgAATTCAATGTGACCAAAGAGCATAGA 4 3
. CTC TAT AT .A..... GGATg . CTAA..... gAAAAATCA. TNT c AC C AAAg AN C ATAg A 118
CCTCCTTATTATGAGGGGATGGCTAAAGAAAGAAAATTCAATGTGACCAAAGAGCATAGA 1080
> AATCAATGTACATGGGGGTCCCGAAATAAGCTTACCCTCACTGAAGTTTCCGGGAAGGGG
< AATCAATGTACATGGGGGTCCCGAAATAAGCTTACCCTCACTGAAGTTTCCGGGAAGGGG
< AATCAATGTACATGGGGGTCCCGAAATAAGCTTACCCTCACTGAAGTTTCCGGGAAGGGG
< AATCAATGTACATGGGGGTCCCGAAATAAGCTTACCCTCACTGAAGTTTCCGGGAAGGGG
< AATCAATGTACATGGGGGTCCCGAAATAAGCTTACCCTCACTGAAGTTTCCGGGAAGGGG
< AATCAATGTACATGGGGGTCCCGAAATAAGCTTACCCTCACTGAAGTTTCCGGGAAGGGG
> AATCAATGTACATGGGGGTCCCGAAATAAGCTTACCCTCACTGAAGTTTCCGGGAAGGGG
> AATCAATGTACATGGGGGTCCCGAAATAaGCTTACCCTCACTGAAGTTTCCGGGAAGGGG
> AATCAATGTACATGGGGGTCCCGAAATAAGCTTACCCTCACTGAAGTTTCCGGGAAGGGG
< AATCAATGTACATGGGG . TCCCGAAATAAGCTTACCCTCACTGAAGTTTCCGGGAA . GGG
< CCAGAAATAAGCTTACCCTCNCTGAAGGTTCCGGGaAGgGN
< AATCAATNTACATgcCC . TCCA. AAATAANCTTACCNTCACTaAANTTTCcGGAAA . GAg
< CA. .GGGGTCCCGAA.TA.GCT.ACCcTCACTGAGGTTT.CGGGA.GGGG
460
899
570
385
732
726
460
460
448
103
41
178
50
1140
621208 > 
revl98 < 
rev2bll8 < 
rev208 < 
rev2al28 < 
rev2bl2 8 < 
621fal28 > 
621fbl28 > 
621198 >
t3109 <
t3x287 <
2 804xhis < 
t3148 <
CONSENSUS>
ACATGCATAGGAAAAGCTCCCCCATCCCACCAACACCTTTGCTATAGTACTGTGGTTTAT 52 0 
ACATGCATAGGAAAAGCTCCCCCATCCCACCAACACCTTTGCTATAGTACTGTGGTTTAT 959 
ACATGCATAGGAAAAGCTCCCCCATCCCACCAACACCTTTGCTATAGTACTGTGGTTTAT 63 0 
ACATGCATAGGAAAAGCTCCCCCATCCCACCAACACCTTTGCTATAGTACTGTGGTTTAT 445 
ACATGCATAGGAAAA. CTCCCCCATCCCACCAACACCTTTGCTATAGTACTGTGGTTTAT 7 92 
ACATGCATAGGAAAAGCTCCCCCATCCCACCAACACCTTTGCTATAGTACTGTGGTTTAT 7 86 
ACATGCATAGGAAAAGCTCCCCCATCCCACCAACACCTTTGCTATAGTACTGTGGTTTAT 520 
ACATGCATAGGAAAAGCTCCCCCATCCCACCAACACCTTTGCTATAGTACTGTGGTTTAT 52 0 
ACATGCATAGGAAAAGCTCCCCCATCCCACCAACACCTTTGCTATAGTACTGTGGTTTAT 508 
ACATGCATAGGAAAAGCTCCCCCATCCCACCAACACCTTTGCTATAGTACTGTGGTTTAT 163 
ACATgCATAGGAAAAGCTCCCCCATaCCACCANCACTTTtGCTNTGGTNCTGTGNTTTAT 101 
ACAT. CATAgAAAAggCTCCCCCATCCCACCAACACCTT. gCTATAgTACTGTGgTaTAT 2 3 8 
ACATGCATAGGAAA. GCTCCCCCATCCCACCAACACCTTTGCTATAGTACTGTGGTGTAT 110 
ACATGCATAGGAAAAGCTCCCCCATCCCACCAACACCTTTGCTATAGTACTGTGGTTTAT 12 00
621208 > 
revl9 8 <
rev2bll8 < 
rev2 08 <
rev2al2 8 < 
rev2bl2 8 < 
621fal28 > 
621fbl28 > 
621198 >
t3109 <
t3x287 <
2 804xhis < 
t3148 <
CONSENSUS>
GAGCAGGCCTCAGAAAATCA 540
GAGCAGGCCTCAGAAAATCAGTATTTAGTACCTGGTTATAACAGGTGGTGGGCATGCAAT 1019 
GAGCAGGCCTCARAAAATCAGTATTTAGTACCTGGTTATAACAGGTGgTGGNCATgCAAT 690 
GAGCAGGCCTCAGAAAATCAGTATTTAGTACCTGGTTATAACAGGTGGTGGGCATGCAAT 505 
GAGCAG . CCTCAGAAAATCAGTATTTAGTACCTNGTTATAACAG . TG . TGg . CATGCAAT 852 
GAGCAGGCCTCAgAAAATCAGTATTTAGTACCTGGTTATAACAGGTGGTGGGCATGCAAT 846 
GAGCAGGCCTCAGAAAATCAGTATTTAGTACCTGGTTATAACAGGTGGTGGGCATGCAAT 5 80 
GAGCAGGCCTCAGAaAATCAGTATTTAGTACCTGGTTATAACAGGTGGTGGGCATGCAAT 580 
GAGCAGGCCTCAGAAAATCAGTATTTAGTACCTGGTTATAACAGGTGGTGGGCATGCAAT 568 
GAGCAGGCCTCAGAAAATCAGTATTTAGTACCTGGTTATAACAGGTGGTGGGCATGCAAT 2 23 
GANCAGACCTCAGAAAATCAGTATTTAGTACCTGGGTKTRNCAGGTGGTGgGcATGCAAT 161 
gAgCAGcCCTCAGAAAATCAGTATTTAgTACCTGgTTATAACAGgTGgTgCgCATNCAAT 2 9 8 
GAGCAGSCCTCAGAAAATCAGTATTTAGTACCTGGTTATaACAGGTGG. GGGCATGCAAT 17 0 
GAGCAGGCCTCAGAAAATCAGTATTTAGTACCTGGTTATAACAGGTGGTGGGCATGCAAT 12 6 0
232
revl9 8 < AcNCGGTCAA 1029
rev2bll8 < ACT.GGTTARCC 702
rev208 < ACTGG..TAACCC 518
rev2al28 < AcT.GGTTAaCCC 865
rev2bl28 < AcT.GGTTARCCCG 860
621218 > GTGTTTCCACCTCAGTCTTCAACCAATCCAAAGATTTCTGTGTC 44
621fal28 > ACTGGGTTAACCCCCTGTGTTTCCACCTCAGTCTTCAACCAATCCAAAGATTTCTGTGTC 640
621fbl28 > ACTGGGTTAACCCCCTGTGTTTCCACCTCAGTCTTCAACCAATCCAAAGATTTCTGTGTC 640
621198 > ACTGGGTTAACCCCCTGTGTTTCCACCTCAGTCTTCAACCAATCCAAAGATTTCTGTGTC 628
t3109 < ACTGGGTTAACCCCCTGTGTTTCCACCTCAGTCTTCAACCAATCCAAAGATTTCTGTGTC 283
t3x287 < ACTGGNTTANCCCCCTGTGTTTCCNCNTCAGTCTTCAACcAATCCATAGATTTCTGTGTC 221
2804xhis < ACTNcCTTAACCCCCTGTGTTTCCACCTCATTCTTCAACCAATCCAAAGATTTCTgTcTC 358
t3148 < ACTGGGTTAACCCCCTGTGTTCCCACCTCAGTCTTCAACCAATCCAAAGATTTCTGTGTC 230
CONSENSUS> ACTGGGTTAACCCCCTGTGTTTCCACCTCAGTCTTCAACCAATCCAAAGATTTCTGTGTC 1320
621218 > ATGGTCCA 52
621fal28 > ATGGTCCAAATCGTCCCCCGAGTGTACTACCATCCTGAGGAAgTGGTCCTTGATgAATAT 7 00 
621fbl28 > ATGGTCCAAATCGTCCCCCGAGTGTACTACCATCCTGAGGAAGTGGTCCTTGATgAATAT 700 
62119 8 > ATGGTCCAAATCGTCCCCCGAGTGTACTACCATCCTGAGGAAGTGGTCCTTGATGAATAT 688
t3109 < ATGGTCCAAATCGTCCCCCGAGTGTACTACCATCCTGAGGAAGTGGTCCTTGATGAATAT 343
t3x287 < ATGGTCCAAATCGTCCCCCGAGTGTACTACCaTCCTGAGGAAGTGGTCCTTGATGAATAT 2 81
2 804xhis < ATgNTCCAAATCNTCCCCCGAgTNTACTACCATCCTGAGGAAGTGgTCCTTGATGAATAT 418 
t3148 < ATGGTCCAAATCGTCCCCCGAGTGTACTACCATCCTGAGGAAGTGGTCCTTGATGAATAT 290
CONSENSUS> ATGGTCCAAATCGTCCCCCGAGTGTACTACCATCCTGAGGAAGTGGTCCTTGATGAATAT 13 80
+  +  +  +  +  +
621fal28 > GACTATCgGTATAACCGACCAAAAAGAGAACCCGTATCCCTTACCCTAGCTGTAATGCTC 760 
621fbl28 > GACTATCGGTATAACCGACCAAAAAGAGAACCCGTATCCCTTACCCTAGCTGTAATGCTC 7 60 
62119 8 > GACTATCGGTATAACCGACCAAAAACAgAACCCGTATCCCTTACCCTAgCTGTAATGCTC 748
t3109 < GACTATCGGTATAACCGACCAAAAAGAGAACCCGTATCCCTTACCCTAGCTGTAATGCTC 403
1 3x2 87 < GACTATCGGTATAACaGACcAAAAAGAGAACCCGTATCCCTTACCCTAGCTGTAATGCTC 3 41
t3208 < GCTC 4
2804xhis < AACTATCGgTATAACCgACCAAAAAGAgAACCCTTATCCCTTACCCTAGCTgTAATgCTC 47 8 
t3148 < GACTATCGGTATAACCGACCAAAAAGAGAACCCGTATCCCTTACCCTAGCTGTAATGCTC 3 50
CONSENSUS> GACTATCGGTATAACCGACCAAAAAGAGAACCCGTATCCCTTACCCTAGCTGTAATGCTC 1440
+  +  +  +  +  +
621fal28 > 
621fbl28 > 
621198 
t3109 
t3x287 
t32 08 
2 804xhis < 
t3148 <
CONSENSUS>
gGATTAGGGACGGCCGTTggCGTANgAACAGGGACAgCTgCCCTgATCACAgGACCACAN 
GGATTAGGGACGGCCGTTgGCGTAGGAACAGGGACAGCTgCCCTGATCACAgGACCACAg 
GGATTAGGGACGGCCGTTGGCGTAgGAACAGGGACAGCTGCCCTGATCACAgGACCACAG 
GGATTAGGGACGGC. GTTGGCGTAGGAACAGGGACAGCTGCCCTGATCACAGGACCACAG 463 
GGATTAGGGACGCC. GTTGGCGTAGGAACAGGGACAGCTGCCCTGATCACAGGACCACAG 401 
GGATTAGGGACGGC . GTTGGCGTAGGAACAGGGACAGCTGCCCTGATCACAGGACCACAG 6 4 
GGATTAGggACGCCCgTTGgCgTAGgAACAGggACAgCTgCCCTgATCACAAGACCACAg 53 8 
GGATT . GGGACGGc . GTTGGCGTAGGAAC . GGGACAGCTGCCCTGATCACAGGACCACAG 410 
GGATTAGGGACGGCCGTTGGCGTAGGAACAGGGACAGCTGCCCTGATCACAGGACCACAG 15 00
820
820
808
 +  +  +  +  +  +
621fal28 > CANCTANAGAAAggACTTNGTgAgCTACATgCGNCCATgACAgAAtATCT 870
621fbl28 > CAGCTANAGAAAgGACTTgGTgAGCTACATgCGgCCATgACAgAAtATCTCCGAgCCTTA 880 
62119 8 > CAGCTAGAGAAAGGACTTGGTGAGCTACATGCgGNCATGACAgAAGATCTCCGAGCCTTA 868
t3109 < CAGCTAGAGAAAGGACTTGGTGAGCTACATGCGGCCATGACAGAAGATCTCCGAGCCTTA 523
13x287 < CaGCTAGAGAAAGGACTTGGTGAGCTACATGCGGCCATGACAGAAGATCTCCGAGCCTTA 461
t3208 < CAGCTAGAGAAAGGACTTGGTGAGCTACATGCGGCCATGACAGAAGATCTCCGAGCCTTA 12 4
2 804xhis < CAGCTAGAGAAAGGACTTGgTGAgCTACATGCGCCCATAACAGAAgATCTCCGAgCCTTA 5 98 
1314 8 < CAGCKRGAGAARGGACTtGGTGAGCTACAtGCGGCCATGACAGAAGATCTCCgAGCCTTA 47 0
CONSENSUS> CAGCTAGAGAAAGGACTTGGTGAGCTACATGCGGCCATGACAGAAGATCTCCGAGCCTTA 1560
+  +  +  +  +  +
233
621fbl28 > AANGA 885
621198 > AAgGAGTCTGTTAGCA.CCTAgA.GAcTCCCTGACTTCTTTgTCTGAAGTgGTTCTACAg 928
t3109 < AAGGAGTCTGTTAGCAACCTAGAAGAGTCCCTGACTTCTTTGTCTGAAGTGGTTCTACAG 583
t3x2 87 < AAGGAGTCTGTTAGCAACCTAGAAGAGTCCCTGACTTCTTTGTCTGAAGTGGTTCTACAG 521
t3208 < AAGGAGTCTGTTAGCAACCTAGAAGAGTCCCTGACTTCTTTGTCTGAAGTGGTTCTACAG 184
2804xhis < AAGGAgTCTgTTAgCAACCTAGAAGAGTCCCTGACTTCTTTGTCTGAAGTGgTTCTACAG 658
t3148 < AAGGAGTCTGTTAGCAACCTAGAAGAGTCCCTGACTTCTTTGTCtGAAGtGGTTCTACRG 530
CONSENSUS> AAGGAGTCTGTTAGCAACCTAGAAGAGTCCCTGACTTCTTTGTCTGAAGTGGTTCTACAG 1620
+  +  +  +  +  +
621198 > NAC C gGAGgGNANTAGATC TGCTGT c TC T A .gAgA.gGTGNGT.ATGTGCAGC.TTAAA. 988
t3109 < AACCGGAGGGGATTAGATCTGCTGTTTCTAAGAGAAGGTGGGTTATGTGCAGCCtTaAAa 643
t3x2 87 < AACCGGAGGGGATTAGATCTGCTGTTTCTAAGAGAAGGTGGGTTATGTGCAGCCTTAAAA 581
t3208 < AACCGGAGGGGATTAGATCTGCTGTTTCTAAGAGAAGGTGGGTTATGTGCAGCCTTAAAA 244
2804xhis < AAC CGGAGGGGATTAGATC TGC TGTTTC TAAGAG AAGGTGG t TTATGT gCAGC C TTAAAA 718
t3148 < AaCCGGAGGGGATKAGATCTGCTGTTTCTAgGAGAAGGTGGGTTATGTGCAGCCTTAAAR 590
CONSENSUS> AACCGGAGGGGATTAGATCTGCTGTTTCTAAGAGAAGGTGGGTTATGTGCAGCCTTAAAA 1680
+  +  +  +  +  +
621198 > GA .GNATGT.GCTTCTATGTAGATCACTCA 1018
t3109 < GAAGAATGTTGCTTCTATGTAGATCACTCAGGAGCCATCAGAGACTCCATGAACAAGCTT 703
t3x2 87 < GAAGAATGTTGCTTCTATGTAGATCACTCAGGAGCCATCAGAGACTCCATGAACAAGCTT 641
t3208 < GAAGAATGTTGCTTCTATGTAGATCACTCAGGAGCCATCAGAGACTCCATGAACAAGCTT 304
2804xhis < GAAGAATgTTGCTTCTATGTAgATCACTCAGGAGCCATCAGAGACTCCATGAACAAGCTT 778
t3148 < GAAGAATGTGGCTTCTATGTAGATCACTCRGGAGCCATCAGAGACTCCATGAACARGCTt 650
CONSENSUS> GAAGAATGTTGCTTCTATGTAGATCACTCAGGAGCCATCAGAGACTCCATGAACAAGCTT 1740
+  +  +  +  +  +
t3109 < AGAAAAAAGTTAGAGAGGCGTCGAAGGGAaAGAGAGGCTGACCAGGGGTGGTTTGAAGGA 763
t3x2 87 < AGAAAAAAGTTAGAGAGGCGTCGAAGGGAAAGAGAGGCTGACCAGGGGTGGTTTGAAGGA 701
t3208 < AGAAAAAAGTTAGAGAGGCGTCGAAGGGAAAGAGAGGCTGACCAGGGGTGGTTTGAAGGA 364
2804xhis < AGAAAAAAGTTAGAGAGgCgTCGAAGGGAAAGAGAGGCTGACCAGGGGTGGTTTGAAGGA 838
t3148 < RGAAaaaaGTKRgAGAGGCGTSgAgGGGARRgAGAgGCTGACCRGGGGTGGTGGGAgGGA 710
CONSENSUS> AGAAAAAAGTTAGAGAGGCGTCGAAGGGAAAGAGAGGCTGACCAGGGGTGGTTTGAAGGA 1800
+  +  +  +  +  +
t3109 < TGGTTCAACAGGTCtCCTTGGATGACCACCCYGCTTTCTGCTCTGACGGGGCCCCTAGTA 823
t3x2 87 < TGGTTCAACAGGTCTCCTTGGATGACCACCCTGCTTTCTGCTCTGACGGGGCCCCTAGTA 761
t3208 < TGGTTCAACAGGTCTCCTTGGATGACCACCCTGCTTTCTGCTCTGACGGGGCCCCTAGTA 424
2804xhis < TGGTTCAACAGGTCTCCTTGGATGACCACCCTGCTTTCTGCTCTGACGGg.CCCCTAgTA 898
t3148 < gGGtTCAACaGGTCKCCtgGGATGACCACCcWGCTTTCtGVTCgGASGGGGCCCCtAGTA 770
CONSENSUS> TGGTTCAACAGGTCTCCTTGGATGACCACCCTGCTTTCTGCTCTGACGGGGCCCCTAGTA 1860
+  +  +  +  +  +
t3109 < GTCCTGCTCCTGTYACTtACAGTTGGGCCTtGCtTAATTAATAGGTTTGTTGCCTTTGTT 883
t3x287 < GTCCTGCTCCTGTTACTTACAGTTGGGCCTTGCTTAATTAATAGGTTTGTTGCCTTTGTT 821
t3208 < GTCCTGCtCCTGTWACTWACAGTTGGGCCTWGATTAAaTAATAGGTtTGTTGCCTTTGTT 484
2804xhis < gTCCTgCTCCTGTTACTTACAgTTGg.CCTTNCTTAATTAATAGATTTNTT.CCTTTNTT 958
t3148 < GTCCGGCRCCTGTRACTRACAGTGGGGCCgAGCTDAATTAAKRGgTgGGTGGCCKgGGTg 830
CONSENSUS> GTCCTGCTCCTGTTACTTACAGTTGGGCCTTGCTTAATTAATAGGTTTGTTGCCTTTGTT 1920
 +  +
t3109 < AGAGAACGAGTGAGTGCAGTCCAGATCATGGTACTTAGGCAAC 926
t3x287 < AGAGAACGAGTGAGTGCAGTCCAGATCATGGTACTTAGGCAACAGTACCAAG 873
t3208 < AGAGAACGAGTGAGWGCAGTCCAGATCATGGTACTTAGGCAACAGTACCAAGGCCATCTG 544
2804xhis < AgAGAACGAGTGAGTGCANTCCANATCATN. TACTTANCaGaCaG . ASCAAN. CCT . CT . 1018
t3148 < AGAGAAgGAGTGAGAGCAGaCCAGATCATGGtACTTaGGCAACAGTACCAAG.CCA.NTG 890
1869109 > AGGCAACAGTACCAAGGCCTTCTG 24
1869208 > AGTGAATASMGT.CAGATCATGGTACTTAGGCAACAGTACCAAGGCCTTCTG 52
CONSENSUS> AGAGAACGAGTGAGTGCAGTCCAGATCATGGTACTTAGGCAACAGTACCAAGGCCTTCTG 1980
234
t3208 < AGCc 548
2804xhis < AgCC 1022
t3148 < AGaCCAA 897
1869109 > AGCCAAGGAGAAAcTGAcCTCTAGGCGGCCGC 56
1869208 > AgCCAAGGMGAaAcTGAcCTCTAGGCGGCCGC 84
CONSENSUS> AGC CAAGGAGAAAC TGAC CTC TAGGCGGC CGC 2 012
 +  . .   +  . . .  +  + .   +  +
235
